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Abstract  
 
Emergence of new bioimaging technologies requires the development of the most 
appropriate contrast agents for each application. In this thesis, we present the 
development of gold nanorods (GNRs) and chromium doped zinc gallium oxide 
(ZGO:Cr) for labelling mesenchymal stem cells (MSCs), which enabled multimodal 
in vivo monitoring of cells. GNRs are excellent contrast agents for Multispectral 
Optoacoustic Tomography (MSOT) due to the high absorbance of their longitudinal 
surface plasmon resonance (LSPR) in the Near Infrared (NIR) region of the 
electromagnetic spectrum. Persistent luminescent nanoparticles such as ZGO:Cr have 
arisen as promising optical in vivo probes due to their long emission lifetime, in the 
order of minutes.  
First, NPs were synthesised and their surface was modified to improve colloidal 
stability, biocompatibility and cell uptake. GNRs were prepared by the seed-
mediated growth method, and modified via ligand exchange using a small thiolated 
PEG with a carboxylic acid terminal group. For ZGO:Cr a hydrothermal approach 
was followed and surface was modified with DMSA. Interactions with cells and how 
these interactions affect the optical properties of the nanoprobes have been also 
studied here.  
To follow a multimodal imaging approach, MSC cells were co-incubated with PEG-
COOH-GNRs and DMSA-ZGO. Imaging by means of MSOT and optical imaging 
was conducted after subcutaneous injection, and also after intracardiac 
administration of labelled cells. The combination of different imaging modalities is 
frequently required to overcome limitations of a particular technique. In our case, 
MSOT offered great resolution deep into the body, enabling sub-organ localisation of 
labelled cells, which is not possible with pure optical-based techniques. However, 
organs such as lungs and stomach cannot be visualised and endogenous absorbers 
with similar optical spectrum than GNRs could lead to false positives. On the other 
side, persistent luminescence did not present those limitations, however its spatial 
resolution is much worse than MSOT. Therefore, the two imaging modalities 
complemented each other to have a more accurate view of the process.  
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Chapter 1 
Introduction 
1.1 Bioimaging: General concepts 
Imaging techniques are indispensable tools in both clinical and preclinical studies. 
They have an important role in the development of different fields of study such as 
drug delivery, cancer diagnosis, guided surgery and stem cells therapies among 
others.
1
  They can be divided in two main groups: anatomical imaging used in the 
clinics on a routine basis and molecular or functional imaging.
2
 The second group is 
attracting a lot of attention recently because it provides not only  anatomical 
information, but it also can be used to evaluate physiological processes such as 
clearance of a specific drug or follow relevant physiological or cellular processes in 
vivo.
3
  
Different imaging methodologies are available, and each one presents different 
advantages and disadvantages. For example, purely optical-based imaging techniques 
are based on the detection of photons by a charge-coupled device (CCD) and are 
ideal for molecular imaging due to their high sensitivity and the possibility to work 
with multiple wavelengths.
4
 However they are limited to very superficial regions due 
to their lack of resolution at depths beyond a few mm.
5
  On the other hand, other 
methods such as MRI are powerful enough for imaging whole human body, although 
they are not as versatile as optical imaging in terms of molecular imaging, and they 
are also not as sensitive as other methods.
6
 Table 1.1 summarizes the main 
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characteristics of the most relevant imaging techniques. The selection of the 
appropriate imaging method and contrast depends on the type of information desired, 
the target and the depth of imaging required or thickness of the subject.  
Optical-based in vivo imaging techniques have a remarkable sensitivity, being able to 
detect probes in a concentration picomolar range.
7
 Techniques based on light in the 
visible region of the spectra are usually limited to in vitro studies due to tissue 
absorption. Hence, the most used optical-based techniques for in vivo imaging are 
based on the use of NIR light (See section 1.2.1).
8
 Due to their high sensitivity, NIR 
luminescence imaging is a valuable tool in molecular imaging. 
8
 In addition, its low 
cost and user-friendly handling make it a popular technique in many different fields. 
However, one of the main limitations of these methods is the scattering of photons by 
biological tissues, which results in a poor anatomical resolution, which is down to 1-
2 mm in superficial regions since the penetration depth is less than 1 cm.
9
 The 
principles and some examples of optical-based imaging technologies are fully 
discussed in section 1.2 of the introduction.  
Other bioimaging techniques such as magnetic resonance imaging (MRI) or X-ray-
based techniques do not have the penetration depth limitation seen for optical-based 
techniques.
6
 MRI is a non-ionizing imaging technique broadly used in clinical 
diagnosis. The endogenous contrast is based on the measurement of relaxation times 
of protons in molecules (such as water, lipids, proteins, etc.) after applying a strong 
magnetic field followed by radio frequency pulse at a resonant frequency.
10
  One of 
its most useful characteristic is the possibility to image soft tissues.
11
  Other assets of 
this technique are high spatial resolution (down to 50 µm) and no limits in 
penetration depth.
6
 However, high cost and the need of highly specialised staff might 
limit its use in research. In addition, due to its relatively low sensitivity (which is in 
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the range of nmols to mmols) the use of exogenous contrasts is usually needed.
12
 
These contrast agents are classified according to the type of relaxation: positive or T1 
contrasts agents such as Gadolinium(Gd)-based composites
13
 and negative or T2 
contrast agents such as iron oxide NPs
14
.  
X-Ray computed tomography (CT), known as well as CAT scan (computed axial 
tomography), is also a well-established imaging technique in the clinical diagnostic 
toolbox due to its high resolution and penetration depth.
6
 It is based on the changes 
in absorption of X-Rays by different tissues; hence it is an ionizing method. 
However, its safety profile has significantly improved during the last decades. This 
was achieved thanks to the replacement of carcinogenic thorium NPs as X-Ray 
contrasts by safer hydrophilic iodinated molecules.
15
 Since early 2000, CT-Scan has 
been coupled to positron emission tomography (PET), a nuclear medicine functional 
imaging system approved by the FDA.
16
 PET is based on the detection of gamma 
rays emitted by a radioisotope without the need of any external excitation source. It 
is the most sensitive imaging method available, allowing the detection of a single 
abnormal cell.
17
In addition, it does not suffer from penetration depth limitations. 
Single photon emission computed tomography (SPECT), is also based in gamma ray 
detection. Although the sensitivity is one order of magnitude lower than PET 
imaging, it allows multiplexing, i.e. imaging different molecular targets 
simultaneously.
8
 However, the poor spatial resolution (1-2 mm) is the main inherent 
drawback of the methods along with the high cost due to the production and storage 
of radioactive materials.
18
 Ultrasound (US) is another broadly used technique in 
clinical diagnosis due to its innocuous and inexpensive nature. It is based on the 
detection of sound waves above 20 KHz (2-3 MHz in paediatrics and 5-12 MHz in 
adults).
6
 Finally, photoacoustic imaging (PAI) is a novel technique that combines the 
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high sensitivity of optical methods with the spatial resolution of ultrasounds.
19
 This 
method will be further discussed in section 1.2.3.    
 
Technique Sensitivity Resolution Penetration 
depth 
Cost 
PAI pmol 50 µm < 5 cm Low 
X-Ray/CT scan µmol 50 µm No limit High 
US nmol 50 µm Several cm Low 
MRI nmol 50 µm No limit High 
PET/SPECT fmol 1-2 mm No limit High 
Optical pmol 1-2 mm < 1 cm Low 
 
Table 1.1: Table of features of different imaging techniques. Adapted from  
reference 6.
6
 
1.2 Optical-based Bioimaging 
1.2.1 Near Infrared (NIR) Window 
In the body tissue, there are endogenous molecules that absorb in the UV-vis-NIR 
region of the electromagnetic spectrum. These molecules are mainly melanin, 
oxygenated and deoxygenated haemoglobin and water.
20
 The absorbance and 
scattering of light by these molecules are minimal in the near infrared (NIR) region. 
This is the so called therapeutic or NIR window (figure 1.1 A).
21
 For this reason, 
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probes with a sharp or intense NIR absorption or emission such as GNRs (Figure 1.1 
B) are often preferred as contrast agents for optical in vivo imaging.
5
  
 
Figure 1.1: A) NIR window. Absorbance of water, oxygenated deoxygenated 
haemoglobin. From reference 21.
21
B) GNRs UV-VIS spectrum. NIR window range 
is shown in pink. 
 
1.2.2 General Bases for Luminescence-based Optical Imaging 
Luminescence is a process where a substance emits light other than as result of heat. 
It has been defined as “a spontaneous emission of radiation from an electronically 
excited species (or from a vibrationally excited species) not in thermal equilibrium 
with its environment”.22 Therefore, luminescence is a type of cold body radiation and 
thus it is distinguished from incandescence. Depending on the source of excitation, 
luminescence can be divided in different categories such as chemiluminescence 
(excitation source: chemical reaction), crystalloluminescence (crystallisation), 
mechanoluminescence (mechanical action on a solid), radioluminescence (ionizing 
radiation), photoluminescence (absorption of photons) or thermoluminescence 
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(enhancement of emission by heat after excitation by other means, usually light) 
among others.  
Fluorescence and phosphorescence are different categories of photoluminescence. 
For a long time the distinction between both was made based on the emission 
lifetimes which is usually in the range of nanoseconds for fluorescence and  
milliseconds to hours in the case of phosphorescence. However, this criterion is no 
longer accurate.
23
 There is a difference in the electronic configuration of the excited 
state. Fluorescence is a result of the relaxation of an electron from the excited singlet 
state (S1) to the ground state (S0). On the other hand, phosphorescence is a result of 
the relaxation from an intermediate state, the triplet excited state (T1). This is 
described in a simplified Perrin-Jablonski diagram in figure 1.2.    
 
Figure 1.2: Schematic representation of Perrin-Jablonski diagram showing 
fluorescence and phosphorescence. From reference 24.
24
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Persistent luminescence (PL) is a phenomenon where inorganic phosphors, called 
long persistent phosphors (LPP), emit for long emission times from minutes to hours, 
similarly to phosphorescence.
25
 Unlike the latter, PL does not rely in the triplet-to-
singlet transitions. PL involves four steps, excitation, storage, release and 
recombination of charged carriers.
25
 LPP can store the optical energy and release it 
progressively after excitation by UV, vis or NIR light.
26
 This is another type of 
photoluminescence called photostimulated luminescence (PSL). For this reason, LPP 
are also called optical batteries. The charge carriers are captured in traps, which are 
electronic levels below the conduction band.
27
 These traps are the result of defects 
that can be either intrinsic defects (defects in the crystal lattice) or extrinsic defects 
(impurities or dopants).
25
 In addition, PL is a type of thermoluminescence that occurs 
at room temperature. Therefore, the driving force for de-trapping the electrons is 
heat. The state of the art of long persistent nanoparticles describing mechanism 
proposed for the chromium-doped zinc gallium oxide (ZGO:Cr) NPs in more 
detailed is described in section 1.3.1. 
1.2.3 Photoacoustic Imaging (PAI): A novel hybrid method 
Macroscopic optical imaging methods have arisen as an answer to the low 
penetration depth of traditional microscopy techniques. Although the latter 
techniques can achieve subcellular spatial resolution, they are limited to cell imaging 
in tissues and do not allow cell tracking studies in the entire organism.
5
 Hybrid 
methods like PAI, also called optoacoustic imaging, were designed to overcome 
some of the limitations of purely optical-based techniques. The advantages of this 
technique are good spatial and temporal resolution as well as a high sensitivity. The 
high temporal resolution (real time acquisition)
28
 enables functional analysis of 
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pharmacokinetics and pharmacodynamics.
5
 For instance, the clearance of 
indocyanine Green (ICG) was successfully studied in vivo.
29
 The penetration depth is 
considerably improved compared to traditional optical imaging; it can achieve up to 
5 cm with a resolution of < 1 mm (up to 50 µm in some systems).
30
 This is thanks to 
the wave component of the technique since the scattering coefficient in biological 
tissue of USs is 2 or 3 magnitudes lower than photons.
31
 This allows the use of this 
technique in the imaging of small animals in preclinical studies
32,33
 or superficial 
organs imaging in the clinic such as breast lesions.
34
    
PAI is based on the photoacoustic effect first described by Alexander Graham Bell in 
1881. It describes the ability of a material to produce a sound wave after absorption 
of light: “Sonoreusness, under the influence of intermittent light, is a property 
common to all matter”. 35 Although this effect, inherent to different materials, has 
been known for over a century, its use in bioimaging has only been proposed in the 
last decades. It relies on the ability of a chromophore to absorb light and generate a 
subsequent sound wave that can be recorded and processed into images (figure 1.3). 
As a consequence of absorption of electromagnetic energy, a thermoelastic 
expansion is generated by local heat produced by electron relaxation. This ultimately 
generates a pressure wave that can be a recorded as an ultrasound signal.
36
 
Multispectral Optoacustic Tomography (MSOT) is a variant of PAI that uses a multi-
wavelength approach. A monochromatic pulsed laser at an excitation wavelength of 
520 nm and a 120 mJ pulse energy is used. An Optical Parametric Oscillator (OPO) 
tunes the wavelength in single nanometre steps.
29
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Figure 1.3: Diagram showing the different elements of MSOT technology. From 
Ithera website.   
1.3 Nanoparticles as imaging agents  
Nanoparticles have proved to be valuable tools in bioimaging due to the 
improvement in signal intensity and stability compared with traditional molecular 
contrasts. Quantum dots (QDs) are a good example of this. Their higher quantum 
yield, photo-stability broad excitation spectra and narrow emission spectra compared 
to organic dyes offer a good alternative for optical imaging.
37
 In addition, NPs have 
potential for higher avidity (multiple ligands per NP) and improved targeting efficacy 
through surface modification (longer circulation times, multimeric binding…). NPs 
also offer the possibilities for multiplexing (i.e. imaging different targets 
simultaneously) due to the improved and defined optical properties. In the specific 
case of cell tracking, the use of reporter genes involves the genetic modification of 
cells, which could be a drawback, especially at the clinical stage. An alternative to 
this approach is the use of gold nanoparticles (GNP) as exogenous contrast agents. 
However, the main drawback of using NPs for cell tracking is the dilution of the 
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signal after sequential cell divisions. Therefore, the use of NPs is restricted to 
relatively short-term cell tracking.  
Nonetheless, several types of NPs have been adapted to imaging in humans. The 
Food and Drug Administration (FDA) has approved NP-based contrast agents for 
different imaging methods.
38
 Colloids have been used in radionuclide imaging for 
years as carriers of radiolabelled isotopes. The most common radioisotope used in 
SPECT is 
99m
Tc
39
. Sulphur colloid is the most widely used carrier for SPECT in 
USA, 
99m
Tc-sulfur is indicated for breast cancer and melanoma imaging.
40,41
 In 
Europe the most popular carrier is colloidal albumin that can be used for bone 
marrow imaging.
42
 Iron oxide nanoparticles coated with different polymers such as 
dextran have also been approved by the FDA for human use (ferumoxtran, 
ferucarbotran and ferumoxytol). These NPs are the most important T2 contrast agents 
for MRI imaging. According to their size, they can be classified as magnetic iron 
oxide NPs (MIONs) when they are 50 µm, superparamagnetic iron oxide NPs 
(SPIONs) when size is bigger than 100 nm and ultra-small paramagnetic iron oxide 
NPs (USPIONs) when size is lower than 50 nm. SPIONs are indicated for the clinical 
use in the diagnosis of liver diseases.
43
 USPIONs, on other hand, are used for lymph-
node imaging, angiography, and blood-pool imaging.
44
 Although SPIONs have a 
large potential for a host of clinical applications (such as stem cell tracking), some of 
the preparations previously used in humans have been held up due to worries related 
to their immunogenicity. Only ferumoxytol (Polyglucose sorbitol 
carboxymethylether-coated iron oxide) is currently being used due to its small size 
and longer circulation times. 
45
    
 In addition, many nanoparticles that promise potential to improve current contrast 
used in the clinic are being subject to study. Composites based on iodinated organic 
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molecules loaded into nano-structures have received a lot of attention as they can 
enhance the local contrast due to confinement of commonly used iodinated 
molecules and improvement of circulation times. Different strategies such as 
liposomes
46
, lipoproteins
47
, nano-milled insoluble compounds
48
, and polymeric 
NPs
49
 have been already successfully tested in animals. In addition, GNPs have also 
been proposed as X-Ray contrasts
50,51
. Interestingly, GNPs were shown to be 
comparable or even better than conventional X-Ray contrasts for mammography and 
trans-torso imaging
52
.         
However, there are some problems associated with the use of NPs as imaging probes. 
Minimizing batch to batch difference and improving characterisation methods is a 
requirement before NPs can become a reality in the clinic. It is also important to fully 
understand NPs behaviour in biological environments (i.e. NP-biomolecules 
interaction) in order to design more effective NP in a rational manner. NPs intended 
for the use as imaging probes need to fulfill a list of requirements. First, colloidal 
stability should be maintained in a variety of physiological environments (resistant to 
differences in pH, ionic strength or temperature). A good contrast quality needs to be 
provided. This is a high quantum yield (fluorescent probes), high signal-noise ratio 
or high extinction coefficient for PAI probes. In addition, for those NPs that will be 
injected systemically, non-specific binding needs to be minimized to reduce 
entrapment by the reticuloendothelial system (RES). This leads to longer retention in 
the blood and hence increasing imaging times. Similarly, if NPs are intended for cell 
tracking, cell uptake should be maximized to mitigate the signal dilution effect after 
cell division.   
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1.3.1 Persistent luminescent NPs (PLNP) 
Advances in the synthetic routes of long persistent phosphors (LPP) have enabled the 
synthesis of these kinds of materials in the nanometre range. The most relevant 
synthetic approaches are described in chapter 3. Persistent luminescent nanoparticles 
(PLNP) are divided in two different components; the activators and the hosts. 
Activators or emitting centres are usually transition metals (such as Mn
2+
 or Cr
3+
)
53,54
 
or rare earth ions (such as Eu
2+
, Ce
3+
, Eu
3+
, Pr
3+
 or Tm
3+
)
55,56,57,58
 into the host. 
Activators are responsible for the emission wavelength while the host provides the 
defects needed for the traps. Therefore, luminescence duration and intensity are 
attributable to them. Cr
3+
 is an excellent dopant for in vivo imaging due to its 
3
d3 
electronic configuration that allows results in a narrow band emission at 700 nm 
(figure 1.5 A).
25
  
Ca0.2Zn0.9Mg0.9Si2O6 NPs, synthesized by Chermont et al were the first LPNPs used 
for in vivo imaging.
59
  NPs had to be pre-activated by UV light before injection, 
limiting the imaging time
59
 (Figure 1.4). In 2013, Liu and co-workers published a 
new LPP material; LiGa5O8:Cr discs which were synthesized by solid state chemistry 
and could glow for over 1000 hours after UV excitation. They described a new 
phenomenon. This material showed a renewable luminescence after being excited 
with a lower energy using a LED lamp. They named this optical property photo-
stimulated persistent luminescence (PSPL). The discs could be recharged for more 
than 20 times, prolonging, the life of the phosphor to over 2000 hours.
60
 They also 
synthesized different sizes of rechargeable LiGa5O8:Cr NPs using a sol-gel approach 
and were able to use them as in vivo contrasts for 10 days.
61
 In 2014, Maldiney et al 
also described this behaviour for ZnGa2O4:Cr. This material possesses a main 
advantage over LiGa5O8:Cr NPs. They do not need to be pre-charged by UV light.
62
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Maldiney et al also proposed a mechanism for this unexpected optical behaviour 
(Figure 1.5). 
 
 
Figure 1.4: A) Activation and in vivo imaging of PLNPs.  B) Image of 
subcutaneously injected PLNPs. C) Image of PLNPs after intramuscular injection. 
Intensity is expressed in photons per s·cm
2
·steradians (sr). From reference 59.
59
 
 
Most of the ZGO nano-crystal has a spinel structure except from around the 3%, 
which exhibit an inverse character.
63
 In an inverse spinel structure, Gallium atoms 
occupy Zn position and vice versa, this is referred as antisite defects. A deeper 
discussion on crystal structure of ZGO can be found in chapter 3 (subsection 3.4.1). 
There are different types of Cr
3+
 ions in the ZGO:Cr crystal. The most relevant, from 
a mechanistic point of view are, CrR, which are Cr
3+
 ions free of neighbouring 
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defects, and CrN2 which are ions close to an antisite positive defect (Ga
●
Zn), i.e. when 
a gallium ion is occupying a Zn position. Bessière et al. proposed that the LPP 
triggered by visible light is mainly ascribed to CrN2.
64
 This is based on the 
observation that after exciting the crystal at  ̴ 3.1 eV, electron-hole pair formation can 
be seen all over the material.
64
 On the contrary, when the excitation is below  ̴ 3.1 
eV, i.e. orange-red light, electron hole migration is restricted to the vicinities of 
CrN2.
65
 Figure 1.5 B shows the energy level diagram of CrN2 and the mechanism of 
LPP after visible light excitation proposed by Maldeney et al.
59
 This mechanism is 
based on the observations made by Bessière et al and the change of thermally 
stimulated luminescence (TSL) spectrum when excitation is higher or lower than 
3.1eV.
64
 It shows that the excited state of the activation centre (CrN2) is located in the 
band gap, 0.6-1 eV below the conduction band.  The LLP process proposed here is 
divided in four steps; first, Cr
3+
 ion
 
is promoted to the excited state after light 
irradiation, when excitation source is visible light, it promotes to the 
4
T2 state leading 
to a charge redistribution of positive and negative defects, Ga●Zn and  Zn
'
Ga 
respectively (step 2), the local charge created by the defects is the driving force to 
“hold” the electron-hole pair trap by interaction with the charged defects and forming 
a relatively stable and neutral state; Ga
x
Zn and Zn
x
Ga. The third step involves the 
detrapping of the electron-hole, it is triggered by thermal activation. LPP is one type 
of TSL which energy of trap depth is low, from 0.5 to 1 eV, allowing a continuous 
and prolonged emission at room temperature. Finally, the excited Cr
3+
N2 formed by 
thermal activation leads to recombination of the charged carriers emission from the 
2
E  to 
4
A2 energy levels (step 4).
62
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Figure 1.5: A) Optical properties of ZGO:Cr. PL excitation and emission spectra in 
black and TSL excitation and emission spectra in green. B) Proposed mechanism for 
the renewable persistent luminescence of ZGO:Cr. From reference 62.
62
 
 
1.3.2 Plasmonic Nanoparticles: Surface Plasmon Resonance (SPR) 
Silver and gold NPs have broadly been used for a wide range of biomedical 
applications such as anticancer research
66,67
, molecular imaging
68,69
 and bio-
sensing
70,71
 thanks to their optical properties. Moreover, the biocompatibility of 
GNPs has favoured its extensive use for biomedical aplications.
72
  
In gold and silver nanoparticles, there is a characteristic extinction band in the 
vis/NIR region of the electromagnetic spectra. The origin of this is a collective 
oscillation of the free electrons in the conduction band of the metal triggered by 
incident light of the same frequency (Figure 1.6). For small nanoparticles the main 
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component of the extinction band is due to absorbance, whilst scattering component 
is low. Interestingly, the frequency of resonance strongly depends on the size and 
shape of the nanoparticle, which enable a fine tuning of their optical properties.
73,74,75 
 
 
Figure 1.6: Surface Plasmon Resonance: Schematic representation of the interaction 
of metal NPs with the electric field of light76.
76
 
 
1.3.2.1 Gold Nanorods as PAI Contrasts 
Gold nanorods (GNRs) are a good example of tuning the position of the SPR band 
just mentioned before. Their singular optical properties stem from the anisotropy of 
these particles. Thus, two different oscillation of electrons with different energies are 
possible here, resulting in two extinction bands: the transverse surface plasmon 
resonance (TSPR) is due to the oscillation along the transverse direction, resulting in 
a weak absorption band around 520 nm; and the longitudinal surface plasmon 
resonance (LSPR) is due to oscillations along the longitudinal direction, resulting in 
a strong absorption band in the vis –NIR region (figure 1.7).77 The position of this 
band strongly depends on the aspect ratio (length divided by width) and therefore is 
relatively easy to tune the position of the band to peak in a specific region of the vis-
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NIR spectrum. Since light absorption triggers the photoacoustic response, contrast 
agents with a high molar extinction coefficient facilitate their distinction from 
endogenous chromophores. In this regard, GNRs are an attractive choice since the 
extinction coefficients are in the range of 4 – 5.5 x 109 M-1cm-1 for longitudinal 
surface plasmon between 728 and 845 nm
78
, i.e. orders of magnitude higher than 
endogenous absorbers or other types of contrast agents (e.g. AlexaFluor750 and 
iRFP720 coefficients are 2.5 x 10
5
 and 9.6 x 10
4
 M
-1
cm
-1
, respectively).
79
 
 Figure 1.7: Optical properties of GNRs. A) Schematic representation of transverse 
and longitudinal Surface Plasmon Resonance of GNRs. From reference 77.
77
 
 
1.4 Motivation: Stem Cell Tracking 
1.4.1 Stem Cell tracking: Why? 
Several regenerative medicine treatments (RMT) have entered in clinical trials for a 
broad range of indication: from acute myocardial infarction to type 1 diabetes 
mellitus (DM).
80
 However, possible risks of using stem cells in medicine have been 
predicted 
80
. The main risks include inflammation, systemic toxicity, 
immunogenicity, fibrosis, mal-differentiation and carcinogenesis. The main concerns 
are their tumorigenic potential and immunogenicity. The fear of a possible 
400 600 800 1000
0.0
0.5
1.0
A
 (
a
.u
)
wavelength
Transverse 
Plasmon
Longitudinal 
Plasmon
A B
Chapter 1: Introduction 
18 
 
tumorigenic outcome stems from two elements: the renewal power of stem cells and 
their ability of differentiating to other type of cells. This might lead to the formation 
of teratomas or, if the cells are genetically altered teratocarcinomas. A 
teratocarcinoma is a teratoma with persisting undifferentiated stem cells
81
. Just like 
any foreign substance, stem cells administrated in an organism can trigger an 
immune reaction that can lead to immunotoxicity. These risks might pose a problem 
in the translation of RMTs into humans. Therefore, the success of this line of 
research will depend on the anticipation and resolution of its side effects.  
Before any novel treatment or drug can become a reality, we need to assess the safety 
profile of the candidate. For this, it is necessary to assess the pharmacodynamics 
(what the drug does to the body) and pharmacokinetics (what the body does to the 
drug) of a determined molecule. The challenge here is the cell nature of RMT. 
Therefore, there is a need to develop novel quantitative real time imaging methods 
and appropriate probes for long-term tracking of stem cells in vivo.  
1.4.2 Stem Cell tracking: How? 
There are two main approaches to label cells: direct and indirect methods. Direct 
methods are based in the introduction of a contrast or labelling agent before in vivo 
transplantation. Indirect labelling involves the genetic alteration of cells and insertion 
of a reporter gene. Main drawback of direct methods is the dilution of the contrast 
agent over cell division.
82
 On the other hand, the use of reporter genes could be held 
back in the clinic due to the inherent DNA manipulation. Frangioni and Hajjar 
described the characteristics of an ideal contrast agent and imaging method system.
83
 
First and most importantly, biocompatibility of the method need to be guaranteed. In 
addition, minimal transfer of contrasts to other neighbouring cells and avoiding 
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dilution of contrast agents after cell division would help to avoid false positives and 
improve the long-term tracking.  Limits to detection of current methods should be 
improved to achieve single cell detection. When contrast agents and imaging 
methods are intended for clinical trials, genetic modification of cells (i.e. indirect 
methods) should be avoided. In addition non-invasive methods that do not require 
additional injections are preferred for humans.
83
   
Contrast agents usually used in direct labelling are organic dyes and NPs. 1,1'-
Dioctadecyl-3,3,3',3'-tetramethylindotricarbocyanine iodide (DiR) is a fluorescent 
organic dye, provides a safety, stable and strong labelling. Embryonic stem cells 
were labelled with a DiR and successfully tracked in vivo.
84
 QDs are arising as a 
promising alternative to organic dyes thanks to their photo-stability. Unlike 
traditional organic fluorochromes, QDs do not suffer from photo bleaching. The 
potential of QDs as stem cells trackers was shown by Lei et al who could track QD-
labelled MSCs in vivo.
85
 Other NPs such as GNRs have been shown not to interfere 
with MSC differentiation in vivo and a powerful potential tool in cell tracking.
86
 
Similarly, SPIONs have also been used track cells in vivo in small animals.
87,88
 More 
interestingly, SPIONs have also been used in  clinical trials.
89,90
 More specifically, 
SPIONs labelled MSCs were injected in multiple sclerosis and amyotrophic lateral 
sclerosis patients successfully tracking stem cells. 
89
 One of the limitations of direct 
methods is the impossibility to track cell viability. This problem can be addressed by 
combining the use of direct contrasts with indirect methods.
91
  
Indirect methods consist in the genetically manipulation of the studied cells to 
introduce a reporter gene. These reporter genes can then be translated into a receptor, 
enzyme or luminescent protein.
92
 The reporter genes are conserved in the subsequent 
generation after cell division.
93
 Thus, the problem of contrast dilution posed by direct 
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methods is overcome. In addition, the presence of the reporter gene is obviously 
inherent to cell survival, allowing studying cell viability. Green fluorescent protein 
(GFP) and other fluorescent proteins derived from GFP has been extensively used for 
years.
94,95
 However, as mentioned before problems with tissue auto fluorescence can 
reduce the signal-to-noise ratio of fluorescent approaches.
92
 Bioluminescence is a 
type of chemiluminescence where the excitation is achieved through a biochemical 
reaction. This way, in bioluminescence imaging (BLI), an external source of 
excitation is avoided, improving signal-noise ratio.
96
 BLI relies in the emission of 
photons during the oxidation of a substrate, D-luciferine, by a luciferase enzyme 
(extracted from firefly or renilla). Luciferase has extensively been used for tracking 
different stem cells such as embryonic
97
, MSCs
98
, and neural stem cells
99
.  Reporter 
genes are essential tools for in vitro and preclinical imaging to understand cellular 
and physiological processes before any therapy can be applied, but their potential use 
as indirect labelling agents in the clinics is unrealistic. Therefore new strategies that 
enable cell tracking with exogenous biocompatible labels will be required to monitor 
those processes. 
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CHAPTER 2 
Synthesis and Surface Modification of 
Gold Nanorods 
2.1 Introduction 
Due to their biocompatibility, versatility of surface functionalization and especially 
their interesting optical properties gold nanoparticles (GNPs) have arisen as 
promising tools for biotechnology and biomedicine.
1
 Their physico-chemical 
properties, and more specifically their optical properties, greatly depend on size and 
shape.
2,3
 For this reason, great efforts have been made to control size and anisotropic 
growth of nanoparticles. Consequently, many preparative routes have been described 
for a variety of shapes such as spheres, stars, triangles, nanoboxes and nanorods.
4
  
This has ultimately opened the way for a host of new applications such as 
bioimaging or phothermal therapy.
5,6
  In the case of GNRs, there is a direct relation 
between optical properties and their aspect ratio (AR).
7
 The AR can be tuned by 
varying the conditions of the synthesis, and it is possible to control the position of the 
longitudinal plasmon band (LSPR) across a wide range, well into the NIR.
8
 In this 
manner, LSPR can be adjusted to overlap perfectly with the optical window
9
 of many 
biological samples (See chapter 1).   
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Cetyltrimethylammonium bromide (CTAB) is a cationic surfactant normally used in 
the preparation of GNRs due to its ability to behave as shape and size controller. 
However, CTAB is cytotoxic at concentrations much lower than the used in the 
synthesis of GNRs, (IC50<1µM).
10
 This cytotoxicity poses a problem in the use of 
GNRs for biomedical applications. Therefore, their surface needs to be modified 
before GNRs can be used as candidates for biomedical research. Different chemical 
strategies can be used for the modification of GNRs which can lead to improvement 
of biocompatibility and colloidal stability. For instance, polymer coating has been 
broadly used for this purposes.
11
 A good example of this is the multilayer formation 
of the electrostatic polymers PAA and PAH developed by Murphy, Wyatt and co-
workers.
12
 Silica coating is another widely used approach in the surface modification 
of NPs. Effective protocols to control the thickness of the silica shell on the surface 
of GNRs can be found in the literature.
13
 In addition, ligand exchange is often based 
on the replacement of CTAB by other molecules that have a greater affinity for the 
gold surface. While a wide range of chemical groups have been used for ligand 
exchange including phosphates, amines or carboxylic acids, thiols remain by far the 
most broadly exploited functionality. This is due to their high binding energy leading 
to a remarkable stable chemical bond.
14,15
 Therefore more stable systems are 
achieved, even under testing conditions such as physiological medium. This high 
affinity is the base for the fabrication of robust self-assembled monolayers (SAMs) 
of different organic molecules.
16
   Following this approach, molecules such as 11-
mercaptoundecanoic acid (MUA)
17
 or  polyethylene glycol (PEG)
18
 have been bound 
to GNRs. Relevant biomolecules such as DNA
19
, lipids
20
, peptides
21
 and proteins
22
 
have also been conjugated to GNRs. The construction of hybrids from GNPs and 
biomolecules can lead to new tools for diagnostics and drug delivery.
23
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2.2 Methods  
Reagents 
The following chemicals were purchased from Sigma-Aldrich and used as received. 
HAuCl4 ·3H2O (>99.0%), NaBH4 (>99.99%), AgNO3(99.0%), 
hexadecyltrimethylammonium bromide (CTAB, >99%), O-[2-(3-
mercaptopropionylamino)ethyl]-O′-methylpolyethylene glycol (mPEG-SH, MW = 
5000 Da) N-Hydroxysuccinimide (NHS, 98%), N-(3-Dimethylaminopropyl)-N′-
ethylcarbodiimide hydrochloride (EDAC, >98%)  and Bovine serum albumin (BSA, 
). Monocarboxy(1-mercaptoundec-11- yl)hexaethylene glycol (PEG-COOH, MW= 
526.73 Da) was obtained from Prochimia and TAT peptide (97%) from Life Tein. 
GNRs Preparation 
The preparation of GNRs was adapted from El-Sayed et al 
24
 and is based on a 
seeding growth approach. Briefly, seeds were made by adding 5 mL of an aqueous 
0.5 mM HAuCl4 solution to 5 mL of a 0.1 M CTAB solution under gentle agitation 
(make sure the CTAB remains fully dissolved at all times, if needed by careful 
heating). Then, 500 µL of an ice-cold 0.01 M NaBH4 solution was added under 
vigorous stirring. The mixture was then stirred gently for 2 hours. To prepare the 
growth solutions, different volumes of AgNO3 (4 mM) ranging from 0.1 to 0.2 mL, 
depending on the desired aspect ratio, were added to 5 mL of CTAB (0.2M). For a 
typical synthesis, volume of AgNO3 was set to 0.2mL (sample f in figure 2.1). Then, 
5 mL of HAuCl4 (1 mM) was added followed by addition of 80 µL of ascorbic acid 
(0.1 M). Finally, 20 µL of the seed solution were added under vigorous stirring and 
left in a water bath at 28 °C overnight. The method was also scaled up to 100 mL.  
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Surface Modification: 
PEG 5000 g/mol:  100 mL GNRs were purified by centrifugation at 15000 g for 20 
minutes; the supernatant was removed and the pellet was resuspended in mQ water. 
A second centrifugation step was carried out and the pellet was resuspended in 100 
mL solution of 0.1 mM PEG (≈105 PEG molecules per GNR) in mQ water. The 
mixture was left stirring overnight. A second ligand exchange was done in the same 
conditions, and left stirring for 2 hours. The particles were further purified by 2 
subsequent centrifugation steps. 
PEG-COOH: PEG-COOH (MW = 526.7 Da) were used. 100 mL of GNRs were 
purified as explained above and added dropwise in a solution of 100 mL PEG-COOH 
(0.1 mM) in acetic acid (10 mM). The solution was kept under vigorous stirring 
overnight to cause reversible GNR coagulation. Then, supernatant was removed, and 
GNRs were resuspended in a solution of PEG-COOH (0.1 mM) in NaOH (10 mM) 
and kept under vigorous stirring overnight. Finally, the functionalized GNRs were 
purified by centrifugation three times and resuspended in HEPES buffer (10 mM, pH 
7.4) for storage. 
BSA conjugation: For the activation of carboxylic acid, 12 mg of EDAC and 24 mg 
of NHS were dissolved in 2 mL of MES buffer (0.5 M MES, free acid, pH 6.3). 
Different volumes of the previous mixture (0, 2, 4, 6, 8, 10, 14 and 6 µL) were added 
to 1 mL of GNRs solution in MES buffer (0.1M, pH 6.3) at atomic Au concentration 
(as measured by the absorbance at 400 nm) of 0.6 mM.  The suspensions were 
incubated under continuous mixing for 1 hour at room temperature, followed by a 
subsequent centrifugation. 100 µL of BSA solution in PBS (0.05 mM) was added to 
1 mL of activated GNRs. The suspension was again incubated under vigorous mixing 
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for 3 hours at room temperature. Finally, samples were purified by a centrifugation 
step. 
Peptide conjugation: Activation of carboxylic acids was performed as explained 
above. 20 µL of TAT peptide (5 mM) were incubated with 1 mL of activated GNRs 
for 3 hours at room temperature followed by a subsequent purification step.   
Characterisation of GNRs  
Vis-NIR spectroscopy was conducted in a Thermo scientific Genesys 10S UV-VIS. 
A  Malvern Zetasizer nanoZS was used for dynamic light scattering and zeta 
potential measurements. For DLS, 3 measurements were carried out for 20 runs each 
measurement per sample, at 25°C. For zeta potential: in 20µM NaCl solution. Three 
measurements per sample were done in clear disposable zeta cell for 20 runs each 
measurement, at 25°C (by Hückel). FT-IR measurements were conducted in a Bruker 
Lumus. 10 µL of previously purified samples were drop cast into a CaF2 window and 
left to dry overnight. Measurements were taken in transmission mode (1000 scans at 
resolution of 4 cm
-1
). Samples were imaged using a Tecnai G3 spirit TEM at 120 
keV. 10 µL were deposited on a 3.05 mm copper grid (purchased from TAAB). 
2.3 Synthesis of GNRs and tuning of optical properties 
GNRs synthesis protocol is based on the seed-mediated growth method developed by 
El-Sayed and co-workers. 
24
 This method is a two steps process where nucleation and 
growth steps are separated. The conditions required for a homogenous nucleation are 
different than the ones required for an effective anisotropic growth of NPs.
25
 
Reductants selection is crucial for the synthesis since the oxidation state of gold in 
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each step has a big impact.  Nucleation step is based on a strong reduction of Au (III) 
to Au (0) by sodium borohydride (NaBH4) resulting in small NPs termed “seeds”. 
The diameter of these seeds is around 4 nm. As a consequence, they do not exhibit 
the characteristic plasmon band around 520 nm of NPs > 10 nm. Since avoiding a 
second nucleation in the next step is essential, a weak reducer is used in the growth 
step. Ascorbic acid reduces Au (III)
 
to Au
 
(I) and only when the seeds are added, 
gold salt is completely reduced. Therefore, the role of seeds in the growth solution is 
similar to a catalyst agent. Surfactants also play an important role in the synthesis. 
CTAB is a quaternary ammonium cationic surfactant made of a polar head (a tertiary 
amine), and a non-polar tail and its use is critical in the synthesis of GNRs. It acts as 
a shape control and stabilizing agent. The shape control is achieved through a soft 
template or micelle formation. 
7
 CTAB molecules are absorbed in the gold forming a 
bilayer with the positive trimethylammonium groups facing the gold and the solvent. 
A mixture of surfactants made of CTAB and 
benzyldimethylhexadecylammoniumchloride (BDAC) can also been used in the 
seed-mediated growth synthesis leading to bigger ARs
24
.  
As mentioned before, the aspect ratio of the GNRs can be easily tuned from the 
synthesis. There are different parameters that can be changed such as volume of 
seeds added to the growth solution, volume of silver nitrate or final gold 
concentration. Here, the synthesis protocol has been adapted by systematically 
increasing the concentrations of AgNO3 in the growth solution. Figure 2.1 shows the 
tuning of GNRs with different aspect ratios and their respective optical properties as 
final concentration of AgNO3 is increased (Figure 2.1B). There is a direct relation 
between A.R and optical properties, longitudinal Plasmon resonance is shifted to the 
infrared region as aspect ratio of GNRs is increased, in agreement with the literature. 
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26
 When we push the AgNO3 condition, a decrease of the AR is observed as 
previously reported in the literature. There is a critical concentration of AgNO3 that 
when exceeded, the aspect ratio stops increasing and even starts decreasing.
24
    
Although the mechanism has not yet been completely elucidated, two theories have 
been described to explain the role of silver ions. One of them involves the formation 
of complex with the polar heads of CTAB decreasing the charge density and 
therefore the repulsion. This has an impact on the size of template that leads to the 
growth of GNRs formed by the CTAB 
24
. The second one is based on the decrease of 
Gold adsorption due to the presence of silver ions in the template
7
. 
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Figure 2.1: Gold Nanorods synthesis using the seed-mediated growth method. 
A) Pictures of different synthesis of GNRs in solution. B) Absorbance spectra of 
GNP and GNRs showing Longitudinal Surface Plasmon Resonance shift as 
concentration of AgNO3 is increased. C) TEM pictures of GNPs and GNR shown in 
B (scales = 200 nm). AR sample a=1, AR sample b=2.3, AR sample c=2.4, AR 
sampled d=2.7, AR sample e=2.9, AR sample f= 3.2  
 
The final application of GNRs in this report is the in vivo photoacoustic imaging of 
GNRs. Therefore, the position in of the LSPR needs to be situated within the optical 
window. More specifically, between 700 and 800 nm or AR between 3 and 4 (sample 
f) where MSOT is more efficient to resolve between endogenous signal and signal 
coming from the probes.
6,27
 Conditions used in synthesis f were selected as the most 
suitable for our purposes due to this reason. 
 
More recently new protocols based on the pre-reduction of gold by aromatic 
compounds, such as 5-bromosalycilic acid, have been described.
28,29
 These 
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modifications led to highly monodisperse GNRs, and better control of the tuning of 
their optical properties. GNRs with a LSPR up to 1200 nm can be prepared. We did 
not have the chance to test these new protocols. However, it should be noted that the 
volume of our GNRs is higher than the ones with similar absorbance peak obtained 
by the new protocol, and therefore absorbance per GNR is higher. Note also that as 
reported by Scarabelli et al. GNRs synthesised with the salicylic acid approach could 
be grown in further steps to increase their volume, which resulted also in an 
increased absorbance per GNR.
30
  
2.4 Surface modification of GNRs for biological applications 
A good strategy to obtain particles for biological applications, and more specifically 
for cell labeling, not only needs to ensure biocompatibility but also colloidal stability 
under physiological conditions. Uptake should be straightforward with minimal 
interference with cellular function. For example, when working with stem cells it is 
important that the NPs do not interfere with cell fate or cell differentiation.  
As mentioned before, CTAB was used in the preparation of GNRs due to its ability 
to behave as shape and size controller. However, it needs to be replaced due to issues 
related to cytotoxicity. Cytotoxicity of CTAB was tested in MSCs; the results are 
discussed in chapter 4.  CTAB acts as a stabilizing agent and excess of CTAB needs 
to be present in the solution to ensure colloidal stability. The latter can pose a 
challenge in the ligand exchange process due to the affinity of CTAB molecules to 
gold surface, which can interfere with the reactivity of the desired ligand.  In order to 
overcome this problem and achieve a higher ligand packing density, we propose a 
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two-step ligand exchange process. This allows maximising CTAB excess removal 
while maintaining colloidal stability. 
GNRs surface modification with two different ligands via ligand exchange will be 
discussed in this section; Poly(ethylene glycol) methyl ether thiol (5000 Da), referred 
as SH-PEG 5000 in this document, and Monocarboxy(1-mercaptoundec-11-yl) 
hexaethylene glycol (526.73 Da) or SH-PEG-COOH. Both of them are thiol-
modified Polyethylene Glycol (PEG) derivatives. From a composition point of view, 
both ligands are very similar. However, colloidal stability is provided by different 
mechanisms. SH-PEG 5000 is bulky enough to stabilize the particles by a steric 
effect while SH-PEG-COOH is smaller and particles are only stable when the 
carboxylic acid is deprotonated creating an electrostatic repulsion. Both molecules 
bind to the particle through gold-sulphur binding. As discussed in section 2.1, the use 
of thiols has been the most successful strategy for ligand exchange until now due to 
its great affinity toward gold. In addition, PEG is a molecule vastly used in the 
biomedical field due to its safety and biocompatibility.
18
 PEGylated GNRs have also 
been broadly used in biological applications and it has previously been shown that 
their toxicological profile is lower than CTAB coated and polystyrene sulfonate 
(PSS) coated GNRs.
31
  
2.4.1 Functionalisation of GNRs with SH-PEG 5000 
Figure 2.2 B shows UV-vis spectra of GNRs before and after surface 
functionalisation, a small red shift inherent to the PEGylation process was observed. 
Dynamic light scattering (DLS) and zeta potential were used as additional 
characterisation of the process (Figure 2.2 C and D). Obtaining two peaks in the DLS 
is a very distinctive feature of GNRs because it is a sign of anisotropy. This effect is 
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caused by two components of Brownian motion due to the anisotropy of GNRs:  
translational (corresponding to the smaller hydrodynamic diameter peak) and 
rotational relaxation rate (corresponding to the bigger hydrodynamic diameter 
peak)
32,33
. However, none of them fits with the actual size. Therefore, DLS is not a 
good technique to determine GNRs size but a shift of the peak can indicate increase 
of size, hence GNRs modification. A shift was observed in both peaks when PEG-
GNRs are compared with CTAB-GNRs suggesting that conjugations were 
successful. 
As synthesized GNRs have a positive zeta potential due to the orientation of the 
trimethylammonium head groups in the CTAB bilayer of GNRs. On the other hand, 
functionalisation with SH-PEG 5000 resulted in a neutral zeta potential. This 
decrease in surface charge is indicative that CTAB was successfully replaced by 
PEG molecules.   
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Figure 2.2: Ligand exchange with SH-PEG 5000. A) General chemical formula of 
SH-PEG 5000 (n≈110) B) UV-vis-NIR spectra of as synthesized and SHPEG 5000-
GNRs C) Hydrodynamic diameter measured by DLS of as synthesized and SHPEG 
5000-GNRs D) zeta potential measured before and after surface modification. 
 
2.4.2 Functionalization of GNRs with SH-PEG-COOH 
 Functionalisation with SH-PEG-COOH poses a very different scenario. In contrast 
to SH-PEG 5000, this ligand is not bulky enough to stabilize GNRs through a 
sterically effect. Chemical structure of this molecule is shown in figure 2.3 A, SH-
PEG-COOH has also been modified with a thiol group, responsible for the binding to 
gold surface. Thiol group is followed by an 11 carbons alkane chain used as spacer. 
The use of these kind of spacers have been found to lead to higher ligand density 
nanoparticles improving the reproducibility of ligand exchange and the colloidal 
stability when compared to pure PEG molecules 
34
. This is especially useful for the 
PEGylation of GNRs since the presence of free and bound CTAB can challenge the 
ligand exchange. Carboxylic acid terminus is the key here for colloidal stability. 
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When the carboxylic acid is deprotonated, the repulsion forces of the negative 
charges of neighbouring GNRs are strong enough to stabilize the colloid. Although 
the pka of this carboxylic acid in solution is ̴ 3.50, SH-PEG-COOH conjugated 
GNRs are only stable under pH conditions and above 7. This unexpected behaviour 
of the acids attached to a surface is explained by the proximity of negative charges to 
each other resulting in higher pka than the same acid in solution where the charges 
can move more freely
35
. This is the reason that encouraged us to work with basic pH 
(pH 10) to ensure the completely deprotonation of the carboxylic acid.  
Despite conjugating GNRs under basic pH, we encountered irreproducibility 
problems with the stability of particles. Aggregation was systematically observed in 
GNRs exhibiting neutral surface charge; most likely caused by a mixture of positive 
CTAB and negatively charged ligand on the nanoparticle surface. Small differences 
in free CTAB amount present in the sample after purification can significantly alter 
the ligand exchange process due to the affinity of the surfactant for gold surface. 
When the process was slowed down due to the presence of surfactant, PEG 
molecules slowly attached to the surface until neutral charge was reached and 
therefore aggregation occurred. This prevented other molecules to be attached to the 
surface. It is noteworthy that at this point aggregation was irreversible. El-Sayed and 
co-workers also noticed this problem when working with SH-PEG-COOH and 
resolve it using a two steps process: first stabilizing particles with a Poly(ethylene 
glycol) methyl ether thiol and then replacing some of the ligands by SH-PEG-
COOH
36
. Phase transfer has also been used as strategy to effectively pegylate 
GNRs.
37
 
We propose here a simple two-steps process in aqueous solution where high 
reproducibility is accomplished through pH shifting. First addition of SH-PEG-
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COOH is done under acidic conditions. Consequently, carboxylic acids on the ligand 
adopt the protonated form resulting in an intentional GNRs coagulation. Ligand 
attachment is enhanced like this due to two reasons; first, a higher number of PEG 
molecules are required to bind to gold surface before the total charge reaches a 
neutral value and colloidal stability is compromised. In addition, protonated forms 
are less bulky than the charged acids reducing steric and electric repulsion problems 
during conjugation, also leading to improving of the method efficiency. The second 
step involves the recovery of GNRs stability by shifting the pH to basic while adding 
a second set of PEG ligands. Figure 2.3 C summarizes this method. The strength of 
this approach is the maximization of the final number of ligands attached to GNRs 
during the first step of the process at the same time that reproducibility problems 
with colloidal stability are solved.   
 
 
Figure 2.3: Surface modification of GNRs with SH-PEG-COOH. A) Chemical 
formula of PEG-COOH. B) Pictures of PEG GNR is acidic and in basic pH C) 
Diagram representing ligand exchange. I) CTAB coated GNRs II) intentionally non 
stable PEG modified GNRs, carboxylic acid is protonated due to an acidic pH III) 
Stable GNRs with deprotonated PEG in the surface due to a basic pH 
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The different steps of the method were characterized by means of zeta potential, DLS 
and UV-vis-NIR spectroscopy. The measured zeta potential data (Figure 2.4 C) is in 
agreement with the diagram showing the different steps of the surface (Figure 2.3 C). 
Shifts observed in the measured zeta potential can be correlated to the presence of 
protonated and deprotonated carboxylic groups. The product obtained in the first 
conjugation step under acidic condition led to a significant drop in the measured zeta 
potential reaching nearly the neutral charge (-8 mV) when compared to the highly 
positive CTAB coated GNRs (+50 mV). The surface charge of the intermediate 
specie was not enough to preserve the electrostatic repulsion, resulting in a controlled 
aggregation of GNRs. This was observed with naked eye (figure 2.3 B). The second 
step consisted on a second injection of ligands under basic pH, which triggered the 
recovery of colloidal stability. This was a fast process; it took seconds to completely 
reverse flocculation of GNRs. This suggests that the colloidal properties were 
restored through the deprotonation of carboxylic groups already attached to the 
particle surface due to shift in the system’s pH conditions, rather than because of the 
attachment of new ligands. This observation was also validated by values obtained 
by zeta potential; there was a significant drop in surface charge when the 
intermediate and final products were compared. The latter reached a negative 
measured zeta potential of -32.2 mV. The repulsive potential energy created by this 
surface charge was strong enough to stabilize the dispersion. Figure 2.3 B shows the 
picture of the final dispersed SH-PEG-COO
-
 coated GNRs. Stability was also 
assessed by UV-vis-NIR spectroscopy (Figure 2.4 A). PEG conjugation led to a 
small NIR shift in the spectrum. Nonetheless, signs of aggregation were not observed 
in the spectrum tested after conjugation under basic pH. PEGylated GNRs were also 
shown to be stable under physiological pH conditions of 7.4. Colloidal stability 
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under physiological conditions is a premise for biotechnological applications. 
Finally, effectivity of PEG grafting was assessed by DLS measurements. An increase 
in the hydrodynamic diameter was observed when the coated GNRs were measured 
and compared to the diameter of as synthesized particles. This increase is attributable 
to PEG molecules attaching to gold surface. GNRs modified with SH-PEG 5000 also 
showed similar results. However, the hydrodynamic diameter obtained with SH-
PEG-COOH is significantly smaller as it is expected from a less bulky ligand.  
 
 
Figure 2.4 Characterisation of ligand exchange: A) UV-vis spectra of CTAB 
coated GNRs and SH-PEG-COOH modified GNRs B) DLS of CTAB coated GNRs 
and SH-PEG-COOH modified GNRs C) zeta potential of : I) CTAB coated GNRs 
(49.7±46.5 mV). II) Non stable PEG modified GNRs (-8.40±4.3 mV). III) Stabilized 
PEG modified GNRs (-32.2 ±15.3).   
 
The chemical composition of SH-PEG-COOH modified GNRs was characterized by 
Fourier-transform infrared (FT-IR) spectroscopy. The spectrum obtained from 
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modified GNRs was compared with the one of CTAB coated GNRs (figure 2.5 A 
and B respectively), as well as with the raw ligand’s spectrum (Figure 2.5 C and D). 
The spectra of SH-PEG-COOH in solution and modified NPs showed similar peaks, 
indicating that the ligand forms part of the NPs composition (Figure 2.5 C). 
Specifically, IR spectrum obtained with PEG-COOH raw material showed a 
characteristic peak at 1111 cm
-1
 attributable to C-O-C stretching, the same peak was 
observed in the PEG modified GNRs at 1107 cm
-1
. From the data acquired here, it is 
impossible to determine if CTAB molecules were still present in the sample or not 
after surface modification steps, since CTAB coated GNRs spectrum only showed 
two bands at 2848 cm
-1
 and 2918 cm
-1
, these are distinctive of C-H stretching. PEG 
molecules are also composed by hydrocarbons and therefore it is impossible to 
determine if these bands, which were also present in the final product, correspond 
either to CTAB or SH-PEG-COOH. Some information about how the ligand binds to 
the gold surface could be extracted from the FTIR data. There is a weak peak at 2551 
cm
-1
 that appears in the PEG raw material spectrum but it is absent in the modified 
GNRs (Figure 2.5). This peak is attributable to S-H stretch (s) binding and usually 
appears from 2560 cm
-1
 to 2510 cm
-1
 as a weak and narrow peak. The absence of this 
peak in the final spectrum might indicate that S-H bound is lost, confirming that the 
ligand binds to the gold in a quasi-covalent manner, dismissing the electrostatic 
binding.   
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Figure 2.5: Composition characterisation of PEG-COOH GNRs by FT-IR. 
Readings are given in transmittance and were done at 1000 scans in transmission 
mode. A) FT-IR spectrum of CTAB coated GNRs B) FT-IR spectrum of PEG-
COOH modified GNRs. C) and D) Spectra of raw PEG-COOH in black and   PEG-
COOH modified GNRs in red.   
 
2.5 PEGylated Gold Nanorods as scaffolds for biomolecules  
Functionalizing GNRs with SH-PEG-COOH has a main advantage comparing to SH-
PEG 5000.  Bifunctional ligands can be used for a broad range of applications since 
they can bind to the gold surface and to other structures simultaneously. Carboxylic 
groups on the surface of nanoparticles are available making possible a further 
modification. In this way, we have used PEGylated GNRs as scaffolds to build 
hybrid structures using NHS/EDAC chemistry. In this section, covalent binding of 
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biomolecules to GNRs will be discussed. Following the same binding approach, a 
hybrid bimodal contrast obtained by the attachment of zinc gallium oxide 
nanoparticles (ZGO) to GNRs will be shown in the third chapter of this thesis.  
Designing appropriate surfaces is not only important for colloidal stability but 
ligands on NPs surface can also trigger a biological response such as a cellular 
signalling.
38
 From here stems the interest of conjugating biomolecules to 
nanoparticles. These hybrid materials allow the interactions of inorganic materials 
with biological systems resulting in a broad range of applications. Bio-sensing, 
targeting, cell uptake enhancement and drug delivery are examples of the potential of 
these hybrid structures.
39,40
 The chemical strategy used to conjugate biomolecules to 
GNP is also crucial for the final result and the choice will depend on the condition 
particles are exposed to. Physiological environments pose an aggressive scenario for 
nanoparticles due to its high ionic strength. The presence of serum proteins in high 
concentrations also can affect NPs surface composition since proteins can form a 
dynamic layer on nanoparticles surfaces and even replace some of the ligands bound 
to the surface. These protein-nanoparticle interactions are known as protein corona
41
 
and they will be further discussed on subsection 2.5.2. Therefore, more stable 
binding that can endure over time under aggressive conditions are preferred for 
biological applications. Here, we will describe the covalent binding of biomolecules; 
specifically, a protein (section 2.5.2) and a peptide (section 2.5.3) to the GNRs using 
a carbodiimide crosslinker. 
2.5.1 Activation of carboxylic acids: NHS/EDAC chemistry  
Among the crosslinkers that can react with carboxylic acids, carbodiimide 
compounds are one of the most prevalent options for activating carboxylic acids.
42
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The versatility of this approach is one of the reasons for this since they can form a 
stable amide binding with a primary amine that acts as a nucleophile. This is 
especially interesting because it allows the binding of biomolecules rich in amines 
such as proteins and peptides. 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
(EDC) is a water soluble carbodiimide derivate broadly used for amide 
condensation.
43
 Figure 2.6 summerizes the method. 
 
Figure 2.6: Activation of carboxylic acids by NHS/EDC crosslinker diagram. 
From thermofisher.com  
 
The reaction intermediate is an stable but highly reactive ester. As it can be expected 
from an ester, the net surface charge was close to neutral. Figure 2.7 shows how the 
net charge of PEG-COOH-GNRs became less negative as the concentration of 
activator (a mixture of NHS/EDC) was increased confirming the success of  the ester 
formation. As mentioned in section 2.4.2, PEG-COOH-GNRs are only stable when 
the carboxylic acid is deprotonated and a negative net charge is sufficient to 
electrostatically stabilized GNRs. The intermidate has a neutral charge and therefore 
colloidal stability can be affected. The solution is finding a compromise between the 
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number of activated carboxylic acids and coloidal stability. Figure 2.7 shows that 2 
µL of NHS/EDAC in 0.25 mL of GNRs ([Au]=0.625 mM, Absorbance at 400 nm 
was 1.5)
44
 is enough to significally change zeta potential but still have a negative net 
charge required for stabilizing GNRs.  
 
 
Figure 2.7: Activation of carboxylic acid by NHS/EDAC chemistry. A) Zeta 
potential of PEG-COOH-GNRs when volume of NHS/EDAC was increased. B)  
UV-Vis spectra of PEG-COOH-GNRs at different activation levels.  
 
2.5.2 Conjugation with a protein: Bovine Serum Albumin (BSA) 
The adsorption of plasma proteins on inorganic surfaces was first described by Leo 
Vroman in the 60’s and this process was named after him as the Vroman effect45. In 
the same manner, when certain nanoparticles are in contact with physiological 
environments, proteins also cover the surface of nanoparticles
46
; this is known as 
protein corona. Protein corona is a spontaneous and dynamic process dominated by 
electrostatic or non-specific interactions. Interestingly, it has been proposed that 
protein corona can dictate NP fate in biological environments via receptor 
interactions.
46,47,48,49
 Factors such as size, surface charge and stealth capacity of the 
ligands amongst others dictate the protein composition and dynamics of the corona. 
Many proteins have been described to interact with nanoparticles
50
; however we 
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chose only the most abundant protein in serum, bovine serum albumin (BSA), to 
simplify our system. Albumin represents approximately the half of the total protein 
content in serum. 
The main aims of this section are binding BSA covalently and compare the dynamics 
of covalent and electrostatic protein corona in physiologic conditions. Figure 2.8 
summarizes the two strategies followed to conjugate BSA to GNRs. Both the corona 
formation and the covalent conjugation have been studied by DLS (figure 9).  
 
 
Figure 2.8: Scheme of the two strategies used to conjugate BSA to GNRs. A) 
Electrostatic protein-GNRs interaction B) Covalent binding of BSA to GNRs.   
 
Carboxylic acids on the surface of GNRs were first activated with different 
concentrations of NHS/EDAC resulting in different zeta potential indicating that the 
level of activation can be controlled (see 2.5.2). Activated and non-activated GNRs 
were incubated with an excess of BSA for three hours at room temperature until the 
condensation reaction was completed. Then both BSA conjugates were purified 
twice in PBS. High ionic strength condition were chosen to promote desorption of 
unspecific bound proteins, at the same time the excess of proteins is reduced. DLS 
was measured and compared before and after purification. Casals et al studied the PC 
over time and described it as a two components process; a temporary  or soft corona 
A B
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and a persistent or hard corona
51
. While the hard corona takes longer to be formed 
(48 hours at least); the soft corona is formed by a rapid equilibrium between bound 
and unbound protein. It was shown that the formation of soft corona intrinsically 
depends on the concentration of free protein. Therefore, when free protein 
concentration is decreased by purification of the conjugates, soft corona is 
reversible.
51
 Following this approach, we characterized the efficiency of the covalent 
binding of BSA to GNRs since a lower desorption was only expected when BSA was 
covalently attached. 
The protein-GNRs electrostatic interactions, i.e. before carboxylic activation, were 
first investigated (Figure 2.9 A). Negative charge of the carboxylic acid and 
relatively small molecular weight of SH-PEG-COOH quenches the inherent stealth 
nature of seen for larger PEG
18
, facilitating the electrostatic interactions required for 
the protein adsorption. This has been confirmed by a shift to larger hydrodynamic 
diameter measured by DLS after incubation of GNRs with BSA (figure 2.9 A in red). 
The absence of big aggregates is a symptom that conformation of BSA was retained 
in our system. The retaining of the native conformation might be important for 
biological applications. Rotello and co-worker previously showed that the terminal 
carboxylic acid in a similar PEG molecule was needed for protein binding.
52
 In 
addition, they also showed that ethylene groups prevented protein denaturalization in 
contrast to MUA ligands.
52
 Therefore, our data are in good agreement with their 
findings.  
Before washing with PBS, there was a significant increase of the hydrodynamic 
diameter in all the cases studied, non-activated and activated with different amounts 
of activator (Figure 2.7). This shift was observed in both components of the 
Brownian motion measured by DLS: translational and  rotational relaxation rate 
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(refer to section 2.4.1). This indicates that in all the particles tested, BSA is bound to 
NPs without any signs of denaturalisation.  
After BSA treatment, the increase in the measured hydrodynamic diameter was 
bigger when carboxylic acids in the ligand were pre-activated with NHS/EDC. The 
difference between the non-activated and the highest concentration of activator was 
almost 12 nm in the rotational motion peak. In addition, a trend was observed in the 
hydrodynamic diameter measured by DLS when concentration of activator was 
increased (Figure 2.9 C black bars). This could mean that the covalent approach was 
more effective to recruit proteins from the solvent and less excess was needed to 
cover GNRs resulting in an increase of the hydrodynamic diameter. It could also be 
an indication that BSA is more or less buried in the ligand layer depending on the 
binding approach used. Pelaz et al found that the increase of the thickness of polymer 
modified FePt NPs was reduced by 50% when PEG was covalently bound to the 
polymer. Their fluorescence and quenching studies suggested that HSA could be 
buried between the PEG chains. They also correlated this finding to a decrease of 
cellular uptake when 10 KDa PEG was linked to the surface of the NP
53
. 
Alternatively, this increase in the hydrodynamic diameter could be due to a small 
change in protein conformation triggered by the amide bond formation. Our results 
are not conclusive to determine the cause of the difference observed between both 
approaches. Nonetheless, a direct relationship between activation and hydrodynamic 
diameter is clear, indicating that proteins interact with the ligand in a different 
manner depending on the chemical methodology used. In addition, there was a 
decrease in the diameter after purification in all the samples tested. Remarkably, 
there was a decrease in the hydrodynamic diameter regardless the activation of 
carboxylic acid (Figure 2.9 A and B in blue). This points to  the formation of a soft 
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protein corona on the surface of all the samples tested, even in the samples where 
carboxylic acids were previously activated. This was likely due to the fact that total 
activation of GNRs is not feasible as some charge need to remain to provide with 
colloidal stability.  Non activated ligands can lead to the formation of a partial 
electrostatic corona on the surface. Nonetheless, while the diameter in the non-
activated rods (figure 2.9 A) reaches virtually the same size as the PEG-COOH-
GNRs before protein incubation, there is a significant difference between the control 
and the activated NP (figure 2.9 B and C). This can only indicate that the BSA 
protein is efficiently binding in a covalent manner to GNRs. 
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Figure 2.9: Characterisation of electrostatic and covalent BSA conjugation to 
GNRs. A) Hydrodynamic diameter measured by DLS of non-covalent BSA-GNRs 
interaction approach; PEG-COOH-GNRs before conjugation (black), after 
conjugation (red) and after washing (blue). C) Hydrodynamic diameter measured by 
DLS of covalent BSA-GNRs binding approach; PEG-COOH-GNRs before 
conjugation (black), after conjugation (red) and after washing (blue). C) 
Hydrodynamic diameter of the rotational Brownian motion component of GNRS 
before protein conjugation (orange), after conjugation (black) and after washing 
(red).  D) vis-NIR spectra of GNRs after washing PEG-COOH-GNRs in black, after 
BSA treatment in red and previously activated GNRs in blue. 
 
2.5.3 Conjugation with a cell penetrating peptide (CPP): 
Transactivator of transcription (TAT) 
Cell penetrating peptides (CPP) are a group of relevant aminoacids sequences 
derived from proteins known for crossing biological membranes.
54
 Proteins such as 
HIV transactivator of transcription (TAT)
55,56
, antennaepedia homeodomain
57,58
, 
Herpes Simplex Virus (HSV) VP22 
59
. Signal sequences
60
 have also been studied as 
cell penetrating peptides. Interest in CPP mainly stems from the need to find a tool to 
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enhance cell uptake of different cargos, especially biologically active molecules.  
CPP have been shown to cross not only cell membranes but also other biological 
membranes including the blood brain barrier (BBB)
61
 expanding the potential 
biological uses of these peptides. The first discovered CPP was the transactivator of 
transcription (TAT) with sequence GRKKRRQRRRPQ. It was isolated from human 
immunodeficiency virus 1 (HIV-1), critical for viral DNA transduction into animal 
cells. TAT peptide can be reduced down to a linear sequence of 9 amino acids; 
including 6 arginine and 2 lysine aminoacids. The ability to cross cell membranes of 
TAT was first described independently by  Green et al 
62
 and Frankel et al 
63
 in 1998. 
Later, Farwell and co-workers delivered different large proteins inside the cells after 
covalent linkage of a sequence of 36 aminoacids delivered from TAT protein
64
.    
Similarly to the data presented in the previous section, TAT peptide was covalently 
bound to PEGylated GNRs using the same crosslinker and results obtained from 
electrostatic and covalent binding were also compared here. The difference with 
BSA is that, as mentioned before, TAT is a peptide rich in positive amino acids 
resulting in an average positive surface charge. Results shown in figure 2.10 
correspond to purified conjugates. As it is expected from a positive ligand, after 
addition of TAT measured zeta potential shifted from a negative surface charge to a 
positive one, independently on the binding approach. After purification of the 
particles, zeta potential measures did not drop as it could be expected from an 
electrostatic interaction. This was likely because in this case electrostatic interactions 
between negatively charged GNRs and positively charged TAT were stronger than in 
the case of BSA.  In addition, as vis-NIR spectrum shows in Figure 2.10 A, no 
aggregation was observed through the two different processes. Hydrodynamic 
diameter of the different conjugates was also measured by means of DLS. Data 
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obtained from both conjugation strategies were significantly different here. While the 
shift observed after employing an electrostatic binding was not notable, when NPs 
have been previously activated there was a significant increase in the measured 
hydrodynamic diameter. TAT is a peptide and therefore a much smaller biomolecule 
than BSA. Possibly, a less bulky molecule can intercalate easier within the PEG 
chains leading to a much smaller hydrodynamic diameter. Or a conformational 
change of the peptide due to the covalent binding could be the reason for this 
increase in the hydrodynamic diameter. Nonetheless, it would be necessary to 
confirm these observations with a different technique. For instance, quantification of 
TAT peptide on nanoparticles can be performed by Ellman’s test. 
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Figure 2.10: Characterisation of electrostatic and covalent TAT peptide 
conjugation to GNRs. A) UV-Vis-NIR spectra of PEG-COOH-GNRs (black), non-
covalent TAT peptide-GNRs interaction (red) and covalent TAT-GNRs conjugate 
(blue) B) zeta potential of the different GNRs conjugated. C) Hydrodynamic 
diameter measured by DLS of PEG-COOH-GNRs (black), non-covalent TAT 
peptide-GNRs interaction (red) and covalent TAT-GNRs conjugate (blue). D) 
Hydrodynamic diameter of the rotational Brownian motion component of the 
different surface modifications.   
2.6 Conclusions  
GNRs with an A.R. ≈3 were synthesized by the seed-mediated growth method. 
Synthesis conditions were adapted to tune the LSPR peak position to around 750 nm, 
overlapping with the NIR window. Cytotoxic CTAB was replaced with PEG in order 
to obtain biocompatible GNRs, resulting in an improvement of colloidal stability 
even under physiological conditions. For this, the surface of GNRs was 
functionalised with a short chain SH-PEG-COOH following a two-step and pH-
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controlled protocol. It involved a controlled agglomeration of GNRs in acidic pH, 
followed by a second step under basic conditions to recover stability. This method 
allowed the surface replacement of the positive charged CTAB with a negative 
ligand, avoiding the irreversible aggregation caused by a mixture of CTAB and PEG 
molecules on the surface of GNRs. Irreproducibility problems due to small 
differences in the purification of CTAB were solved this way at the same time that 
ligand loading was improved. Another advantage that this method offers is that the 
carboxylic acids available on the surface of nanoparticles can be used as scaffolds for 
covalent binding of biomolecules or other structures. Here, BSA and TAT peptide 
were conjugated to PEG-GNRs via EDAC/NHS coupling chemistry. Versatility is 
the main advantage of this approach. Composites can be built with any structure 
containing amines, including other contrast agents to form a multi-modal probe (See 
section 3.6).  
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Chapter 3 
Synthesis and Surface Modification of 
Chromium-doped Zinc Gallium Oxide 
Nanoparticles 
3.1 Introduction 
The interesting optical properties of persistent luminescent (PL) phosphors; or 
alternatively called long persistent phosphors (LPP), have been used since the 
ancient China for decorative proposes.  Currently, LPPs such as strontium aluminate 
(SrAl2O4) are broadly being used for safety signalling, decoration and military uses. 
Recently, PL materials have attracted a lot of attention due to their great potential in 
biomedical applications. Moreover, PL materials have risen as promising optical 
probes for bio-imaging due to the possibility of synthesizing these materials in the 
nanometre range and shifting both emission and excitation to the NIR/optical 
window.
1
 In 2014 the number of publications was doubled over 2013
2
, illustrating 
that persistent luminescent nanoparticles (PLNPs) is an emerging field. This increase 
in attention stems from the advances in the field done thanks to the development of 
new materials and synthetic routes. Here we summarize the most relevant preparative 
methods for these materials.  
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3.1.1 Synthesis of Persistent Luminescent Nanoparticles 
Traditionally, solid-state reaction has been the most widely used method to 
synthesize LPP. Easiness of the method and possibility to scale up to mass 
production are the main reason for this popularity. The high temperature required to 
react solids normally reaches 1000-1500ºC and leads to crystals with extraordinary 
long emission times. The use of high temperatures creates more and deeper defects in 
the crystal surface, which are responsible for the long lifetimes shown by these 
materials. However, at the same time that temperature improves optical properties, it 
also leads to bigger and more poly-dispersed particles in the sample. The size usually 
obtained by this route of synthesis is in the order of microns. This situation is far 
from ideal for the use of LPP in biology and new synthetic routes have been 
described lately in the literature trying to give an answer for this problem. Still not a 
perfect approach that ticks all the boxes has been defined but advances in wet-
chemistry and physical routes have been done in the past years
3
. The synthetic 
method influences optical properties, morphology, size and monodispersity. 
Therefore, reviewing the most common methods available before selecting the most 
convenient for the final goal is crucial.  
Different approaches to synthesise luminescent nanoparticles can be found in the 
literature. The synthetic approaches based on liquid-phase synthesis are the most 
popular ones due to their easiness, lower cost, higher yields and versatility. Among 
them, sol-gel and hydrothermal synthesis are the most predominant strategies. Other 
approaches include physical methods such as laser ablation/deposition
4
, and electron 
beam bombardment
5
. Here we will only focus on the ones based on liquid-phase 
synthesis due to their relevancy for our work.  
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Sol-gel method is one of the most common bottom-up methods for inorganic NPs 
synthesis. This method has also been broadly used for the synthesis of metal oxides, 
particularly silicon and titanium. Shortly, this method involves a two-step process; 
first a hydrolysis of the precursor, typically metal alkoxides or chlorides, followed by 
a condensation. The latter process leads to the formation of an integrated network or 
gel. The gel obtained needs then to be dried in order to remove the solvent. For the 
formation of LPP, a final calcination treatment is needed in order to achieve a further 
polycondensation state and mechanical properties improvement. This final thermal 
treatment notably enhances the optical properties achieving very long emission times 
(even hours). Starting bulk material used by Chermont et al was synthesized by solid 
state which resulted in the range of µm size particles. In order to synthesized smaller 
Ca0.2Zn0.9Si2O6:Eu
3+
,Dy
3+
,Mn
2+
 particles they developed a sol-gel method followed 
by calcination, grinding and selective sedimentation. The final product was reported 
as 50-100 nm NPs with a narrow size distribution detectable for more than 24 hours.
1
 
In 2013 Liu and co-workers developed a new bulk material; trivalent chromium 
doped lithium gallate (LiGa5O8:Cr
3+
) with superior optical properties
6
, since 
emission lifetime after excitation with UV light was 1000 hours longer than any LPP 
known up to date. Similarly to Chermont et al, they used a sol-gel approach to 
synthesize this material in the range of nanometres. They reported a size range of 50-
150 nm. However, due to the method procedure the emission times were shorter, up 
to 4 hours after UV excitation. Fu et al showed that the size of these material NPs 
could be easily tuned from 50 nm to 150 nm by controlling calcination temperature
7
. 
 Hydrothermal synthesis is a crystallisation procedure where single crystals are 
formed under high pressures and temperatures higher than RT in aqueous solutions. 
The synthesis has to be carried out in a Teflon autoclave, a sealed steel cylinder 
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which allows working under high pressures. Crystals of substances that are unstable 
under the melting point temperature can be obtained by this method. In addition,  
good quality single crystals are obtained at the same time that composition control is 
achieved. Indeed, hydrothermal synthesis has been broadly used for the synthesis of 
commercial single crystals such as synthetic quartz and gems. Maldeney et al 
published one of the most successful approaches to synthesize PL nanomaterials in 
2014
8
. Chromium-doped zinc gallium oxide (ZGO:Cr) nanoparticles, with a 
chemical formula Zn Ga1.995Cr0.005O4, were synthesized by hydrothermal method 
followed by a low temperature sintering (750ºC). The reported size of NP obtained 
by this approach was in the range between 20 and 60 nm, after selection by 
centrifugation. PL emission decay curve was taken for more than 80 minutes after 
UV excitation. Luminescent NPs were then used for successfully tracking 
macrophages in vivo. Hydrothermal method followed by sintering has been a 
prevalent method to slightly modify the composition of ZGO:Cr NPs. The host can 
be modified by introducing germanium molecules in the formulas and also co-
dopants can be integrated in the crystals such as europium
9
. By this method, crystals 
are synthesized under relatively mild conditions which lead to homogeneous NPs, 
the methodology mentioned so far require a sintering process to activate the LPP also 
leading to bigger and poly-dispersed NPs. In 2015 Li and co-workers reported a 
hydrothermal methodology that does not involve high temperature treatments 
achieving like this, as small as sub 10 nm NPs and improving homogenicity
10
.  
Others: Template method is another well-developed method. LPP layer can be 
deposited on the surface of mesoporous silica nanospheres (MSNs) to form the 
MSNs@LPPs composite which can also be used for drug delivery.
11
 NPs have also 
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been prepared by other liquid phase methods including co-precipitation
12
 and 
combustion
13
. 
Some conclusions can be drawn from the synthesis methods described. First, there 
are many approaches in the production of these crystals and all of them have 
different advantages and drawbacks. Physical methods are complex and expensive, 
while liquid-phase synthesis approaches are easier and cheaper, but have other 
drawbacks that need to take into account.  For example in sol-gel methods, 
composition is highly controllable, and long lifetimes are achievable due to 
calcination step. However, they typically lead to a broad size distribution of bigger 
particles. Therefore, a physical post-treatment is usually needed to reduce their size. 
Hydrothermal method poses similar problems after the sintering process and 
template methods lead to lower yields and smaller particles are difficult to 
synthesize. Unfortunately, the high temperatures required for the activation of a 
longer and stronger PL is also responsible for the broad size distribution. Therefore, 
there is a need to develop new synthetic routes for LPP and optimize the morphology 
and size of NPs while improving optical properties. Some authors have tried to tackle 
this problem; Zou et al reported that NPs synthesized by hydrothermal synthesis 
could be protected by a silica shell during calcination. This silica could be removed 
by alkali etching afterwards. They reported an average size of 15 nm and  a 3-fold 
signal enhancement compared to NPs before undergoing the calcination process
14
.       
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3.2 Experimental 
Reagents 
The chemicals were purchased from Sigma-Aldrich and used as received. 
Ga(NO3)3·xH2O (99.9%), Zn(NO3)2·6H2O (≥99%), Cr(NO3)3·9H2O (99.99%), 
ammonium hydroxide (28%), HCl (37%), Poly(allylamine hydrochloride) (PAH, 
MW 15 KDa) and Polyvinylpyrrolidone (PVP, MW 10 KDa), (3-
Aminopropyl)triethoxysilane (APTES, 99%) Dimethyl sulfoxide (DMSO, ≥99.9%), 
meso-2,3-Dimercaptosuccinic acid (DMSA, 98%), N-Hydroxysuccinimide (NHS, 
98%), N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDAC, 
>98%). TAT peptide (97%) was purchased from Life Tein.  
Preparation of ZGO 
ZnGa2O4:Cr NPs were synthesized via hydrothermal synthesis adapted from a 
previous reported method.
10
 Briefly, 2 mL of Zn(NO3)2 (1M), 1 mL of Ga(NO3)3 
(2M) and 1 mL Cr(NO3)3 (4 mM) were pre-mixed under vigorous stirring and 
volume was adjusted to 15 mL with milli-Q water. 1 mL of ammonium hydroxide 
was added to the mixture to achieve a pH of 9-9.5 and left under gentle stirring for 
30 minutes.  The mixture was sealed into a Teflon-lined autoclave and transferred to 
an oven at 220̊ C for 10 hours. Once the hydrothermal reaction was finished, the 
autoclave was left to cool  down at room temperature. The mixture obtained was 
centrifuged at 1000 g for 10 mins and the pellet was re-suspended in  HCl (0.01M) to 
remove excess of Zn. HCl was finally washed off by centrifugation at 29000 g for 20 
mins. Particles were further purified by 24 hours dialysis.  
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Surface modification 
Polymers: 1 mL of ZnGa2O4:Cr NPs (at 0.3 mg/mL) was sonicated for 15 mins 
before adding drop-wise a solution of 100  µL PAH or PVP (20 mg/mL) under 
vigorous stirring. The mixture was left stirring overnight and the excess of polymers 
was washed off by centrifugation. 
APTES: ZGO:Cr NPs were coated according to an existing method
1
 with slight 
modifications. Briefly, 0.5 mL of ZnGa2O4:Cr NPs (2.5 mg/mL) in DMSO was 
sonicated for 15 mins before 20 µL of APTES (previously diluted x 100 times) were 
added drop-wise under vigorous stirring. The mixture was further sonicated for three 
minutes and left stirring overnight. Excess of APTES was washed off by 
centrifugation. The pellet was re-suspended in 1 mL of DMSO followed by 2 
subsequent purification steps in milli-Q water.     
DMSA: Modification with DMSA was adapted from a previously described method 
for iron oxide NPs.
15
 100 mL of ZGO:Cr nanocrystals (previously sonicated) were 
added to 100 mL of an aqueous solution of DMSA (0.1 mg/mL) under vigorous 
stirring and left to react overnight. Particles were purified and concentrated by 
centrifugation. 
TAT: For the activation of DMSA-ZGO, 12 mg of EDAC and 24 mg of NHS were 
dissolved in 2 mL of 0.5 M MES buffer. 200 µL of the mixture were added to 200 
mL of DMSA-ZGO (0.05 mg/mL). The suspension was incubated under continuous 
mixing for 1 hour at room temperature, followed by a subsequent centrifugation. 600 
µL of TAT peptide (5 mM) were added to the activated DMSA-ZGO:Cr. The 
suspension was again incubated under vigorous stirring for 3 hours at room 
temperature. Finally, samples were purified by a centrifugation step. 
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Binding with GNRs: PEG_COOH-GNRs were activated as shown in chapter 2. 1 mL 
of GNRs was added drop-wise to 500 µL of APTES- ZGO (1.25 mg/mL). The 
mixture was left overnight under stirring. Particles were centrifuged at 6000 rpm and 
re-suspended in milli-Q grade water.  
Characterisation 
Vis-NIR spectroscopy was conducted in a Thermo scientific Genesys 10S UV-VIS. 
A  Malvern Zetasizer nanoZS was used for dynamic light scattering and zeta 
potential measurements. For DLS, 3 measurements were carried out for 20 runs each 
measurement per sample, at 25°C (0.03 mg/mL of ZGO). For Zeta potential: Three 
measurements per sample were done in clear disposable zeta cell for 20 runs each 
measurement, at 25°C (0.03 mg/mL in 20µM NaCl solution, by Hückel). FT-IR 
measurements were conducted in a Bruker Lumus. 10 µL of previously purified 
samples were drop cast into a CaF2 window and left to dry overnight. Measurements 
were taken in transmission mode (1000 scans at resolution of 4 cm
-1
). Samples were 
imaged using a Tecnai G3 spirit TEM at 120 keV and HR-TEM and EDX was 
carried out on a JEOL JEM 2100FCs equipped with a spherical aberration corrector 
(CEOS GmbH), operating at an accelerating voltage of 200 kV. 10 µL of particles 
were deposited on a 3.05 mm copper grid (purchased from TAAB). Excitation and 
emission spectra were measured in a Horiba Fluoromax-4 (3mg/mL ZGO). 
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3.3 Synthesis of Chromium-Doped Zinc Gallium Oxide 
(ZGO) Nanoparticles 
Zinc gallate nanoparticles have been synthesized following a single step 
hydrothermal method adapted from the methodology reported by Li et al
10
. Shortly, 
precursors were premixed and pH set to 9 before carrying the hydrothermal synthesis 
at 220̊ C for 10 hours. We chose this method because it produces good quality sub-10 
nm and mono-dispersed single crystals. These crystals are ready functionalised and 
forming a stable colloid in aqueous solvent. Contrary to other approaches, no solid 
state annealing or sintering steps are needed. Consequently, no post-treatments such 
as ball milling are either required. 
The final products are nanocrystals with a chemical formula as follows; 
ZnGa2O4Cr0.004. Size of particles is tuneable by adjusting ratio of precursors. 
However, as conditions are changed to get bigger particles, the colloid become more 
polydispersed.
10
 As it can be observed in Figure 3.1, under optimized conditions, the 
size distribution obtained is relatively narrow when compared with similar PL 
materials. The average size obtained is 6.3±1.16, figure 3.1 B shows the size 
distribution of NPs obtained after purification without performing any physical 
treatment or size selection. The ratio between Ga
3+
 and Zn
2+
 ions has big 
implications on the size and mono-dispersity of the sample. Optimal Zn/Ga molar 
ratio used here is 2:2. The excess of Zn that did not react to form crystals is thought 
to form either complexes with ammonium or ZnO as impurities that can be easily 
removed by washes with hydrochloric acid
10
. 
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Figure 3.1: Synthesis of ZGO:Cr NPs A) TEM picture showing ZGO:Cr NPs as 
synthesised (Scales 200 nm). B) Size distribution. 
3.4 Characterisation 
3.4.1 Crystal structure and Elemental characterisation 
Figure 3.2 shows HRTEM image of the ZGO:Cr NP and its highly ordered structure  
in atomic resolution, confirming the formation of a single crystal. With a interplanar 
distance of approximately 2.86 Å, which is in agreement with the interplanar (311) 
distance in the original work.
10
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Figure 3.2: High resolution (HR) TEM of a single crystal. A) Bright field HR 
TEM image B) High angle annular dark field HR TEM. (Scale bars are 5 nm). 
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Crystal structure was studied by TEM electron diffraction. The pattern obtained by 
this technique is the same as the X-Ray diffraction (XRD) pattern in the reference 
paper
10
 (figure 3.3 A). This confirms the formation of a pure cubic spinel crystal 
structure (JCDPS card no. 01-082-0466). Cr
3+
 ions can be easily brought together 
into the Gallium lattice forming a very stable structure due to the similar size and 
valence of both atoms.
7
 ZGO followed a pure spinel structure (JCDPS card no. 01-
082-0466) where the Zn
2+
 occupies the tetrahedral sites and Ga
3+
 the octahedral sites 
(Figure 3.3 B). Spinel crystals usually have the same general chemical formula: 
A
2+
B2
3+
O4
2-
, composed by cubic close-packed oxides coordinated with four 
octahedral and two tetrahedral sites per formula. Usually, A
2+ 
ions occupy 1/8 of the 
tetrahedral and B
3+ 
1/2 of the octahedral sites. However, it has been shown that 
around the 3% of the ZGO crystal is actually an inversed spinel, where 3% of Zn 
occupies Ga sites and vice versa, these sites are termed as antisite defects.
16,17,18
 
Following Kröguer-Vink notation, this defects are referred as Ga
●
Zn when a gallium 
ion is in a Zn site resulting in a positively charged defect; and Zn
'
Ga, in this case Zn 
fills Ga forming a negative defect. These local charges in the crystal when they are 
close to the activator, in this case the doped Cr are believed to be the driving force 
for the trapping of the electron-hole.
8,17,18 
Therefore, it is not surprising that 
modification of the ZGO structure has been a common strategy to improve the 
optical properties of this class of material. Bessière et al. showed that a deficiency of 
Zn leads to a longer and more intense luminescent signal
19
. Pan et al synthesised a 
LPP ceramic discs, with a decay time of more than 360 hours measured by a night 
vision system. They introduced Germanium (Ge) and formed a gallogerminate 
(Zn3Ga2Ge2O10:Cr
3+
) to achieve those properties.
20
 M. Allix and co-workers went 
one step further by replacing Ga atoms by germanium and tin in the ZGO matrix 
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with a chemical formula Zn1-xGa2-2x(Ge,Sn)xO4:Cr
3+
 where 0≤x≤0.5. Superior optical 
properties were obtained when x=0.1; they also showed that the mechanism behind 
this improvement was not related to the inverse spinel character like in ZGO, but to 
the distortion of the octahedral site close to the Ge and Sn positive defects forming 
new traps.
17
        
   
 
 
Figure 3.3: Crystal structure of ZGO. A) TEM electron diffraction of as 
synthesized ZGO:Cr crystals B) Crystal structure of ZGO. From reference 18.
18
 
 
The composition of ZGO:Cr nanoparticles were studied by Energy-dispersive X-Ray 
spectroscopy (EDX). Data obtained by EDX shows that they are very close to the 
theoretical atomic percentage; 0.12% of Zn and 0.24% of Ga, (i.e. 1:2 Zn/Ga ratio). 
This also indicates that the excess of Zn formed impurities that were efficiently 
washed out afterwards.     
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Figure 3.4: Energy-dispersive X-Ray spectroscopy (EDX) of ZGO:Cr crystals.
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3.4.2 Optical properties characterisation 
ZGO:Cr nanoparticles are part of a second generation PL NPs. The classification 
attends to the optical properties; this second generation of LP NPs has a special 
characteristic; excitation bands are within the NIR window, and more importantly, 
they can be re-activated by exposure to light, feature that is commonly referred as 
optical batteries. This represents a step forward in the use of LPP for long-term in 
vivo imaging. Understanding the role played by Cr as a dopant in our system is 
fundamental to explain its special optical properties. Interestingly, ZGO:Cr does not 
need to be pre-charged with UV-light, as it is the case of other materials such as 
LiGa5O8:Cr discs mentioned in chapter 1. 
Excitation and emission spectra of ZGO:Cr nanoparticles synthesised by 
hydrothermal method following Li et al protocol
10
 were measured (Figure 3.5 A). As 
expected from Cr
3+
 doped materials, we recorded a sharp emission band in the NIR 
region at 696 nm. This sharp emission spectrum in the NIR window make of Cr
3+
-
doped ZGO nanoparticles ideal candidates for in vivo imaging. Similarly to the 
excitation spectrum obtained by Maldiney and co-workers
8
 (who synthesized 
ZGO:Cr by hydrothermal synthesis followed by sintering), our measurement shows a 
strong absorption band in the UV region of the spectrum. Bessière et al proposed that 
it corresponds to an excitation with a higher energy than the band gap.
19
 There is a 
similar small excitation band in the range of 500 to 650 nm corresponding to lower 
energy than the band gap, matching the Cr
3+
 d-d transition
18
. This absorption band is 
especially relevant for in vivo experiments since is located close to the NIR window. 
This absorption band is responsible for the possibility to reactivate the particles once 
they are injected to the animal.  Decay time is affected by changes in the depth of 
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crystal defects. Afterglow time is directly proportional to the number and the depth 
of defects. Figure 3.5 B shows the room temperature intensity decay curve obtained 
with ZGO:Cr colloid before and right after exciting it by the fluorometer xenon lamp 
at 570 nm for 5 minutes. The curve intensity was recorded for ̴500 seconds, which is 
shorter than the reported for the same material obtained after sintering.   
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Figure 3.5: Optical properties of Cr:ZGO nanoparticles synthesized by 
hydrothermal method. Concentration of 3mg/mL of ZGO was used for the 
measurements. A) Excitation (in black) and emission (in red) spectra B) Intensity 
decay curve before and after excitation, in black and red respectively measured for 
500 seconds at room temperature.     
 
Chapter 3: Synthesis and Surface Modification of ZGO:Cr Nanoparticles 
84 
 
3.4.3 Colloidal stability characterisation 
The final sintering step used by Maldiney et al seems to improve the optical 
properties of this material. However, as explained in the introduction of this chapter, 
sintering or generally high temperature treatments induce the formation of bigger 
NPs and broader size distributions. High temperatures also causes desorption of any 
molecules on the NP surface previously adsorbed during the liquid phase synthesis. 
This lack of surface molecules leads to very poor colloidal stability; therefore many 
authors opt for a hydroxylation by wet grinding of the powder obtained after the heat 
tratment
8,21,22,14,7,23,9
. The biggest advantage of the method used here is that mild 
conditions are used through all the synthesis process and therefore stable, small and 
monodispersed NPs are obtained. What is more, to the authors’ and our knowledge, 
this is the only published method in which active LP nanoparticles are directly 
synthesised in aqueous-phase as a colloid.           
DLS measurements of purified NPs in mQ water (Figure 3.6 B) confirmed the sharp 
size distribution calculated by TEM data (Figure 3.1 B). Typical zeta potential 
measurement of the particles as synthesised showed a consistent positive global 
surface charge (41.9±1.11 mV for this particular batch in neutral pH). Colloidal 
stability can be certainly attributed to the electrostatic repulsion created by the charge 
of nanoparticles in solution. Colloidal stability is a requirement for bio-medical 
application but it also influences the surface modification approach. In contrast to 
NPs synthesized by sol-gel method, no hydroxylation step is needed here and a direct 
functionalisation can be applied (see next section). We have tried colloidal stability 
in different media, as it can be expected from highly charged particles; stability is 
directly proportional to polarity of the solvent (Figure 3.6 A). As an attempt to study 
the surface chemical composition, FT-IR spectrum was studied after a thorough 
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purification (Figure 3.6 C). FT-IR peaks at 3443, 1627 and 1411 nm could be 
attributable to the N-H stretching of primary amines. The only source of amines 
added during the synthesis was ammonia solution used to raise the pH of the 
solution. Therefore, according to this data, ammonia might be the molecule 
responsible for the colloidal stability of the as synthesized nanoparticles. In addition, 
the peak at 891 nm is also attributable to ammonia, confirming the presence of this 
molecule.  
 
Figure 3.6: Colloidal properties of ZGO:Cr as synthesised. A) ZGO:Cr in 
different solvents. B) Hydrodynamic diameter measured by DLS of ZGO:Cr C) FT-
IR spectra of as synthesized ZGO:Cr.   
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3.5 Surface Modification  
Colloidal stability in complex environments such as physiological medium as well as 
control over the interaction with cells greatly relies in selecting a proper surface 
functionalization approach. Several factors need to be taken into account before 
selecting the most appropriate functionalization strategy. Mainly, which is the 
medium the nanoparticles are suspended and which surfactant/s are exposed. 
Exposure to high temperatures during the synthesis causes evaporation or desorption 
of molecules on the NPs’ surface, ultimately leading to poor or complete loss of 
colloidal stability. For this reason, an intermediate hydroxylation of the surface is 
needed to recover colloidal stability before the final functionalisation can be 
achieved. On the other hand, when LPP NPs are synthesized readily dispersed in the 
solvent, this intermediate step is not needed broadening the election of appropriate 
ligands.  In this section, four different surface modification approaches applied to 
ZGO:Cr NPs synthesized by hydrothermal approach are shown as well as 
characterization by means of DLS, Z-potential, TEM and FT-IR spectroscopy. First, 
polymers coating was used following an electrostatic approach. Silanization of ZGO 
was achieved through covalent binding of (3-Aminopropyl)triethoxysilane (APTES). 
DMSA was also proved to coordinate with ZGO:Cr surface and finally data obtained 
with bioconjugation of a CPP are shown here. All these functionalization strategies 
provided us with a library of candidates to be tested for cell labelling. Use of ZGO 
for cell labelling is an emerging field in which the a priori knowledge is limited and 
it needs to be tested. An ideal candidate should accomplish different parameters such 
as colloidal stability, abundant cell uptake, luminescence not affected, cell viability 
not compromised, which will be discussed in chapter 4 for the relevant candidates.  
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2.5.1 Electrostatic binding: Polymers 
The use of polymer for modifying inorganic NPs is frequent due to its simplicity, 
efficiency and reproducibility. Li et al modified ZGO:Cr NPs with 
Poly(ethyleneimine) (PEI), a positively charged polymer
10
. Here we used two 
different polymers: Poly(allylamine hydrochloride) (15 KDa PAH) and 
Poly(vinylpolypyrrolidone) (10 KDa, PVP). 100 µl of polymer (20 mg/mL) were 
mixed with 1 mL of ZGO (0.3 mg/mL) overnight.  Binding of polymers on the 
surface of the nanoparticles resulted in a significant increase of their hydrodynamic 
diameter as measured by DLS (Figure 3.7 A and B). Interestingly a bigger shift is 
observed when NPs are mixed with PVP, this is not attributable to a bigger size of 
the polymer, but probably to a different folding on the NP surface (note that in both 
cases, NPs surface were saturated since no further increase on size was observer after 
adding more polymer).  
Surface charge of the resulting particles was also measured confirming the positive 
charge expected from this surface (Figure 3.7 B). As expected, PAH-ZGO showed a 
strong positive charge, whilst PVP-ZGO tend to a more neutral charge. Since, ZGO 
before functionalization exhibited a positive charge; we think DLS is more 
appropriate here to track the binding to these specific polymers. 
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Figure 3.7: Characterization of ZGO:Cr polymer coating with PAH and PVP 
A) Hydrodynamic diameter measured by DLS of as synthesized ZGO:Cr (in black) 
and PAH coated ZGO:Cr (in red) B) as synthesized ZGO:Cr (in black) and PVP 
coated ZGO:Cr (in red). C) ζ potential of PAH and PVP coated ZGOs.   
 
2.5.2 Covalent binding: APTES 
Silanization is a common surface modification approach for metal oxide 
nanoparticles. In general, silica coated oxide NPs have previously been reported
24
 as 
well as specifically coated LPNPs
25,14
. Silane derivatives such as bifunctional 
APTES has  been broadly used to modified ZGO NPs since the silane binds to NPs 
surface while amine functionalisation allows further surface modification with a 
different ligands. Following this approach, PEG,
8,21
peptides
9,23,26
 and cancer 
targeting ligands
27,22
 have been conjugated to ZGO NPs.       
APTES modified NPs were characterized by FT-IR spectroscopy (Figure 3.8 A). 
Two bands present at 1119 and 1035 cm
-1
 are only present in the modified NPs. 
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These bands are attributable to the Si-O-Si stretching, indicating that silane is part of 
the analysed sample. In addition, colloidal stability of APTES-ZGO:Cr was assessed 
by means of DLS (Figure 3.8 B). While the increase in hydrodynamic diameter 
indicates that the surface was modified, the decrease in intensity might indicate the 
presence of bigger structures. This is probably due to the need to carry APTES 
functionalization in organic solvents. As seen in section 3.4.3 synthesized ZGO:Cr 
are stable in mQ water but the stability of the colloid decreases with the increase of 
the hydrophobicity of the solvent. Some aggregation might be the consequence of 
working with other solvent than mQ water. Alternatively,  a lack in the control of 
hydrolysis and condensation of APTES could be the problem. Data obtained by TEM 
(Figure 3.8 C) seems consistent with what was observed by DLS showing big 
agglomeration of NPs in some regions of the grid.  
We could have introduced an intermediate functionalization step, which would have 
enabled the transfer of ZGO to organic solvent without losing colloidal stability in 
order to solve this problem. However, we were having good results with the 
functionalization with DMSA and we focus our efforts to this strategy instead (see 
next sections). 
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Figure 3.8: Characterization of APTES functionalization. A) FTIR spectra of as 
synthesized and APTES modified ZGO:Cr NPs. B) Hydrodynamic diameter 
measured by DLS of as synthesized ZGO:Cr (in black) and APTES-ZGO:Cr (in red) 
C)TEM picture of APTES modified ZGO:Cr (scale bar: 200nm). 
 
2.5.3 Coordination binding: DMSA 
Dimercaptosuccinic acid (DMSA) is a water-soluble and potent chelating agent and a 
drug used in the treatment of heavy metals poisoning approved by the FDA. It has 
previously been used for the functionalisation of gold nanoparticles
28,29
, silver 
nanoparticles, iron oxide
29,15
, zinc oxide nanorod arrays
30
 and preparation of CdS 
quantum dots
31
. However, to the best of our knowledge, DMSA has not previously 
been used to functionalize LPNPs.  
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The formation of the NP-DMSA coordination complex formation was assessed here  
by changes of zeta potential from very positive (+49.7) of as synthesised ZGO NPs 
to very negative (-45.5 mV) after conjugation to DMSA. In addition, an increase in 
their hydrodynamic diameter was also observed confirming the success of the surface 
modification with DMSA. Although the binding mechanism of DMSA to Zn is not 
clear, it forms an efficient and strong complex with Zn atoms which improves 
colloidal stability of LPNPs.   
 
 
Figure 3.9: Characterization of DMSA functionalization. A) ZGO:Cr-DMSA 
coordination complex formation B) Hydrodynamic diameter measured by DLS of as 
synthesized ZGO:Cr (in black) and DMSA coated ZGO:Cr (in red) C) Zeta potential 
measurements of as synthesized ZGO and DMSA coated ZGO.   
 
DMSA is a promising capping agent for biomedical research due to the ability to 
form strong and stable binding with NPs surface through metal coordination, water 
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solubility, biocompatibility and tetra-functionalisation that offers the possibility to 
conjugate biomolecules. Bioconjugation with TAT peptide is discussed in the next 
section as a model peptide. 
3.5.4 Bioconjugation with cell penetrating peptide  
Similarly to the GNRs bioconjugation discussed in section 2.5.3 of Chapter 2, ZGO 
was modified with TAT peptide using the carboxyl acid available in DMSA as 
scaffolds for bioconjugation.  Condensation reaction was carried out between the 
amine end of the peptide and activated carboxylic acid on LPNPs surface to yield an 
amide bound. Activation of carboxylic acid was accomplished by the use of a 
carbodiimide, EDC, and an active ester; NHS. This leads to a highly active 
intermediate that reacts with a primary amine forming an amide bound (See section 
2.5.1). Using this system, HSA (human serum albumin) was previously bound to 
ZnO nanorod arrays using DMSA as a capping agent
30
.  
Here, bioconjugation was again assessed by measuring the hydrodynamic diameter 
and the surface charge of the NPs. Consistently, in each step of the process there was 
an increase of the hydrodynamic diameter, confirming the surface modification 
(Figure 3.10 A). In addition, Z potential measurements were in agreement with the 
data obtained by DLS (Figure 3.10 B). When carboxylic acids were activated, 
surface charge became less negative, Z potential shifted from -45.5 mV to -26.3 mV, 
confirming the formation of a neutral charged ester, but the composite remains still 
negative enough to stabilize the colloid (not all groups were activated). When TAT 
was conjugated to ZGO:Cr NPs surface charge of the hybrid material became 
positive, exhibiting a zeta potential of +39 mV. This confirmed the surface 
modification of TAT peptide, which is rich in positive aminoacids, conferring an 
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average positive surface charge to the bioconjugate. We have conjugated TAT to 
ZGO:Cr NPs because it has been reported that cell penetrating peptide such as TAT 
can increase cellular uptake, which might be beneficial for our labelling purposes. 32 
However, this strategy can be extrapolated to bind other type of molecules or 
structures that have an amino group available.   
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Figure 3.10: Characterization of TAT bioconjugation. A) Hydrodynamic diameter 
measured by DLS of as synthesized ZGO:Cr (in black) and DMSA coated ZGO:Cr 
(in red) B) zeta potential of unmodified ZGO:Cr, DMSA coated ZGO:Cr, 
intermediate activated  ZGO:Cr and TAT conjugated ZGO. 
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3.6 Gold Nanorods-Zinc Gallium Oxide Bimodal Probe 
An ideal probe or imaging system has not been established up to date. Moreover, 
every technique and their corresponding contrast agent have advantages and 
disadvantages. A possible solution is the imaging by two complementary techniques 
simultaneously. Indeed, one of the perspectives for NPs as contrast agents is 
multimodal imaging. Recent advances in imaging techniques allow the fusion of 
different imaging methods such as CT-PET coupled systems, already mentioned in 
section 1.1.
33
 This combines the high spatial resolution of CT with the high 
sensitivity of PET. Under these promises, 
18
F-doped cross-linked iron oxide (CLIO) 
have been successfully used to simultaneously image the liver and the blood pool of 
mice in vivo.
34
 Radiolabelled isotopes have also been introduced in other NPs for 
multimodal imaging such as NIRF contrasts loaded in  silica NPs in combination 
with optical imaging
35
  and iron oxide NPs for MRI.
36
     
Here, we used a core-shell approach where SH-PEG-COOH modified GNRs (See 
section 2.4.2) were used as scaffolds to bind APTES modified ZGO particles (See 
section 3.5.2) though EDAC/NHS amide condensation reaction (See section 2.5.1). 
Unfortunately, as it can be observed in the TEM image (Figure 3.11), binding of 
LPNPs was very efficient. This might be due to the tendency shown by APTES-ZGO 
NPs to agglomerate (Figure 3.11). A better control of the colloidal stability could 
lead to a better LPNPs shell formation around GNRs. An alternative to this method 
could be the use of DMSA coated ZGO:Cr, since DMSA functionalisation is carried 
out under hydrophilic conditions ensuring the stability of particles.  
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Figure 3.11: TEM image of GNRs-ZGO composites. 
3.7 Conclusions 
ZGO NPs were synthesized following a single step hydrothermal approach resulting 
in monodispersed nanoparticles with an average diameter of around 6 nm. A sharp 
emission at 696 was measured, appropriate for in vivo imaging. The crystal structure 
and elemental composition was characterized showing the presence of a pure cubic 
spinel crystal structure with a Zn/Ga ratio of 1:2. In addition, these as synthesized 
nanocrystals were stable in water.  
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Different surface modification strategies were studied such as polymer coating or 
APTES modification. Among the ligands used, DMSA was the most promising one 
for different reasons. First, it is a FDA approved treatment for heavy metal poisoning 
in humans. In addition, DMSA is soluble in water and a stable binding to ZGO NPs 
is achieved via metal coordination. This ligand also offers the possibility to conjugate 
biomolecules. In this chapter the bioconjugation with TAT peptide was shown as an 
example. DMSA has been used to modify the surface of different NP (GNPs, silver 
nanoparticles, iron oxide, zinc oxide nanorod arrays and CdSe quantum dots). 
However, to the best of our knowledge, DMSA has not previously been used for 
functionalizing LPNPs. 
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Chapter 4  
Labelling Cells with Gold Nanorods 
and Chromium-doped Zinc Gallium 
Oxide Nanoparticles 
4.1 Introduction 
4.1.1 Transport Pathways Across the Cell Membrane 
Cell membrane (CM) is the first and most relevant barrier a NP has to deal with to 
internalise inside cells. CM is a dynamic structure that protects cells from their 
extracellular environment. Its main function is to maintain homeostasis inside cells 
acting as a selective barrier regulating the entry and exit of ions and molecules. There 
are different mechanisms of transportations across the CM. While ions and small 
molecules can cross through passive diffusion or protein pumps and channels, big 
biomolecules are transduced into the cell through a process called endocytosis
1
. 
Although some small NPs (< 5 nm) have been reported to cross the CM in a receptor 
independent manner such as passive diffusion
2
, it is agreed that the main mechanism 
of cell entrance for NPs is endocytosis.
3
 Therefore, we will focus here on the 
different types of regulated endocytosis.  
Chapter 4: Labelling Cells with GNRs and ZGO:Cr Nanoparticles 
103 
 
Endocytosis is a type of active transport that consists in an engulfment of molecules 
by membrane invaginations that leads to a pinching-off of fragments of the 
membrane, finally forming endocytic vesicles containing the different molecules and 
nutrients inside the cell. Endocytosis can be divided in two big types; phagocytosis 
and pinocytosis. Phagocytosis in mammals primary occurs in Phagocytes such as 
macrophages, monocytes and neutrophils. It is a highly specific process that is 
usually triggered by opsonisation, i.e. binding of opsonins such as immunoglobulins, 
blood proteins that are later specifically recognized by receptors on cell surface.
4
 
Different families of receptors are involved in phagocytosis such as scavenger 
receptors, Fc receptors and complement receptors. Binding of opsonins to these 
receptors triggers a signalling cascade mediated by Rho-family GTPases leading into 
the formations of phagosomes. Phagocytosis has special relevance in the 
inflammatory response against pathogens such as bacteria or in the clearing of 
apoptotic cells. Phagocytosis response to NPs has also been broadly studied after 
systemic injection.
5
 Pharmacokinetics of nanocarriers can be compromised when 
detected by the mononuclear phagocyte system (MPS), previously referred as 
reticuloendothelial system (RES), reducing the circulation half-life of NPs. The use 
of sterically shielding polymers such as PEG have been shown to escape the MPS by 
protecting NPs from opsonisation which leads to an improvement of the 
pharmacokinetic profile by increasing the circulation time.
6
 Doxil
®
 is the first 
liposome-based chemotherapeutic drug approved by the FDA and it is a good 
example of the latter.  
Pinocytosis, on the other hand, occurs in all cells and four main mechanisms have 
been described; chlathrin-mediated endocytosis (CME), caveolae-dependent 
endocytosis (CDE), Chlatrin/caveolae independent endocytosis (CIE) and 
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macropinocytosis. CME takes place in a region of the membrane rich in chlathrin. 
Chlathrin is actively involved in the formation of vesicles in CME. Examples of 
receptors involved in CME include low-density lipoprotein (LDL) receptors, which 
play a role in the metabolism of cholesterol, and transferrin (TFn) receptors, which 
have been exploited for active drug delivery systems. Sometimes CME occurs in a 
receptor-independent manner. In these cases, non-specific hydrophobic or 
electrostatic interactions triggers cell uptake.
4
 Another endocytic mechanism is CDE, 
involving caveolae, which are flak-shaped invaginations in cell membrane very 
abundant in both epithelial and non-epythelial cells.
7
 CDE has been proposed to 
facilitate many physiological processes such as regulation of signalling cascades, 
homeostasis of intracellular cholesterol and other lipids and membrane tension.
8
 An 
important role of CDE is the uptake of serum albumin (SA) though receptors Gp60 
present in caveolae structures. Abraxane
®
 is a cancer nanotherapeutic based on the 
binding of paclitaxel to albumin proteins. It exploits the albumin affinity toward this 
endocytic receptor, facilitating its transport across the tumour interstitial spaces, 
where paclitaxel is released.
9
  Other membranes microdomains are involved in CIE. 
These lipid-rich microdomains are generally referred as rafts. The mechanisms and 
structures involved in this type of endocytosis are poorly understood.
1
 However, folic 
acid has been reported to undergo this mechanism of cellular transport through folate 
receptors.
10
 Folate-modified NPs are also uptaken after recognition and binding to 
this receptors.
11
 Interestingly, particles undergoing cellular uptake by folate receptors 
are taken in endocytic compartments or directly transported into the cytoplasm.
12
 
Finally, macropinocytosis differs from the previous endocytosis pathways since it is 
based on a rearrangement of the protrusion of the CM that collapse and fuses with 
the membrane. This leads to the formation of big endocytic vesicles (0.2-5µm), 
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referred as macropinosomes.
13
 It is thought to play a role in the downregulation of 
signalling molecules such as some growth factors
14
 and in immune surveillance.
15
 
This entrance pathway could be relevant for the cell uptake of larger NPs due to the 
big volume of macropinosomes.
16
 
         
    
Figure 4.1: Different mechanisms of endocytosis in the cell. From reference 1 
4.1.2 Cell Uptake of Nanoparticles 
Cellular uptake is a crucial step in the development of NPs for biomedical 
applications. Therefore, a deep understanding of this process is needed for the design 
of effective NPs-based treatments. As it was shown before, entry to the cell is a 
highly regulated and sophisticated process where many factors play an important 
role. These factors can be divided in three main groups; physicochemical properties 
of NPs, the biological component and the experimental conditions (such as 
incubation time, temperature, cell type, etc.). 
4
      
The effect of physicochemical properties on NP-CM interactions has been 
thoroughly studied. Properties such as size, shape, charge and hydrophobicity have 
been reported to play a role in cell uptake. Regarding size, different studies 
conducted with macrophages indicate that larger NPs experienced a higher 
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phagocytic internalization.
17-18
 Furthermore, 50 nm NPs have been indicated to be 
the optimum size in different cell lines.
19
 It has been theorized that 50 nm can occupy 
an elevated number of receptors while not being too big to pose problems with the 
membrane wrapping process.
20
   In addition, size not only has a repercussion on the 
quantitative uptake of NPs but also dictates the intracellular localization. It was 
shown that while  non-functionalized red quantum dots QDs (2.1 nm) accumulated in 
the nucleus and nucleoli of cells, red QDs (3.4 nm) were found in the cytoplasm.
21
 
Related to size is the effect that aggregation of NPs has on cell uptake. It is well-
known that some NPs may aggregate when exposed to physiological conditions due 
to its high ionic strength.  Both theoretical models
22
 and experimental studies
23
 agree 
that clusters or aggregates formation enhances cell uptake, probably due to a higher 
sedimentation rate. Shape of nanomaterials also modulates cell uptake. Different 
studies have highlighted the more efficient uptake shown by spherical shaped NPs 
compared to its rod-shaped counterpart.
24,19,25
 Two possible explanations have been 
proposed; membrane wrapping of rods takes longer and also surfactants adsorbed in 
the longitudinal axis of rods could have a negative effect. Uptake experiments with 
different sized rod-shaped NPs have also been conducted and have concluded that 
Aspect ratio (AR) also plays a decisive role. Shorter rods with a smaller AR were 
shown to have a better uptake profile than those longer with bigger AR due to the 
longer wrapping time, previously mentioned.
26,19
 It has also been proposed that not 
only longer GNRs inhibits cell uptake but also the absolute size/area value influences 
cell uptake.
27
     
Surface charge has an important impact on the interactions of NPs with the CM as 
well. It was shown that positive and negative NPs underwent different endocytosis 
pathways in Hela cells. Cationic particles are internalized only via CME while 
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negatively charged particles undergo both CME and caveolae-dependent 
endocytosis.
28
  An extensive work has been done for a better understanding of the 
interactions between charged particles and CM all of them highlighting the 
importance of charge to trigger cell uptake. Molecular dynamic simulations showed 
that attraction of cationic NPs to membrane phospholipid is bigger than uncharged 
NPs and that they can also trigger membrane wrapping.
29
 In addition, similar studies 
revealed that the membrane disruptive effect of cationic NPs increases with charge.
30
  
Studying interaction of NPs with artificial lipid bilayer assemblies has brought some 
light to this topic as well. It was found that both, positively and negatively charged 
NPs bind to lipids exerting changes in the bilayer. It was shown that the particles can 
bind either to N
+ 
or T
-
 terminus of lipids.
31
 Moreover, cationic NPs were divided in 
three groups according to their disruptive effect of the lipid bilayers. Some NPs such 
as PAMAN G3-NH2 dendrimers, tend to accumulate around a defect without creating 
new defects. NPs such as GNP-NH2 diffuse across existing defects enhancing them. 
Finally, TAT sequence was found to create new holes and defects.
32
 This different 
mechanisms of cellular uptake have also implications on the amount of NP’s uptake 
and intracellular localization. For example, a study showed that cationic GNPs 
induce a 5-fold bigger uptake than their negatively charged counterpart. In addition, 
the authors showed that half of the cationic NPs diffuse across the CM creating holes 
and could be found in the cytoplasm while anionic particles were also found inside 
cellular endosomes.
33
 Our group also found that positively charged TAT-modified 
GNPs could diffuse across the cell membrane directly to the cytosol and nucleus and 
the mitochondria.
34
 Positively charge GNRs were also found to transduce more 
effectively inside Hela cells than negatively charged particles.
35
 However, it was 
found that cationic NPs induce membrane depolarisation in several cell lines which 
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increases the intracellular concentration of Ca
2+
. This might result in modification of 
cellular pathways such as inhibition of proliferation or reduction of viability.
36
 
Finally, hydrophobicity is another parameter to take into consideration to understand 
cell uptake of NPs. Molecular dynamic simulations showed that while hydrophobic 
NPs are thermodynamically stable in the core of lipid bilayers, hydrophilic NPs have 
a higher affinity for the surface of the lipid bilayer.
37
 Moreover, hydrophobic QDs 
were found to form hybrids with lipid of the bilayer being dispersed around the 
bilayer.
38
 It is important to understand that NPs intended for biological applications 
need to be stable in physiological conditions which are hydrophilic. Therefore there 
is a need to find a compromise between hydrophobicity and hydrophilicity. 
Lipinski’s rules of 5, also called Pfizer’s rules of 5, predicted that molecules with 
drug-like properties (i.e. good solubility in physiological conditions are able to cross 
biological membranes), octanol-water partition coefficient log P should not be 
greater than 5.
39
    Our group recently reported a work studying the interaction of 
amphiphilic GNPs with  biological membranes acting as artificial ion channels.
40
    
The interaction of NPs with biological components can interfere with cellular uptake. 
NPs used for biological studies are exposed to physiological environments such as 
blood and cell-culture medium. Biomolecules such as serum proteins are present in 
these environments at high concentrations. These proteins can be adsorbed on the 
surface of NPs forming a protein corona, changing the composition of NPs surface.
41
 
Since NPs are presented to cells through their surface, this protein layer could have a 
great importance in cellular-NPs interactions.
42
 Lesniak et al showed the relevance of 
protein corona in silica NPs. Serum free incubation of this particles resulted in a 
higher cell uptake than when particles where incubated with serum proteins. They 
also showed that protein corona also affected to the cellular location of NPs. While 
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complete medium resulted in entrapment of NPs in endosomes, some NPs were 
found free in the cytosol when serum free medium was used.
43
 In addition,  different 
variants of the protein corona  such as composition  (i.e. source of proteins and type 
of proteins), number of protein bounds and conformation influences the fate of 
NPs.
44,45
      
4.1.3 Chapter Overview 
The aim of cell labelling is to confer a distinctive contrast to our cells of interest in 
order to distinguish them from endogenous components using bioimaging 
techniques. In this chapter, cell labelling with the different probes described in 
chapter 2 and 3 is discussed. Selecting the most appropriate nanoparticle-ligand 
conjugates was the main aim here. The selection is based on the efficacy of 
nanoparticles as contrasts for the different imaging techniques employed in each case 
(see chapter 5). Cell uptake is one of the parameters studied to assess the effectivity 
of nanoparticles as potential probes. As mentioned in the introduction many factors 
affect the cell uptake of nanoparticles. In this chapter we will only focus on the 
differences that stem from the modification of surface of GNRs and ZGOs, because 
the other parameters such as size and shape were fixed to obtain the desired optical 
properties as seen in previous chapters. It must be noted that cell uptake, understood 
as number of nanoparticles inside the cell, is not the only parameter to take into 
account here. The highest uptake is not necessarily the best condition.  We optimised 
our conditions to achieve the highest contrast or in other words the highest increase 
of a specific optical parameter, obviously, without affecting cell viability. Thus, it is 
crucial for us to assess the optical properties of labelled cells, better than the absolute 
amount of material (Au or ZGO) in cells. Hence, for GNRs, we focused on the 
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conservation of optical properties of GNRs after cell uptake measured by vis-NIR 
spectroscopy, since PAI ultimately relies in the absorption of light by contrast agents. 
Whilst for ZGO the efficacy was assessed by measuring luminescence of labelled 
cells in the same instrument than preclinical imaging it has to be performed, i.e. in 
vivo imaging system (IVIS).    
4.2 Experimental 
Cell line: murine mesenchymal stem/stromal cell line MSCD1 (CRL-12424) cell 
line, were used for cell culture experiments. The cells were purchased from ATCC
®
 
and obtained from the bone marrow of Mus musculus, mouse. 
Reagents: Dulbecco’s Modified Eagle Medium (DMEM) was obtained from Gibco. 
Phosphate-buffered saline (PBS), penicillin−streptomycin and silver enhancer kit 
from Sigma Aldrich. Fetal bovine serum (FBS) was purchased from Life 
Technologies. 
Protein corona and medium stability: PEG-COOH-GNRs and TAT-GNRs were 
incubated overnight with cell culture medium (DMEM supplemented with 10% 
FBS). Size of particles before and after incubation was determined by Dynamic Light 
Scattering (DLS) and optical properties by vis-NIR spectroscopy.  
Cell labelling: In a typical experiment, 2 × 10
5
 MSCs were seeded in 6-well plate 
with 2 mL cell culture medium (DMEM supplemented with 10% FBS) and incubated 
at 37°C with 5% CO2 humidified atmosphere for 24hs. After 24 h, medium was 
replaced with 400 µL of NPs in 1.6 mL of fresh medium with 1% 
penicillin−streptomycin. For GNRs labelling, 400 µL PEG-COOH-GNR at an 
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optical density (O.D) of LSPR band = 6 were mixed with 1.6 mL of  fresh medium 
(i.e. final concentration in cell culture medium was 1.2 O.D). For ZGO labelling, 400 
µL of 10 mg/mL DMSA-ZGO:Cr were mixed with culture medium (i.e. final 
concentration was 2 mg/mL). For dual labelling, a mixture of NP of PEG-COOH-
GNRs at 24 OD and 10 mg/mL of DMSA-ZGO was used instead giving a final 
concentration in cell culture medium of 4.8 and 2 mg/mL respectively.  Finally, cells 
were incubated with NPs for 24 h. 
Silver enhancement staining: Cells were labelled as described above, but seeding 
5× 10
4
 MSCs cells in 24-well plates. After 24 hours incubation, cells were fixed with 
4% para-formaldehyde (PFA) at room temperature. Cells were washed with PBS and 
dH2O. 400 µL of a mixture prepared with equal volumes of the kit’s two reagents 
were added in each well and left to 10 mins. Cells were washed with dH2O before 
adding 400 µL of sodium thiosulfate (2.5% in aqueous solution) and washed several 
times with dH2O. Finally cells were imaged using a Leica’s light microscope.      
Sample preparation for vis-NIR spectroscopy: After incubation with PEG-
modified GNRs in 6-wells microplate, cells were washed several times with PBS and 
dissociated using trypsin. Cells were resuspended in fresh medium, washed twice 
with PBS by sequential centrifugations (500g for 3 mins), and number of cells was 
determined using an automated cell counter (TC10, BioRad). 9 × 10
5
  cells were 
transferred to eppendorfs in PBS for vis-NIR measurements. 
Persistent luminescence measurements: Persistent luminescent measurements 
were acquired using an IVIS spectrum system (PerkinElmer).  10
4
 MSCs cells were 
seeded in 96 black well flat bottom plates and incubated for 24 hours. Dilutions of 
naked ZGO:Cr, DMSA-ZGO:Cr and TAT-ZGO:Cr were prepared to average 
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emission intensity to 600,000 p/s (photons per second) in all samples as measured by 
IVIS. MSCs were incubated with 20 µL of ZGO with the different functionalities in 
80 µL of fresh medium for 24 hours. Cells were washed several times with PBS. 
Excitation of particles was performed by exposing the plate to 2 BLS-series white 
BioLED light sources (3000K, 12W), purchased from Mightex, for 5 minutes. 
Persistent luminescence measurement were performed by open filter and acquisition 
time was set to 2 minutes. Each condition was prepared and measured in triplicates.      
Preparation of cells for TEM: The samples were prepared for transmission electron 
microscopy (TEM) using the following protocol: after 24 h incubation, cells were 
fixed with a solution containing 1% paraformaldehyde and 3% glutaraldehyde in 0.1 
M cacodylate buffer (pH 7.4). Then, cells were incubated with a reduced osmium 
staining solution, containing 2% OsO4 and 1.5% K4[Fe(CN)6], for 1 hour. This was 
followed by a second 1 hour osmium staining (2% OsO4) step and overnight staining 
with 1% uranyl acetate. Cells were washed with water for 3 minutes, 3 times after 
every staining step. Samples were then dehydrated in graded ethanol (30%, 50%, 
70%, 90% and 2x 100%) for 5 minutes each. Finally, samples were infiltrated with 
medium TAAB resin 812 and embedded within the same resin. The resin was cured 
for 48 h at 60°C. Finally, ultrathin sections of 350 μm x 350 μm x 74 nm were cut 
and placed in 200-mesh Formvar/Carbon filmed grids. They were post-stained with 
uranyl acetate (4% UA in a 50:50 ethanol/water solution) and Reynolds lead citrate 
before TEM imaging. 
Cell Imaging: Cell were imaged using a Tecnai G3 spirit TEM at 120 keV, For cryo 
TEM, cells were labelled on a TEM grid and placed inside an FEI Vitrobot Mk2 
vitrification system at 8 °C. The samples were blotted twice before being plunged 
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into liquid ethane. Environmental scanning electron microscopy  (ESEM) was performed 
in a FEI Quanta 250 FEG scanning electron microscope. 
Cell viability (ATP assay): Cell viability was assessed with Cell Titer Glo ATP 
Assay (Promega). Cells were labelled as described above, but seeding 10
4
 MSCs 
cells in 96-well plates. Cells were incubated with 0, 0.1, 0.5, 1, 3, 5 mg/mL ZGO:Cr 
in medium, for assessing toxicity of dual labelling cells were incubated with 2mg/mL 
DMSA-ZGO, 1 nM (4.8 O.D in cell medium Approx.) PEG-COOH-GNRs and a 
mixture of both NPs at the same concentrations (80% medium and 20% NPs solution 
in each case) for 24 h. After labelling, cells were washed 3 times with PBS. 50 μL of 
medium were added to each well and then 25 μL of the ATP reagent was added. The 
plate was mixed in an orbital shaker and, after 10 minutes, the contents of the plate 
were transferred to white, opaque, 96-well plates and the luminescence measured 
with a plate reader (Fluostar Omega, BMG Labtech). Each condition was assessed in 
triplicate and results are given as % ± SD in respect to cells that were incubated with 
no GNRs.  
Notes about concentrations of nanoparticles 
Concentration of nanoparticles is expressed in many different ways in the literature 
depending on the type of nanoparticles, application, or author’s preferences. Some 
times this can make the comparison between types of nanoparticles or between 
different works difficult. To facilitate comprehension to the reader of this thesis, we 
include here a table with approximate equivalences. Note that we normally expressed 
GNR concentration as O.D. of the LSPR peak because they were going to be used as 
probes for optical imaging and it is the best way to minimize the slight variations 
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between batches. ZGO concentrations are normally given in mg/mL because it is the 
most usual way in the literature for these NPs. 
For the calculations we used absorbance at 400 nm of GNRs to obtain atomic Au 
concentration
46
 and the size of nanoparticles to obtain the theoretical weight of a 
nanoparticle (m=d×V). 
LSPR peak 
(O.D.) 
A400 atomic Au  
(mM) 
mg Au/mL GNR/mL GNR 
 (pM) 
0.1 0.03 0.01 2.79 X 10-6 1.35 X 1010 22.38 
1 0.34 0.14 2.79 X 10-5 1.35 X 1011 223.80 
2.4 0.82 0.34 6.70 X 10-5 3.24 X 1011 537.11 
3.6 1.22 0.51 1.00 X 10-4 4.85 X 1011 805.67 
4.8 1.63 0.68 1.34 X 10-4 6.47 X 1011 1074.22 
 
Table 4.1: Calculations of GNRs concentrations. 
 
 
mg ZGO:Cr/mL NP/mL NP (µM) 
0.5 6.37 X 1014 1.06 
1 1.27 X 1015 2.11 
1.5 1.91 X 1015 3.17 
2 2.55 X 1015 4.23 
2.5 3.18 X 1015 5.28 
 
Table 4.2: Calculations of ZGO:Cr NPs concentrations. 
4.3 Labelling cells with GNRs 
As seen in section 2.1, the use of surfactants such as CTAB in GNRs synthesis is 
crucial for the synthesis of anisotropic nanoparticles. However, CTAB is a cytotoxic 
surfactant at the concentration used in the synthesis (100 mM)
47,48,35
. As table 4.1 
shows, CTAB cytotoxicity is dose dependant. Concentrations above 20 µM resulted 
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in cell death when incubated for 24 hours with murine mesenchymal stem/stromal 
cell line (MSCs). It was also found that at this range of concentrations, the quantity 
of CTAB is too low to guarantee the colloidal stability of GNRs and the particle tend 
to aggregate in cell culture medium. Therefore, it is clear with those results that 
surface of GNRs had to be modified to avoid toxicity. Different strategies have been 
discussed in chapter 2; in this section we will focus on the interaction with cells of 
the 2 types of PEG explained in chapter 2. Note that PEG is a biocompatible 
molecule widely use in pharmaceutical products (such as the stabilizer Carboxwax®) 
and as capping agent/surfactant for a range of nanoparticles.
49
  
 
 
Table 4.3: Cell viability by trypan blue test after 24 hours incubation of MSCD1 
with different concentration of CTAB in solution.  
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4.3.1 SH-PEG 5000 Vs. SH-PEG-COOH: protein corona formation 
and its implications on cell uptake. 
4.3.1.1 Incubation of SH-PEG-5000 with stromal-mesenchymal cells  
In our first approach SH-PEG-5000 was used as capping agent. GNRs functionalised 
with SH-PEG-5000 as explained in section 2.4.1 were incubated with MSCs for 24 
hours. Presence of GNRs in cells was screened with optical microscopy.  To 
facilitate their visualisation, contrast of GNPs was improved by using a silver 
enhancer which uses colloidal gold as a nucleation core, leading to a higher contrast, 
which enables visualisation of GNPs with an optical microscope.
50
 Black stains in 
the area of the cells is an indication of GNPs inside cells. However, other techniques 
such as electron microscopy would be needed for conclusive results. CALNN-capped 
GNPs were incubated simultaneously as a positive control of cell uptake.  Figure 4.2 
shows the optical microscopy pictures of labelled cells before and after silver 
enhancement. Cells incubated with CALNN-capped GNPs showed a great amount of 
black stains after silver enhancer, indicating a relevant internalisation of NPs. On the 
other hand, no significant uptake was observed with PEGylated GNRs. Nonetheless, 
cell death and aggregation problems observed with CTAB were overcome using PEG 
as a capping agent.  
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Figure 4.2: Optical microscopy picture of unlabelled cells, CALNN NPs and SH-
PEG-5000 labelled cells before (A) and after (B) silver enhancement. This 
preliminary experiment shows that SH-PEG-5000 did not elicit any major effect on 
cell viability, but no uptake was observed. CALNN NPs was used here as a positive 
control of uptake.  
 
4.3.1.2 Incubation of SH-PEG-COOH with stromal-mesenchymal cells 
Optical microscopy studies indicated that GNR-SH-PEG-5000 did not show a 
significant cell uptake, or at least, it was shown to be much lower than CALNN NPs 
suggesting that PEG 5000 is not a good candidate for our final application. This is in 
agreement with other works.
51
 This effect on cell uptake has been proposed to be 
achieved by avoiding or reducing protein adsorption due to the “brush” conformation 
that PEG particles adopt in solution.
52
 This fact has been related to a lower uptake by 
immune cells (often described as a stealth effect) observed for nanoparticles capped 
with this type of PEG.
53
 We therefore, started working with a short (523 Da) 
carboxyl-terminated PEG (SH-PEG-COOH). Briefly, this new PEG provides a thiol 
group, which has high affinity to gold surface; a short hydrocarbon chain to improve 
ligand packing; and finally a carboxylic group which is deprotonated at physiological 
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pH, providing negative charge and therefore electrostatic stability (see chapter 3.4.2 
for details on the conjugation). In this section, some of the results obtained by 
labelling stem cells with GNRs modified with SH-PEG-COOH will be discussed. 
Further results are shown in the next sections as well. 
MSCs were incubated with SH-PEG-COOH-GNRs for 24 hours and imaged by 
optical microscopy. Black stains in cells were easily spotted for this condition even 
with no need to use silver enhancement, thus indicating presence of gold in cells. 
(Figure 4.3 A). It was observed that those stains followed a circular pattern around 
the central part of the cells. These types of patterns are indicative of the accumulation 
of nanoparticles around the nucleus after their uptake. 
54
 All in all, this supports the 
hypothesis that contrarily to SH-PEG-5000, this smaller PEG induced uptake of 
GNRs by MSCs. We believe that the different interaction with proteins from the 
serum might explain why these GNRs were uptaken by cells. To study these 
interactions, we incubated GNR-SH-PEG-COOH in cell medium supplemented with 
serum and measured changes on their hydrodynamic diameter by Dynamic light 
scattering (DLS) (figure 4.3 C). A shift to larger diameters was observed after 
incubation. This increase in the hydrodynamic diameter can only be explained with 
the recruitment of proteins on the particle surface, since the nanorods did not 
experience any degree of aggregation as demonstrated by the maintenance of their 
optical properties (Figure 4.2 D).  This is therefore very likely attributed to 
unspecific adsorption of proteins from the medium. As mentioned in chapter 2, this is 
a well-known process affecting many different types of nanoparticles in biological 
medium, often known as protein corona. 
55
 It must be noted here that DLS is unable 
to provide the actual values of the increase in the hydrodynamic diameter of GNRs. 
As we mention in previous chapters, anisotropy of GNRs resulted in two components 
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of Brownian motion, which is translated in two peaks in DLS data. Therefore more 
than the absolute values, the important information here is the observed shift to 
larger diameters and the conservation of the anisotropy, which agrees with the 
adsorption of proteins and absence of aggregation. 
In order to further study our system, SH-PEG-COOH GNRs were incubated in a 
serum free medium (i.e. cell medium without proteins). In the absence of proteins, 
optical microscopy pictures showed big aggregates of particles around the cells but 
no black contrast was observed around the central part of cells (Figure 4.3 B). This 
data suggests that serum proteins in medium plays an important role on the stability 
of GNRs, and consequently on their interactions with cells. Although PEG-COOH 
GNRs were stable under physiological pH (Figure 2.4 A in chapter 2), the high ionic 
strength of cell culture medium is likely to be the reason of their aggregation. 
Therefore, spontaneous adsorption of serum proteins not only protects SH-PEG-
COOH-GNRs from aggregation in cell culture medium, but they also are very likely 
to favour their uptake. Charge provided by COO
-
 seems to quench the shielding 
effect observed in large PEGs. It has been reported that the charged counterpart of 
PEG have a greater affinity toward proteins and  therefore a higher cell uptake.
56
 
With all this information, PEG-COOH was selected as a better candidate for our 
purposes. Uptake of these GNRs and their bioconjugates are studied in greater detail 
in the next sections.  
Chapter 4: Labelling Cells with GNRs and ZGO:Cr Nanoparticles 
120 
 
 
Figure 4.3: Cell uptake of GNRs modified with PEG-COOH. Figure A) Optical 
microscopy pictures (40 x magnification) of MSCD1 cells incubated GNRs with 
serum (A) and without serum (B) C) vis-NIR spectra of PEG-COOH modified GNRs 
in HEPES (in black) and after 24hs incubation with cell medium (in red). D) 
Normalized vis-NIR spectroscopy of PEG_COOH-GNRs before and after incubation 
in cell medium. 
 
4.3.1.3 Uptake of SH-PEG-COOH-GNRs and the effect on the optical properties of 
labelled-cells.  
As mentioned before in this chapter, Photoacoustic Imaging (PAI) deeply relies on 
the ability of probes to absorb light, rather than on gold content inside the cells (See 
chapter 5). Therefore, it is important to study vis-NIR spectrum of labelled cells 
since confinement of GNRs inside vesicles in cells (e.g. endosomes) can alter their 
optical properties due to agglomeration and/or plasmon coupling. After incubation of 
cells with GNRs, the resulting labelled cells were trypsinized and vis-NIR 
spectroscopy conducted (Figure 4.4). It was observed a significant gain in the 700-
900 nm region of the spectrum, which is the region used in PAI. It was also observed 
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a broadening and a decrease in intensity of the LSPR absorbance, compared to the 
one corresponding to the same GNRs in solution  This phenomenon is symptomatic 
of GNRs agglomeration inside the cell 
57
. When the labelled cells were lysed by 
ultrasounds, the intensity and shape of the LSPR was completely recovered (figure 
4.4 in blue). This proved that it is an agglomeration rather than sintering. The 
broadening of the LSPR is ascribable to the well-known plasmon coupling effect 
58
. 
When particles are confined in a small volume, the electric field of a particle disturbs 
the neighbouring particles fields which leads to an alteration of the optical properties 
59
. This is the precise scenario when particles are uptaken by cells via endocytosis 
and packed in the endosomes. GNRs only retrieve their stability and resulting optical 
properties when they are released from this confinement after cell lysis. Despite an 
evident broadening and loss of intensity of the LSPR band, there is still a clear 
increase in the absorbance at 700-900 nm, which made this strategy suitable for PAI 
of cells. Obviously avoiding plasmon coupling and/or agglomeration in endosomes, 
would result in higher sensitivity. In this regard, we have observed that co-incubation 
of GNR-SH-PEG-COOH with ZGO have a huge impact in avoiding this phenomena 
(see details in section 4.5.1). Also, in a parallel work we have developed a strategy to 
minimise plasmon coupling in cells by coating GNRs with a 35 nm silica shell.
60
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Figure 4.4: Optical properties of PEG-COOH-GNRs-labelled cells. vis-NIR 
spectra of PEG_COOH_GNRs in solution (black), GNRs- labelled cells (red) and 
labelled cells after lysis by ultrasounds (blue). 
 
4.3.1.4 Electronic microscopy imaging of cells labelled with SH-PEG-COOH-
GNRs 
Optical microscopy and vis-NIR spectroscopy of labelled cells provided information 
indicating that GNRs modified with SH-PEG-COOH were transported inside the 
cell. However, electron microscopy imaging is still needed to confirm uptake and 
localize GNRs inside the cell. A battery of electron microscopy techniques were used 
here for imaging labelled cells after 24 hours incubation. Transmission electron 
microscopy (TEM), Cryo-TEM and environmental scanning electron microscopy 
(ESEM) were selected here as complementary techniques to image labelled cells. 
TEM (Figure 4.5) is one of the most widely used techniques due to its high 
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resolution, which can be down to 0.1 nm. Due to the possibility to image not only 
NPs but also subcellular structures, allows discriminating the mechanism of uptake 
(e.g. endocytosis) and also the assessment of signs indicative of cytotoxicity such as 
apoptotic vesicles. However, the sample preparation is time consuming so high 
throughput of samples is not possible. Sample preparation and staining may lead to 
shrinking problems changing the physiognomy of cells
61-62
. For this reason a 
cryogenic approach (Figure 4.6), where fixation process is avoided, provides 
complementary information about the cell in more similar conditions to the standard 
hydration level while still being able to image cellular organelles
63
. In addition, 
ESEM (Figure 4.7) allows the possibility to control the humidity levels of samples 
during the imaging. This permits the imaging of hydrated cells, i.e. in similar 
conditions to the cells culture. However, contrast is not good enough to see details at 
the subcellular level.  
All in all these techniques allowed the imaging of individual particles and provided 
with complementary information about the localisation of GNRs and physiognomy 
of cells after different treatments.  From the images obtained with the three 
techniques, it is consistent that GNRs form mainly clusters inside the cells. 
Moreover, from the TEM and cryo-TEM images, it is observed that GNRs are 
closely packed in cell vesicles, most likely endosomes. This indicates that PEG-
GNRs are transported across the cell membrane via endocytosis. In some vesicles of 
the cell, it seems that gold cores are even being fused. This is consistent with data 
obtained with the vis-NIR spectroscopy which showed a broadening of the LSPR due 
to agglomeration of NPs and plasmon coupling. 
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Figure 4.5: TEM imaging of MSCs labelled with PEG-COOH-GNRs.  
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Figure 4.6: Cryo-TEM imaging of MSCs labelled with PEG-COOH-GNRs. 
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Figure 4.7: ESEM imaging of MSCs labelled with PEG-COOH-GNRs. 
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4.3.2 SH-PEG-COOH modified GNRs and its bioconjugates 
derivatives  
SH-PEG-COOH is a promising ligand for labelling cells with GNRs as results 
discussed in the previous section suggests that they are stable under physiological 
conditions and they can be transported through the cell membrane. This ligand can 
also be used as scaffolds to bind biomolecules as it was discussed in section 2.5 of 
chapter 2. This offers many possibilities such as attachment of drugs for drug 
delivery or building complex structures with other active NPs to form bimodal 
probes (section 3.6 in Chapter 3). Figure 4.8 summarizes the conjugation approach. 
In this section, we focus on the relevant biological differences between PEG-GNRs 
and its covalent bio-conjugates.  
 
Figure 4.8: Diagram summering the bio-conjugation of GNRs with CPP and 
BSA.  
 
Bovine Serum Albumin (BSA) protein and transactivator of transcription (TAT) 
peptide were selected for being bound to GNRs (See sections 2.5.2 and 2.5.3 
respectively). We selected these biomolecules due to its biological relevance. BSA is 
the most predominant protein in cell culture medium. Our aim here was to study the 
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differences in cell uptake between a spontaneous protein corona formed in situ in the 
cell culture dish and a covalently bound BSA to GNRs. In addition, as mentioned in 
chapter 2, TAT (GRKKRRQRRRPQ) was the first discovered Cell Penetrating 
Peptide (CPP). It is the basic domain of HIV TAT protein and a polycationic 
arginine-rich peptide. The first NP conjugated with TAT was presented by Josephson 
et al in 1999.64 It was shown that there was a 100-fold enhancement of cellular 
delivery when superparamagnetic NPs were conjugated with TAT. 64 It has been 
debated that TAT can traduce into cells in a receptor-independent manner. This was 
supported by the observation that small Antp peptides (RQIKIWFQNRRMKWKK), 
which is the third helix of Antennapedia homeodomain, can cross cell membranes at 
4 °C
65
, indicating that receptors do not have a role in the mechanism and therefore all 
cell type could benefit from the observed enhanced cell uptake triggered by the 
peptide. However, the cell uptake mechanism has not yet been completely 
elucidated.  
In order to assess stability, PEG and TAT modified GNRs were incubated in 
complete cell medium for 24 hours before GNRs were purified by centrifugation. 
Zeta potential measurements (Figure 4.9 A) showed that TAT and PEG modified 
NPs had very different surface charge in aqueous solution. The deprotonated 
carboxylic acids on the surface of the particles make an average negative charge 
while TAT is a peptide rich in positively charged aminoacids. However, the final 
surface charge after incubation of both particles in cell medium was virtually the 
same, even when particles were purified. Proteins in medium have an average 
negative charge. Therefore, these results show that proteins covered the surface of 
both particles, leading to the same final average surface charge.  
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On the other hand, hydrodynamic diameter distribution curves obtained after 
incubation of the particles in cell culture medium showed differences when the two 
conditions were compared. PEG-COOH-GNRs retained colloidal stability since only 
a shift of a few nanometres and two peaks were always observed (Figure 4.3 C). This 
also revealed that proteins do not lose their native conformation as denaturalized 
protein would precipitate and form big aggregates. TAT modified GNRs posed a 
different scenario; shift in the hydrodynamic diameter was not only bigger after 
incubation with cell culture medium, but big structures close to 10000 nm were 
observed (Figure 4.9 B). In addition, the two peaks in the diameter distribution 
graph, distinctive of anisotropic particles, were starting to be lost. Alike PEG-GNRs, 
surfaces modified with TAT triggers the formation of big particle aggregates as 
measured by the DLS. Most likely this was due to the denaturalization of serum 
protein which led to a crosslinking of GNRs.
66,67
 vis-NIR spectroscopy of the 
different GNRs is consistent with the latter results. No changes in the optical 
properties were observed when PEG-COOH-GNRs were incubated under 
physiological conditions (Figure 2.3 D), proving their remarkable colloidal stability. 
On the contrary, vis-NIR spectrum of TAT-GNRs after incubation showed a 
broadening of the LSPR. In addition, the increase in optical density at long 
wavelengths indicated an increase of the scattering component in the optical 
spectrum, which is related to the presence of bigger particles. This confirmed the 
aggregation of GNRs functionalised with TAT when exposed to cell medium.  
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Figure 4.9: Stability of TAT-GNRs and PEG-COOH-GNRs in complete cell 
culture medium. A) Zeta potential of GNRs before and after incubation in cell 
culture medium. B)  Hydrodynamic diameter measured by DLS of TAT-GNRs 
before and after incubation. C) Normalized vis-NIR spectroscopy of PEG_COOH-
GNRs before and after incubation in cell medium. 
 
Figure 4.10 shows the spectrum obtained after labelling MSC with PEG-GNRs and 
its two different bioconjugates after a subsequent washing of the treated cells. All 
samples tested showed a broadening in the LSPR, which is a “symptom” of plasmon 
coupling. This might indicate that all the different surfaces triggered cell uptake 
through endocytosis and particles were tightened inside cell vesicles.  However, 
differences in the shape of plasmons and in area under the curves (AUC) are 
observed in the graph. The type of binding of proteins to GNRs had an effect on the 
cell uptake of particles. Area under the spectrum of PEG modified GNRs was bigger 
than in the covalent protein corona one. This indicated a bigger uptake when PC was 
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formed in situ in the dish. It is difficult to predict what was causing this difference 
since many variables have to be taken into consideration when working with cells. 
Only BSA was available on the surface of covalent protein corona while there was a 
big range of proteins in the serum used in cell culture. Different protein composition 
on the surface of particles could create a different response. It is also possible that 
when the amide bond is formed between an amine of the protein and the carboxylic 
acid, BSA could suffer a small change of conformation, which could lead to a lower 
affinity toward the Gp60 receptors (serum albumin receptor) on cell membrane.
45
 On 
the contrary, as it was expected from the vast literature on TAT conjugated NPs, 
TAT-GNRs showed an increase in AUC when vis-NIR of labelled cells was 
measured. This indicates an enhancement of cell uptake when compared to PEG-
COOH-GNRs. However, broadening of LSPR is more prominent with these 
particles. As it was shown in figure 4.9, TAT-GNRs showed a lower colloidal 
stability under physiological conditions than PEG-COOH-GNRs which had an 
impact on optical properties of labelled cells. Here we measured the vis-NIR spectra 
of labelled cells because we were interested in the optical properties of GNRs and 
how they change after cellular uptake. Amount of gold inside the cell can be 
measured more accurately by inductively coupled plasma mass spectrometry ICP-
MS.            
C. Fleischer et al
68
 showed that positively charged polystyrene NPs triggered the 
denaturalisation of BSA while negatively charged NPs were able to retain the native 
structure. They demonstrated by binding assays, that the secondary structure of the 
protein corona regulated the binding to different membrane receptor. They 
speculated this is the reason for the difference observed in cell uptake. This 
unfolding of proteins triggered by positive charges could be the explanation for the 
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bigger shift observed with TAT modified GNRs after incubation with cell-culture 
medium (Figure 4.9). To recapitulate, it seems that the protein structure of the 
proteins adsorbed or deliberately attached to NPs have a repercussion on cellular 
uptake. While unfolded proteins could  have an enhance effect (TAT-GNRs), small 
changes of conformation (covalent PC) could have the opposite effect.
45
  
 
Figure 4.10: Optical properties MSCs labelled with different bioconjugated 
GNRs. vis-NIR spectroscopy of labelled cells with PEG_COOH, TAT and covalent 
BSA capped GNRs. 
To summarize, optical microscopy showed that PEG-COOH was a better ligand than 
PEG 5000 in terms of cell uptake, since no internalisation of particles were observed 
with the latter ligand. In addition, although TAT was shown to improve cell uptake, 
stability problems in cell medium led to a change in the optical properties of labelled 
cells due to agglomeration and plasmon coupling. Therefore, we selected SH-PEG-
GNRs as the most promising probes to continue to the in vivo experiments. 
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4.4 Labelling cells with ZGO  
Results regarding the labelling of MSCs with Chromium-Doped Zinc Gallium Oxide 
(ZGO) Nanoparticles are presented in this section. Synthesis, surface modification 
and characterisation of this material are fully discussed in chapter 3. From the library 
of ligands created in section 3.5, DMSA and TAT modified ZGOs were selected for 
the in vitro studies due to their superior colloidal stability along with the stability of 
the binding form between ZGO surface and DMSA. Briefly, DMSA forms a 
coordination bound with heavy metals, in this case Zn. Then, TAT peptide was 
bound in a covalent manner via condensation reaction. See section 3.5 for details in 
the conjugation of ZGO. The performance of the different surfaces was assessed by 
means of IVIS signal and compared with “naked” ZGO.   
4.4.1 “Naked” ZGO Labelling  
Unlike GNRs, as synthesized ZGO did not elicit any major cytotoxicity. Moreover, 
cell viability assays showed that cell survival is over 92% even at a concentration of 
5 mg/mL of ZGO (Figure 4.11 C). In addition, MSCs were incubated for 24 hours 
with unmodified and IVIS signal of the resulting labelled was measured. Results 
obtained by IVIS showed that cells labelled with ZGO concentrations as low as 0.5 
mg/mL are detectable. However, total flux, defined as photons per second, increases 
linearly only after incubations with higher concentrations than 1 mg/mL. Therefore, 
the aim for surface modification here was improving cell uptake of naked particles at 
the same time that colloidal stability in physiological conditions was maintained.    
Chapter 4: Labelling Cells with GNRs and ZGO:Cr Nanoparticles 
134 
 
 
Figure 4.11: Incubation of MSCs with ZGO:Cr. A) Luminescence images shown 
in radiance, i.e. photons per second per square centimetre per steradian (p/s/cm2 /sr)] 
of ZGO-labelled MSCs at different concentration after white light excitation for 5 
min. B) Total flux recorded with labelled cells. Error bars are the standard deviation 
of the average over 3 replicates. C) MSCs cell viability after 24 hr of incubation with 
ZGO:Cr. Error bars are the standard deviation of the average over 3 replicates.  
 
4.4.2 Naked ZGO Vs. DMSA-ZGO Vs. TAT-ZGO 
In order to select the most appropriate surface functionality between non-
functionalized particles, DMSA-ZGO and TAT-ZGO, we studied the luminescence 
intensities of labelled cells after 24 hours incubation. The optical signal was 
normalized to photons per second also expressed as total flux. For this, dilutions of 
the different particles were prepared so all samples were emitting at the same 
intensity in total flux (600,000 p/s) before incubation with cells. Note that different 
concentrations were needed to achieve the same number of photons per second 
(Table 4.2). IVIS measurements of cells seeded directly in a well-plate, showed a big 
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variance between the different functionalities used (Figure 4.12). While cells labelled 
with non-functionalized NPs showed luminescence intensity similar to unlabelled 
cells, TAT NPs presented a remarkable intensity. These results indicate that TAT 
NPs underwent a much higher cellular uptake than uncoated NPs and DMSA-NPs. 
Conversely to GNRs, ZGO optical properties are not inhibited by proximity of 
neighbouring NPs. Therefore, in this case a higher cell uptake is always synonym of 
better optical properties. However, TAT labelling showed a poorer reproducibility 
when compared to results obtained with DMSA-ZGO. The higher level of 
aggregation in cell medium observed with TAT NPs (not only ZGO but also GNRs) 
could be the cause for this. The formation of these aggregates could also be one of 
the reasons causing this remarkable cellular uptake along with the cell penetrating 
properties of TAT peptide. As mentioned in the introduction, it was reported that for 
some systems, aggregates could enhance cellular uptake. 
 
Figure 4.12: Cell uptake of ZGO:Cr, DMSA-ZGO and TAT-ZGO A) 
Luminescence image of ZGO:Cr, DMSA-ZGO and TAT-ZGO- labelled cells  B) 
intensities (expressed in p/s) of MSCs labelled with ZGO:Cr, DMSA-ZGO and TAT-
ZGO. Error bars are the standard deviation of the average over 3 replicates. 
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Functionality Concentration Total flux of ZGO in 
solution (p/s) 
Total flux of 
labelled cells (p/s) 
Non-functionalized 1.8 mg/mL 600000 1464 
DMSA-ZGO 0.3 mg/mL 600000 9597 
TAT-ZGO 1.7 mg/mL 600000 88237 
 
Table 4.4: Actual concentration of NPs used in figure 4.11 and the intensity 
shown in total flux (p/s). 
 
Interestingly, when luminescence intensities of labelled cells are related with the 
actual concentration of NPs used in cell medium, the performance of DMSA and 
TAT were comparable (31990 and 51904 p/s per mg of ZGO in cells). The fact that 
lower concentrations of DMSA-ZGO were needed to achieve the same luminescence 
than their counterparts seems to indicate that this functionalization strategy might 
improve the performance as contrast agents of ZGO NPs. However, a deeper study of 
the effect that DMSA has on the optical properties of ZGO would be required to 
confirm this. A similar effect triggered by the use ligands but in a different system 
was reported in the literature. Alterations in the intensity of NIR luminescence of 
protecting monolayers of Au38and Au140 quantum dots were shown by Wang et 
al.
69
   They conducted a systematic study about the effect of ligand on NIR 
luminescence on this system.
69
 They found out that the increase in NIR luminescence 
is proportional to the polarity of the ligands and the level of ligand exchange.  They 
also showed that this increase is due to the binding of electron-withdrawing groups to 
the gold cores. In addition, they also reported an increase in NIR luminescence 
intensity after functionalization with carboxylic acids linked by a small chain.
69
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DMSA is a short molecule functionalised with two thiols and two carboxylic acids. 
Therefore, we might be observing a similar effect on the ZGO NPs. However, as 
mentioned before a thorough study of the effect of ligands on our system needs to be 
conducted before jumping into conclusions. In addition, we expect that this effect is 
size-dependent. Smaller NPs (like ZGO) have greater surface areas and seems likely 
that this effect on optical properties caused by ligands is happening only on the 
surface of NPs.  
4.4.3 DMSA-ZGO  
DMSA was selected as the most appropriate ligand due to its effective luminescence 
intensity per mg of product and its stability in cell medium. In addition, there is one 
step less in the DMSA functionalization protocol, improving the final yield 
comparing to TAT-coated NPs. Cell uptake of DMSA was studied in more detail and 
compared to non-functionalized ZGO. Figure 4.13 shows the luminescence measured 
of labelled MSCs with non-functionalized and DMSA coated ZGO at different 
concentration. Similarly to section 4.4.2, dilutions were made here so the particles 
were emitting at a comparable intensity in solution and then MSCs were incubated 
for 24 hours. As it can be observed in figure 4.13 A DMSA-ZGOs clearly underwent 
a much higher cellular uptake. In the graph it can be seen that the intensities of MSCs 
labelled with DMSA-ZGOs are 3-fold higher than with “naked” ZGO. Moreover, 
TEM pictures confirmed the remarkable uptake with DMSA ligands. Similarly to 
GNRs, ZGO particles are trapped in cellular vesicles, indicating that NPs were 
uptaken via endocytosis. As mentioned before, the luminescent optical properties of 
ZGO NPs are not affected by the packing in endosomes.  
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Figure 4.13 Cell uptake of DMSA coated NPs. A) Luminescence intensities of 
MSCs labelled at non-functionalized and DMSA-ZGOs at different concentrations. 
Error bars are the standard deviation of the average over 3 replicates. B) TEM 
pictures of MSCs slices after 24 hours incubation with DMSA-ZGO at 2 mg/mL.  
4.5 Dual labelling 
Multimodal imaging is a necessary field since it can overcome the drawback of a 
particular imaging technique by combining it with a different technique. When 
probes are designed to be injected systemically, there is a reasonable need to bind 
both probes to make sure that the signal measured by the different techniques is 
located in the same anatomical region. In our case, NPs are used for cell labelling 
and both GNRs and ZGO were shown to be uptaken via the same cellular 
mechanism, being both of them found in the endosomes. Another advantage of co-
labelling over hybrid probes is that the different components can be easily modulated 
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by increasing (or decreasing) the concentration before the incubation. In addition, it 
is well known that metals such as gold can quench emission of fluorophores 
depending on distance
70,71,72
. In addition, in our specific case, the number of ZGO 
NPs incubated with cells was much bigger than GNRs. For example, 2 mg/mL ZGO 
corresponded approximately to 4.75 x 10
15
 NP/mL, whilst GNRs were incubated at a 
concentration = 1 nM (i.e. 6.47 X 1011). Although, this proportion was not necessarily 
maintained inside cells, seems obvious that the number of ZGO needed to provide a 
good signal has to be much higher than that for GNRs, which for this application 
makes it difficult the use of hybrids. For this reason we chose a co-labelling 
approach. Instead of binding both probes together, we decided to co-incubate both 
types of NPs with the cells simultaneously. We expected to find both probes in the 
same endosomes; hence we should be able to locate both signals inside cells. The 
potential drawbacks of co-labelling to be considered are: adverse effects on colloidal 
stability due to interparticle interactions and effects on cell viability much bigger 
than the ones for individual NPs. DMSA modified ZGO NPs and PEG-COOH 
modified GNRs were pre-mixed at the appropriate concentrations before incubation. 
No aggregation effects were observed, the negative charge of both NPs resulted in an 
electrostatic repulsion attributable for the colloidal stability of the mixture. In order 
to quantify the percentage of viable cells we used a luminescent based assay which 
measures the amount of ATP after cells are lysed. ATP available is directly 
proportional to cell viability. Note that colorimetric assays such as MTT were not the 
most appropriate here because the absorbance of GNRs could interfere with the final 
results, contrarily ZGO does not interfere with luminescence assays since they need 
to be activated with white light to show emission. Figure 2.14 shows the results 
obtained with ATP assay after 24 hours of incubation with PEG-COOH-GNRs (1 
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nM), DMSA-ZGO (2 mg/mL) and dual labelling (i.e. 1 nM GNRs and 2 mg/mL 
ZGO). The results showed that no dramatic changes resulted from the incubation of 
MSCs with the different probes since the viability of all the samples tested was 
higher than 80 %.  
     Figure 
2.14: Cell viability of MCDs. ATP assay after labelling cells with PEG-COOH 
modified GNRs, DMSA modified ZGO and co-incubation of both probes at the final 
concentrations used for 24 hours. Error bars are the standard deviation of the average 
over 3 replicates.   
 
4.5.1 Effect of dual labelling on optical properties of GNRs 
As shown in section 4.3.1.3, optical properties of GNRs might change after being 
uptaken by cells and packed in endosomes, which might favour agglomeration and/or 
plasmon coupling. We showed in a parallel work that optical properties of GNRs in 
solution could be preserved inside cells by physically separating the gold cores using 
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a 35 nm silica shell.
60
 We showed that this leads to the improvement of sensitivity in 
photoacoustic detection of stem cells in vivo. 
 Figure 4.15 A shows the vis-NIR spectra of MSCs labelled cells with GNRs alone 
and dual labelling with GNRs and ZGOs. As it was expected, cell labelling with 
GNRs alone (in red) resulted in a broad plasmon band and decrease of intensity in 
the 700-900 nm range. Conversely, when ZGOs and GNRs are co-incubated 
simultaneously, LSRP was better preserved and intensity in this range was much 
higher. Moreover, when the spectra obtained with dual labelled cells was compared 
with the spectra of GNRs in solution, there is a shift of just a few nanometres. 
Therefore, these results show that co-incubation of GNRs with ZGOs had a 
protective effect against plasmon coupling. Figure 4.15 B shows the spectrum 
obtained from the two different labelled cells after lysis and plasmon coupling 
reverted. As it was previously explained, packing of NPs in endosomes is reverted 
when cells are lysed, recovering their optical properties. Interestingly, AUC was 
higher when GNRs were incubated alone. This indicates that the concentration of 
gold in cells was actually higher, but less effective in maintaining the optical 
signature of GNRs. These results highlight the importance of avoiding plasmon 
coupling to enhance the efficiency of GNRs when the final application relies on their 
optical properties.             
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Figure 4.15: Optical properties of labelled cells with GNRs and co-labelling with 
GNRSs and ZGOs. A) vis-NIR of labelled cells. Dashed line shows the spectra of 
PEG-GNRs in solution for a comparison with the labelled cells. B) vis-NIR of cells 
shown in A after sonication and consequent lysis of cells.  
 
TEM pictures of labelled cells confirmed the packing of NPs inside endosomes. 
Figure 4.16 A shows the agglomeration of GNRs inside the cellular vesicles. 
Moreover, fusion of gold cores can be observed in some cases. This is in agreement 
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with the decrease in intensity and broadening of the LSPR band observed in the vis-
NIR spectra. On the other hand, TEM pictures of co-labelled cells showed that ZGOs 
physically separated GNRs (Figure 4.16 B), improving like this the optical properties 
of GNRs in cells. Avoiding plasmon coupling not only improves the intensity of our 
contrast and hence, sensitivity of the imaging method but it can also avoid 
irreproducibility problems since plasmon coupling inside the cell has a random 
nature.    
 
Figure 4.16: TEM pictures of A) PEG_COOH-GNRs labelled cells and B) Dual 
labelling (i.e. DMSA-ZGOs and PEG_COOH-GNRs).   
 
4.5.2 Effect of dual labelling on optical properties of ZGOs 
The effect that GNRs may produce in the luminescent properties is more delicate. As 
mentioned before quenching of fluorescence by metallic NPs has widely been 
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reported in the literature. While this effect depends on many conditions, distance is 
one of the most important. Longer distances between the metallic NPs and the 
fluorophore  have been reported to decrease the quenching and even avoiding it 
completely if distance between probes is big enough.
70
 Figure 4.16A shows the 
luminescence of GNRs (4.8 O.D. in cell culture medium, approximately 1 nM), ZGO 
(2 mg/mL, or 7.9 µM) and co-incubation of both NPs in cell medium (4.8 O.D. 
GNRs + 2mg/mL ZGO in cell culture medium). Figure 4.16B shows the luminescent 
intensities of cells labelled with the previous conditions for 24 hours. In both 
scenarios, GNRs seem to have an inhibition effect on ZGO luminescent signal. 
Interestingly, this quantitative decrease is similar in both cases, being around the half 
of the intensity measured with ZGOs alone.  The decrease in luminesce is observed 
in both the cell medium before labelling and inside the labelled cells. Hence, 
selective cell uptake of the different NPs is not causing it. In addition, the relatively 
small number of GNRs compared to ZGO as observed in the TEM picture could 
indicate that a local quenching is not causing this effect, at least not completely. An 
inner filter effect is more likely to be causing this decrease that accounts for the half 
of the luminesce. ZGO NPs have a emission spectra with a sharp peak at 694 nm 
which partially overlaps with LSRP of GNRs.    
This inhibition of the luminescence of ZGO caused by GNRs could be reduced by 
using longer GNRs that absorbs at longer wavelength in the second optical window, 
avoiding the overlap of optical properties of both probes. For timing reasons we 
could not carry out the experiment changing these conditions. In addition, MSOT is 
measuring between 660 and 900 nm in standard conditions. Therefore LSPR fitting 
this range are the most appropriate for photoacoustic measures. Despite the decrease 
on luminescence caused by GNRs, the signal is still high enough to be able to detect 
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a small number of cells (≈30000). In the next chapter, in vivo studies obtained with 
these labelled cells are shown.  
 
Figure 4.17: Luminescence intensities of A) mixture of ZGO and GNRs in cell 
medium. B) Different strategies of labelled cells. Error bars are the standard 
deviation of the average over 3 replicates.  
4.6 Conclusions 
Cellular interaction of GNRs modified with a long chain PEG and a short chain with 
a COOH terminus PEG were investigated. Long chain PEG-GNRs did not show any 
cellular uptake. On the contrary, negative surface charge of GNRs modified with 
short chain PEG-COOH allowed protein adsorption leading to an increase in the 
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colloidal stability in physiological media and promoted cellular uptake. In addition, 
TAT and BSA-GNRs bioconjugates exhibiting different surface charges in aqueous 
solution were studied. However, the average surface charge shifted to negative after 
incubation with cell culture media in all cases due to the adsorption of proteins on the 
surface. Therefore, physicochemical properties of NPs need to be assessed before 
and after exposure to physiological environments in order to understand NP-cell 
interactions.  
DMSA conjugation of ZGO significantly increased cell uptake while maintaining 
colloidal stability. In addition, the surface effect of DMSA observed on ZGO 
luminescent intensity needs to be further studied. For this, measuring the intensity of 
luminescence with different number of DMSA molecules on ZGO surface would 
provide more information.  
Cells were co-labelled with ZGO and GNRs following a simultaneous co-incubation 
approach. Since the amount of ZGO needed to provide a good signal has to be much 
higher than that for GNRs, this approach is more appropriate than the use of hybrids. 
Co-labelling resulted in an alteration of the optical properties of both probes. First, a 
decrease in the intensity of the luminescent signal was caused by the presence of 
GNRs. Differences in cell uptake does not seem to be the problem since this was 
observed  also in the cell medium before cell labelling. Absorption of emitted light 
by GNRS is more likely to be causing this decrease. On the other hand, LSRP of 
GNRs was better preserved; it only shifted a few nanometres compared with the 
spectra of GNRs in solution. Moreover, intensity was significantly improved in 
contrast to cells labelled only with GNRs. This indicates that co-incubation of GNRs 
with ZGOs attenuates the effect of plasmon coupling on the optical properties of 
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GNRs. TEM pictures confirmed that both particles are located inside cellular 
endosomes, separating the gold cores.  
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Chapter 5 
Photoacoustic and Optical Imaging 
5.1 Introduction 
The recent advances in the development of non-invasive in vivo molecular imaging 
techniques and their respective appropriate contrast agents are having a large impact 
on different biomedical fields including oncology
1
, cardio-vascular deseases
2
 and 
cell tracking
3
. Studying the fate of implanted stem cells (i.e. biodistribution, viability 
and possible tumorigenicity) might help in the translation of regenerative medicine 
treatment into humans.
4
 
Optical imaging is broadly being used in biological research thanks to the advances 
made in the field such as the development of the fluorescent protein technology.
5
 The 
improvement of near infrared (NIR) optical contrast along with appropriate 
instruments enables the use of this technique in the whole-body imaging of small 
animals.
6,7
 Their remarkable sensitivity (in the picomolar range), its low cost and 
user-friendly handling make it a popular imaging technique. 
8,
 
9
  However, this 
technique is limited by the poor penetration depth (< 1 cm) due to the photon 
scattering in tissue. On the other hand, Photoacoustic imaging (PAI) is arising as a 
versatile  and powerful tool in bioimaging.
10
 It relies on the ability of a chromophore 
to absorb light pulses and generate a subsequent ultrasound.
11
  Thus, PAI is a hybrid 
method that combines the high sensitivity of optical methods, in the picomolar range, 
with the high resolution of ultrasound detection, 150 µm in our system.
12
 In addition, 
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scattering coefficient in biological tissue of USs is 2 or 3 orders of magnitude lower 
than photons,
13
 improving the penetration depth of pure optical imaging techniques. 
Multispectral optoacoustic tomography (MSOT) is an imaging method derived from 
PAI, the distinctive characteristic of MSOT respect to other photoacoustic imaging 
devices is the possibility to irradiate at different wavelengths.
14
 This enables the 
spectral resolution of different endogenous chromophores in animal tissues (e.g. 
haemoglobin and melanin) in real time
15 
and even the volumetric quantitative 
molecular imaging in entire small animals at the same time that anatomical 
information is provided.
14
 The signal is based on the generation and propagation of 
ultrasounds. Therefore, imaging of anatomical regions where density and sound 
speed varies from the rest of the body is challenging.
16
 Moreover, organs such as 
lungs or stomach cannot be imaged by this technique due to air content. We have 
combined the high resolution and penetration depth of MSOT with the sensitivity 
and whole-body imaging that pure optical methods offer.  
The detection capabilities of MSOT can be greatly enhanced by the use of exogenous 
contrast agents. While direct labelling methods are predominant for this technique, 
including nanoparticles (NPs) and dyes, some reporter genes such as near infrared 
fluorescent protein iRFP720 have been used as well.
17
 Among the different 
approaches for direct labelling, gold nanoparticles (GNPs) have attracted a lot of 
attention as PAI contrasts due to their strong absorption as a consequence of the 
surface plasmon resonance (SPR) effect.
18
 Optical absorption of GNPs is several 
orders of magnitude higher than organic dyes.
19
 For in vivo PAI, only GNPs that 
absorb in the NIR or optical window are used.
20
 This includes gold nanorods 
(GNRs), gold nanoshells, gold nanoprisms, gold nanocages and gold nanostars.
21
 
GNRs have been extensively used due to the relatively simple preparation method 
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and the possibility to tune the optical properties within the NIR window. MSOT is a 
spectroscopic technique able to resolve different chromophores, false positives due to 
endogenous cromophores with a similar absorption profile can occur. This may 
happen especially in highly vascularized organs such as the liver due to the 
absorption of pulsed light by haemoglobin.
22
 Therefore, using a complementary 
technique might be beneficial not only to image regions where photoacoustic 
imaging is not possible, but also to discriminate false positives.   
Here we explore the combination of GNRs with persistent luminescent 
nanoparticles (PLNPs). PL is an optical phenomenon that involves 
photoelectron storage after optical charging with UV, vis or NIR light and the 
slow release of charged carriers that can last from minutes to hours.
23,24
 These 
long lifetimes addresses the auto-fluorescence reported in fluorescent probes 
that increases the background signal since excitation and emission 
measurement can be separated in time.
25
 This ultimately increases the signal-
to-noise ratio, improving the limit of detection of the method.
26
 This along 
with the optical properties (excitation and emission) in the NIR and 
improvement of synthetic routes made in the recent years has positioned 
LPNPs as promising optical contrast agents.
23
 Here we have used Chromium 
doped zinc gallium oxide (ZGO:Cr) nanocrystals synthesized by a single-step 
hydrothermal approach,
27
 as a complementary imaging method to MSOT.    
Direct methods (i.e. labelling with probes) suffer from the signal dilution of 
the contrast agent over cell division. In addition, cell viability cannot be 
tracked and the release of probes after cell death may lead to misinterpretation 
of data.
28
 Reporter genes overcome these problems  since are retained in the 
successive generation after cell division.
29
 Bioluminescence imaging (BLI) has 
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the potential to offer an extraordinary sensitivity when reporter genes such as 
luciferase are used.
30
 Firefly luciferase has extensively been used due to the 
fact that its substrates are well tolerated by animals and their emission peaks at 
around 562 nm, closest to the infrared window for in vivo imaging.
31
 
However, not all cells can be transfected. For example, primary cells such as 
macrophages have very low transfection efficiency being very challenging to 
image them by BLI.
32
 In addition, this approach is obviously restricted to 
preclinical models due to the need to genetically modify the cells. Thus, 
although it is still in the early stages, the emerging field of PLNPs has a huge 
potential to extend the use of luminescence for in vivo imaging.  
In this chapter, we present the imaging results obtained by MSOT, BLI and persistent 
luminescence imaging in mice after subcutaneous and intracardiac injection of GNRs 
and ZGOs-labelled mesenchymal stem cells (MSCs). 
5.2 Experimental 
Cell labelling: 5 × 105 MSCs were seeded in a 60 mm dish with 5 mL of cell culture 
medium (DMEM supplemented with 10% FBS). After 24 h, medium was replaced 
with 400 µL of NPs in 1.6 mL of fresh medium with 1% penicillin−streptomycin. 
For GNRs labelling, cell culture media was replaced with 5 mL of PEG-COOH-
GNRs at a final concentration of 1.2 optical density (O.D.) in fresh media. For ZGO 
labelling, a final concentration 2 mg/mL of DMSA-ZGO in fresh was used. For dual 
labelling, a NPs mixture of PEG-COOH-GNRs at 4.8 O.D. and DMSA-ZGO:Cr at 2 
mg/mL in fresh media .  Finally, cells were incubated with NPs for 24 hours and 
dissociated using trypsin. Cells were resuspended in fresh medium, washed twice 
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with PBS by sequential centrifugations (500g for 3 mins), and number of cells was 
determined using an automated cell counter (TC10, BioRad). An appropriate number 
of cells for each experiment in 100 μL of PBS were transferred to microcentrifuge 
tubes. 
Animals. 8–10 week-old female SCID hairless outbred (SHO) mice (Charles River, 
Margate, UK) for whole body imaging or 8-10 week-old female CD1 mice 
(Charles River, Margate, UK) for the initial subcutaneous experiments were 
housed in individually ventilated cages at a 12 h light/dark cycle, with  ad 
libitum access to food and water. Experimental animal protocols were performed 
in accordance with the guidelines under the Animals (Scientific Procedures) Act 
1986 (licence PPL70/8741) and approved by the University of Liverpool Animal 
Welfare and Ethical Review Body. 
All cell injection and imaging procedures of mice were carried out under general 
isoflurane/oxygen anaesthesia. 
Subcutaneous injection: For GNRs-labelled cells, 8 to 10 week old female CD1 
mice were shaved, and fur was epilated around the abdomen using depilatory cream. 
2 × 10
6
 unlabelled MSCs and 1 × 10
6
, 2 × 10
6
, and 6 × 10
6
 PEG-COOH-GNR-
labelled MSCs in 100 μL of PBS were injected subcutaneously at four different 
positions of the mouse flank (top right, top left, bottom right, and bottom left). For 
multimodal imaging,  7.5× 10
5 
MSCs were injected in SCID hairless outbred (SHO)  
instead.    
Intracardiac injection: 10 weeks female Nude mice were positioned supine on a 
heated platform. Fur around the chest area was removed using depilatory cream and 
limbs were taped down to keep the mouse position fixed. Ultrasound gel was applied 
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liberally to the chest area and the ultrasound transducer (Prospect imaging system, S-
Sharp) was positioned above the chest so the long axis view of the left ventricle was 
visible. 100 µl of cell suspension was drawn up into an insulin syringe (29 G) and, 
using the ultrasound image as guidance, was inserted into the left ventricle of the 
heart. Cell suspension was then administered slowly over a period of approximately 
30 s.   
Bioluminescence imaging: IVIS spectrum system (PerkinElmer) was used. Animals 
received an intraperitoneal injection of D-luciferin (150 μg/g body weight, in PBS) 
10 min prior to imaging (open filter, automatic mode).  
Persistent luminescence imaging: Persistent luminescent measurements were 
acquired using an IVIS spectrum system (PerkinElmer). Excitation was performed by 
exposing the animals to 2 BLS-series white BioLED light sources (3000K, 12W), 
purchased from Mightex, for 5 minutes. Persistent luminescence measurements were 
performed by open filter and acquisition time was set to 2 minutes. 
Photoacoustic imaging: An MSOT inVision 256-TF small animal imaging system 
(iThera Medical GmbH, Munich, Germany) was used. 
33
 After acclimatisation for 10 
min inside the water bath, a whole-body scan was performed on the mouse with 1 
mm steps and the following wavelengths for acquisition: 660, 670, 680, 690, 700, 
705, 710, 715, 725, 735, 750, 765, 780, 795, 810, 820, 830, 840, 850, 860, 870, 880, 
890, 900, 910, 920, 930, 940, 1025, 1050, 1075, and 1100 nm. Heavy water was used 
in the water bath due to its low absorbance at wavelengths >910 nm (contrary to 
regular water). Linear-mode-based reconstruction and guided ICA or lineal 
regression multispectral processing were applied using view MSOT software v3.6 
(iThera Medical GmbH). 
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5.3 Imaging of Nanoparticles in solution 
5.3.1 Imaging of GNRs in solution by Multispectral Optoacoustic 
Tomography (MSOT) 
MSOT relies in the detection of ultrasonic waves generated as a consequence of a 
rapid thermoelastic expansion of photoabsorbing agents. The thermoelastic 
expansion and the consequent mechanical waves are a result of a temporal increase 
of temperature initiated by the absorption of light pulses.
34
 For this reason, GNPs 
have arisen as powerful PA contrasts due to their strong and sharp absorption which 
results from surface plasmon resonance (SPR) effect. 
21
  
We assessed the performance of our GNRs in terms of sensitivity and multispectral 
resolution. Increasing concentration of GNRs were placed in phantoms and imaged 
by MSOT, corresponding MSOT intensities were calculated after multispectral 
reconstruction (Figure 5.1). GNRs at concentration as low as 6.5 pM were detected 
in phantoms. In addition, a linear relation between concentration of GNRs and 
MSOT signal was observed.  
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Figure 5.1: Limit of detections of MSOT. MSOT signal in arbitrary units (a.u.) of 
as synthesized GNRs in solution at different concentrations measured in phantoms. 
Concentration of GNRs is expressed in absorbance of the LSPR peak (a.u.) and in 
molarity.       
 
The multi-wavelength approach of MSOT allows distinguishing between different 
cromophores. To test this feature with our system,  GNRs with different aspect ratio 
(A.R) and therefore, different vis-NIR spectrum, were imaged in a phantom (Figure 
5.2 A and B). The left well of the phantom was loaded with GNRs with an AR= 2.7 
and the right well with GNR with an AR= 2.0. Acquisition wavelengths from 680nm 
until 900 nm in 5 nm wavelengths steps were used for this experiment. Images were 
processed in two different ways; single wavelength or multispectral (Figure 5.2 C 
and D respectively). Figure 5.2 A shows the single wavelength images of a phantom 
cross-section. MSOT intensities as a response to pulses of different wavelengths are 
presented (I=690nm, II=700nm, III=760 and IV=870 nm), showing the different 
intensities of MSOT signal in the different samples, which correlates with the 
different vis-NIR spectrum of the GNRs used here. For example, MSOT intensity at 
800 nm is much higher for GNRs with AR=2.7, which absorb at longer wavelengths. 
Images processed by multispectral reconstruction (Figure 5.2 D), showed that the 
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technique resolved GNRs with different A.R. After applying the reconstruction with 
the corresponding spectra, it perfectly discriminates between both GNRs.  
 
Figure 5.2: MSOT analysis of GNRs in solution. A) UV-VIS spectra of GNRs. B) 
TEM images of GNRs I) aspect ratio is 1.9. Scale bar represents 500 nm. II) Aspect 
ratio is 2.7.  Scale bar represents 200 nm. C) Cross-section of commercial phantom at 
different wavelength. MSOT reconstruction was made by mode lineal method. I) 
image recorded at 690 nm. II) at 760 nm. III) at 800 nm. IV) at 870 nm. D) 
Multispectral reconstruction of a phantom cross-section using lineal regression 
reconstruction. 
 
5.3.2 Imaging of Chromium doped zinc gallium oxide (ZGO:Cr) in 
solution 
Persistent luminescent materials (PL) have arisen as promising candidates as optical 
probes for in vivo imaging due to its long emission times. These materials can glow 
for seconds, minutes or even hours after excitation is finished. This, allows the 
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measurement in the absence of any excitation source, avoiding tissue auto-
fluorescence and ultimately improving the signal to noise ratio.
26
  
To investigate if ZGO:Cr NPs are suitable for optical bioimaging, optical properties 
of nanocrystals in solution were studied by IVIS Spectrum system (PerkinElmer). A 
good characterisation of probes in vitro is a crucial step to success in the in vivo 
stage. For this, first ZGO:Cr at a concentration of 10 mg/mL were excited at different 
wavelengths and the fluorescent emission signals measurements were compared 
(Figure 5.3 A). The highest emission signal recorded was a result of excitation at 570 
nm and decreased as we moved from this wavelength. This is consistent with the 
optical properties measured with a fluorometer shown in chapter 3 and with the 
literature
27
. In addition, persistent luminescence of ZGO:Cr in solution was also 
studied. NPs were activated with a white LED lamp for 5 minutes and imaged at time 
0, 2.5 minutes and 5 minutes after the activation (Figure 5.3 B). Intensity of the IVIS 
Spectrum System signal decreased with time until 5 minutes, when it was barely 
detectable. Once again, there was a consistency with the decay time measured with 
the fluorometer presented in Chapter 3. 
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Figure 5.3: Optical properties of ZGO: Cr in solution measured by IVIS 
Spectrum system. A) Fluorescent emission signals after excitation at different 
wavelengths. Inset shows water and ZGO:Cr fluorescence at 570 nm B) 
Luminescence decay after activation with a white LED lamp for 5 mins. 
Measurement times shown are t=0, t= 2.5 mins and t=5 mins after the activation. 
Colour scale from 1.32 × 10
4
 to 2.59 × 10
5
 p/sec/cm
2
/sr  
5.4 Imaging of labelled cells  
5.4.1 Imaging of GNRs-labelled cells by MSOT 
Cells were labelled as previously explained, briefly MSCs were incubated with 
GNRs at O.D.= 1.2 in cell medium for 24 hours, washed with PBS and trypsinised. 3 
× 10
5
 GNRs-labelled MSC on a phantom were imaged by means of MSOT. Figure 
5.4 shows the imaged processed by single wavelengths (A) and multispectral 
reconstruction (B). Labelled cells (right well of the phantom) were compared to 
unlabelled cells (left), used as control. Similarly to section 5.3.1, different intensities 
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were obtained as a response to pulses of different wavelengths. Wavelengths from 
690 to 900 with 5 nm steps were used for MSOT imaging. Here we show: I) 690 nm 
II) 730 nm III) 780nm IV) 900 nm). The higher intensities obtained correspond to the 
wavelength close to the LSPR peak, proving that the signal is generated by GNRs 
and excluding any artefact.    
Multispectral processing was conducted as well with the labelled cells (Figure 5.4 
B). Figure 5.4 C shows the MSOT intensities given by the background, the 
unlabelled cells used as negative control and the labelled cells. It is worth mentioning 
that the background and the control have equivalent intensities. The signal recorded 
by labelled cells is four times higher than the ones in the control and in the 
background. Note that background comes from the phantom, which is made out of a 
polymer with properties that mimics biological tissue in terms of transparency and 
sound propagation.  
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Figure 5.4: A) Mode lineal reconstruction of PEG-COOH GNRs labelled 
mesenchymal cells. Cross section phantom at different wavelengths I) 690 nm II) 
730 nm III) 780nm IV) 900 nm. Colour scale from 4.4 x10
2
 to 5.8 x10
3
 MSOT units 
B) Multispectral reconstruction of PEG-COOH GNRs labelled mesenchymal 
cells. Lineal regression method was used here. Colour scale from 2.1 x10
3
 to 8.1 x10
3 
C) MSOT intensities of the multispectral reconstruction in arbitrary units of 
background, unlabelled cells used as control and PEG-COOH GNRs labelled 
mesenchymal cells. 
 
5.4.2 Imaging of ZGO-labelled cells by Luminescence Imaging 
Results obtained with cells labelled with ZGO:Cr NPs were presented and discussed 
in chapter 4. 
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5.5 In vivo Imaging after Subcutaneous injection of labelled 
cells 
5.5.1 Cells labelled with GNRs 
GNRs-labelled cells were diluted in PBS to obtain 6 million, 2 million and 1 million 
cells. 100 µ𝐿 of each sample, including 2 million unlabelled cells used as control, 
were subcutaneously injected in a CD1 mouse. The animal was irradiated with 
pulsed light ranging from 680nm to 900 nm in 5 nm wavelengths steps. Figure 5.5 is 
a good example of the main advantages of MSOT imaging: it provided functional 
imaging allowing the detection of a specific optical signature (GNRs in our case), 
and the spatial resolution was much better than classic optical-based imaging 
technologies, enabling anatomical imaging. For example, here organs such as 
kidneys and spinal cord were easily imaged.   
Multispectral analysis allowed the detection and quantification of GNR-labelled cells 
and effectively avoids the overlap between target probe and signal coming from 
endogenous absorbers in internal organs as figure 5.5 illustrates. Only the injection 
sites where labelled cells were implanted had a photoacoustic spectrum similar to our 
GNRs. Therefore, after applying the multispectral approach, the signal was localized 
in the injections sites and not in other regions such as spinal cord vessels, even they 
had strong photoacoustic signal (but at different wavelengths)  
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Figure 5.5: In vivo imaging of subcutaneously injected MSCs labelled with 
GNRs. Cross-section of the flank of the mouse showing 2 injection sites and some 
anatomical details such as left kidney and spinal cord. Colour scale from 4.5 x10
3
 to 
1.5 x10
4
 MSOT units. Background image corresponds to 900 nm. 
 
MSOT intensity is proportional to the concentration of GNRs (or number of GNRs 
per voxel). Figure 5.6 shows how the intensity in the region of interest increased on 
the positions where cells had been implanted. As expected the intensity was bigger as 
the number of cells increased. Since cell clusters had different volumes, area under 
the curve provided a better approximate estimation of the total intensity. Hence, the 1 
million cells cluster had an AUC = 16175 a.u. and the 2 million cells cluster had an 
AUC = 31045 (calculated with the integration tool in OriginPro 2016, background 
intensity was chosen to close the area to be measured). In the case of the 6 million, 
AUC was lower than one would expect (AUC = 60600). The explanation is that the 
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intensity was saturated for many voxels in this condition, thus the mean intensity was 
underestimated.  
 
Figure 5.6: A) Multispectral reconstruction of cross section of a mouse first day after 
subcutaneous injection, showing 1 Million labelled cells (I) 2 and 6 Million labelled 
cells (II). Colour scale from 4.5 x10
3
 to 1.5 x10
4
 MSOT units B) MSOT Intensity 
given in arbitrary units of the different injection sites. The intensity represents the 
mean pixel intensity of the regions of interest selected for analysis.  
 
We follow up the evolution of the different cell clusters for 19 days by MSOT 
(Figure 5.7) and bioluminescence (Figure 5.8). 3D maximum MSOT intensity 
projections provided additional information of the labelled cells distribution in the 3 
axes. Cells were monitored without problems up to 19 days with MSOT. At that time 
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intensity was still higher than background but decreased considerably. Interestingly, 
in bioluminescence imaging (Figure 5.8) it was observed an exponential growth of 
cells after 12 days. Thus, it is very likely that GNRs concentration per cell decreased 
as cell clusters grew, which was translated in a decrease in MSOT intensity. Other 
factors such as cell death and clearance of their content or GNRs aggregation in cell 
vesicles may also account for that decrease of intensity. It must be also noted that 
bioluminescence intensity, which is proportional to the expression of luciferase and 
therefore to the number of cells, was the same for control cells and GNR-labelled 
cells, which confirmed the lack of cytotoxicity of GNRs.  
 
Figure 5.7: Maximum intensity 3D projection at 7
th
, 12
th
 and 19
th
 day after 
injection. x-y planes (top row), and x-z planes (bottom row) gives an idea of the 
thickness and length of the different cell clusters. Note that black regions correspond 
to regions of the flank without implanted cells that were not imaged for time reasons.  
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Figure 5.8: Bioluminescence imaging of different number of cells injected 
subcutaneously. A) Optical imaging pictures signal expressed in radiance 
(photons/sec/cm
2
/sr) of 2 million unlabelled cells (top left flank), 1 Million cells (top 
right flank), 2  Million labelled cells (bottom left flank) and 6 million labelled cells 
(bottom right flank). Colour scale from 4.28 × 10
6
 to 6.55 × 10
7
 p/sec/cm
2
/sr B) 
Luminescence intensity increase with time.  
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5.5.2 Cells labelled with GNRs and ZGO 
For studying the effect of the dual labelling in vivo 7.5 × 10
5  
cells were 
subcutaneously injected at four different positions into the flank: A control (i.e. 
unlabelled cells) was injected into the top left flank, cells labelled with ZGO:Cr into 
the top right, GNRs-labelled cells into the bottom left and cells labelled with ZGO:Cr 
and GNRs into the bottom right. Mouse was imaged by MSOT and optical imaging 
(IVIS Spectrum System) 3 hours after injection  
5.5.2.1 Optical Imaging: Persistent Luminescence Imaging and BLI 
After injection of labelled cells, the whole mouse was irradiated with a white LED 
lamp for 5 minutes before the mouse was set in the imaging chamber and 3 
sequential images acquired for 2 minutes each (Figure 5.9 left).  As expected, signal 
was observed only in the two sites where cells contained ZGO:Cr NPs. These sites 
correspond to the ZGO:Cr labelled cells and dual labelling. As seen for in vitro 
studies (Chapter 4), the presence of GNRs in the dual labelled cells had an effect in 
decreasing the intensity of the luminescent signal. As explained, this was most likely 
due to reabsorption of the light emitted by GNRs. In addition, the decay in intensity 
with time of ZGO-labelled cells is in agreement with what was observed with NPs in 
solution. This is a clear prove that ZGO:Cr NPs preserve their optical properties after 
cell uptake and subsequent subcutaneous injection of labelled cells.  
To confirm viability of cells labelled with the different strategy, the mouse was also 
imaged with BLI (Figure 5.9 right). As explained before, chemiluminenscence 
resulting from the biochemical reaction between luciferase (expressed by the cell 
line) and its natural substrate luciferin is directly proportional to the number of living 
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cells. As expected from our previous in vitro studies, viability was not compromised 
with any of the treatments.  
 
Figure 5.9: Optical Imaging of a whole mouse injected with MSCs labelled with 
3 different strategies. Left picture shows the persistent luminescent imaging of the 
same animal measured at different time points after LED light activation. Right 
picture shows the bioluminescence imaging of the same mouse after Luciferine 
injection. Colour scale from 3.33 × 10
3
 to 2.37 × 10
4
 p/sec/cm
2
/sr (left) and from 
1.87 × 10
6
 to 3.26 × 10
7
 p/sec/cm
2
/sr. 
 
ROI PL Intensity in Total Flux 
(p/sec) 
ZGO-labelled cells 1.22 × 10
5
 
ZGO & GNRs-labelled cells 5.07 × 10
4
 
Background 2.23 × 10
4
 
 
Table 5.1: PL intensities of the different region of interests (ROIs) expressed in 
total flux (p/s) 
5.5.2.2 Photoacoustic Imaging 
MSOT was measured 30 min after the subcutaneous injection of cells. The whole 
mouse flank was scanned longitudinally with 1 mm steps and a wavelength range 
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between 660 and 1100 nm for every step. Water tank of the instrument was filled 
with heavy water to minimize absorption at longer wavelengths. As explained above, 
MSOT relies on the ultrasounds produced after absorption of light pulses. In 
addition, spectral information of the images can be achieved by processing the 
information of the images obtained at the different wavelengths. For that purpose, 
different algorithms can be used to find the components of interest in MSOT images. 
Here we used 2 of them which are available in the software provided by MSOT 
manufacturer (iThera viewMSOT v6.2). The first one is the linear regression 
algorithm which takes into account changes on the intensity at the different 
wavelengths. Therefore, it emphasises the increases on intensity respect to the 
background. On the other hand, the guided ICA gives more value to the fitting 
spectral information of a pixel with a known spectrum. Normally, linear regression 
works better with high absorbance contrast agents whilst guided ICA works better 
with slight changes in intensity produced by a known spectrum. In our case, the 
optical properties were greatly preserved for cells labelled with GNRs and ZGO, 
whilst plasmon coupling and consequently change in the optical properties occurred 
for cells labelled only with GNRs as we have explained on chapter 4. Therefore, 
guided ICA resolved better the condition where spectrum was preserved. On the 
other hand, both conditions were resolved when linear regression was applied due to 
the large increase on photoacoustic intensity in both cases (Figure 5.10). Obviously, 
conditions without GNRs (i.e. control cells and ZGO-labelled cells) did not produce 
any MSOT signal. GNR-labelled cells were injected into the bottom left of the 
mouse flank and GNR+ZGO:Cr NPs-labelled cells into the bottom right of the 
mouse flank. Figure 5.10 shows a cross-section of the part of the flank where cells 
were injected (top row) and maximum intensity projection of the whole flank 
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(bottom row). Left column shows the analysis after applying a linear regression 
algorithm for multispectral processing, whilst on the right the algorithm used is 
guided ICA.  
 
 
 Figure 5.10: MSOT imaging of a mouse after subcutaneous injection of MSCs. 
Only cells with GNRs produced a MSOT signal. The differences between 
multispectral reconstructions algorithms are observed here. Colour scales are 1.3 
x10
5
 to 9.9 x 10
5
 for linear regression and 1.8 to 17 for guided ICA. Note that this 
units are arbitrarily generated after resolving the algorithms and they do not have any 
physical value.  
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5.6. Systemic biodistribution of labelled cells  
MSCs were incubated with NPs for 24 hours (2mg ZGO:Cr, GNRs at O.D. = 4.8 and 
a mixture of both NPs). 1.5 million labelled cells were injected via intracardiac 
injection. Mice were imaged 3 hours after injection. Contrarily to subcutaneous 
injection of cells, where cells were localised in the injection point, cell distribution 
after systemic administration was much broader, which made it extremely 
challenging to follow. It must be noted here that cells were administered via 
ultrasound-guided intracardiac (IC) injection into the left ventricle. Left ventricle 
administration was chosen for cells to enter the arterial circulation rather than the 
venous. This allows cells to pass through all organs before returning to the right 
ventricle and subsequently lungs, where they become sequestered in the pulmonary 
microvasculature. 
35,36
  
The imaging routine we used here was as follows: MSOT scan before IC injection, 
IC injection of cells, MSOT scan after injection of cells, illumination of the animal 
with a LED light, IVIS imaging, intraperitoneal administration of D-luciferin, 15 min 
waiting, IVIS imaging. 
As we have shown in another work, cells accumulate preferentially in brain 
capillaries, kidneys, and spinal cord after intracardiac injection.
17
 Thus, we will focus 
on these regions to show our results. Similar cell distribution after IC injection has 
also been reported previously by other groups using different bioimaging 
techniques.
37
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5.6.1 Photoacoustic imaging. 
5.6.1.1 GNRs labelled cells after systemic administration  
As we explained above, optical signature of GNRs was not preserved for this 
condition. Therefore, the best multispectral approach to try to detect cells labelled 
only with GNRs was linear regression. Unfortunately, no differences were observed 
before and after injection of GNR-labelled cells (Figure 5.11). We show here only 
the kidneys region, but same analysis thorough the animal did not give any 
significant increase in any region respect to the same animal before injection of cells. 
This was not surprising since we have already seen the negative effects of GNRs 
packing in cell vesicles had on their optical properties. Moreover, cells were 
expected to have a broad distribution after systemic administration. Therefore a more 
sensitive approach would have been required for detection. A very different scenario 
occurred when GNRs were co-incubated with ZGO NPs, we have seen in the 
previous chapter that optical properties of GNRs were maintained in this condition 
thanks to the physical separation of GNRs facilitated by ZGO NPs. Results are 
exposed in the next section  
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Figure 5.11: MSOT imaging following systemic administration of GNR labelled 
cells. Scans taken before and after injection of 1.5 × 10
6
 labelled-MSCs are shown. 
Guided ICA multispectral reconstruction was applied. Colour scale from 0 to 6.2 
x10
5
 MSOT units.  Unfortunately, cells could not be monitored using this strategy.  
 
5.6.1.2 GNRs + ZGO labelled cells after systemic administration  
A guided ICA multispectral reconstruction was applied here. We have observed that 
when spectrum is preserved, this approach is able to fit slight changes of 
photoacoustic intensity fitting with the spectrum of interest, which makes it more 
suitable when great sensitivity is required, as it is the case due to the broad 
distribution of cells. In addition, a pre-scan of the animal before receiving the cells 
was performed to use it as a kind of a baseline to discard false positives, i.e. regions 
with an endogenous absorption similar to our GNRs.  
This was observed, for example, in the region marked with a white circle on Figure 
5.12. A MSOT signal was detected after IC injection, but it was also present before 
IC injection, which indicates a false positive. This region corresponds to the 
intestines, we noticed in previous experiments that food contained some pigments 
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which resulted in an increase of the signal in similar regions of the spectra than the 
GNRs used here. Note also that regions with high photoacoustic intensity such as the 
spleen do not produce any signal after multispectral processing since its optical 
spectra is quite different to our GNRs. This fact is illustrative of the importance of a 
multispectral approach to gain sensitivity in molecular imaging. 
Taking into account the increase of signal that was seen only after IC injection, we 
were able to clearly detect cells in kidneys and in the spinal cord, and a slight 
increase in the brain region, which is indicative of cells being present there. As we 
explained above, lungs cannot be imaged with techniques based on photoacoustics. It 
is also observed in this experiment, that MSOT enabled localisation of cells with a 
much better spatial resolution than bioluminescence, enabling sub-organ localisation, 
which made possible to precisely localise signals in certain regions such as spinal 
cord, which would not be possible with fluorescence or bioluminescence imaging.  
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Figure 5.12: MSOT imaging following systemic administration of GNR & ZGO-
labelled cells. Cross-section images of relevant areas before and after intracardiac 
administration of cells. Cross-section of the head is shown in the top row, whilst 
cross-section of the abdominal region where kidneys are located is shown in the 
bottom row. Guided ICA reconstruction is applied. Colour scale from 1.04 to 8.05 
MSOT units.   
 
Distribution of cells could not be determined when GNRs absorption band was much 
broader and less intense due to the strong plasmon coupling produced when cells 
were labelled only with GNRs (Fig 5.11). This was an interesting observation for us. 
ZGO:Cr NPs are more abundant than GNRs in cell’s endosomes, enabling those 
GNRs to be well separated and consequently, no plasmon coupling was observed, 
increasing the efficiency of photoacoustic detection. This means that combining 
GNRs with an excess of other nanomaterials that do not have absorption in the same 
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region is a good strategy to avoid the loss of optical properties following 
agglomeration inside cell endosomes and therefore to maximize sensitivity for 
optical detection. We also reported in another work that silica coating is very 
efficient in maintaining gold cores separated enough to avoid plasmon coupling 
inside endosomes
38
. However, one may find it not feasible for some applications 
(e.g. when GNRs functionalised with a specific molecule are needed) so combination 
with inert, transparent NPs would be an alternative approach to preserve GNRs 
optical signature in these cases.  We used here ZGO:Cr, but other nanomaterials such 
as silica, TiO2, etc. could be employed for this purpose.  
5.6.2 Optical imaging of ZGO labelled cells 
1.5 × 10
6
 MSCs labelled with 2 mg/mL of ZGO:Cr were injected systemically as 
explained above. Imaging measurement were performed 3 hours after the injection. 
As a control, an untreated mouse (i.e. no injection) was exposed to the same 
experimental condition as the treated one with labelled cells (Figure 5.13). Images 
were taken before and after excitation with LED light of the whole animal for 5 
minutes. The images showed a signal in the head in both animals. Moreover, there is 
no clear difference between the control and the treated animal. This reveals that this 
signal was not coming from the ZGOs but from other source that was activated by 
light as well. Although luminescence background is less known than auto-
fluorescence, it is equally relevant to avoid misinterpretations of imaging data. This 
spontaneous luminescence background has previously been related to animal diet.
39
  
The authors of this work systematically studied the spontaneous luminescence of 
food pellets and of Nu/Nu mice after light exposure. They concluded that the 
background was very likely to be due to the persistent luminescence of some 
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molecules present in the food. They finally advise that in order to minimize problems 
related to spontaneous luminescence, food need to be studied before animal 
experiments and choose the type of food with a lower PL.
39
   It was impossible for us 
to do a last minute change of diet because a modification of the project licence would 
have been required and approval from UK home office granted. Thus, we were 
forced to leave this test for a future experiment.  
Note also that condition of ZGO + GNRs would have resulted in lower signal due to 
the inner-filter effect of GNRs. 
 
Figure 5.13 In vivo optical imaging of mouse injected with ZGO-labelled cells. 
Images were acquired for 2 minutes before and after excitation with a white LED 
lamp for 5 minutes 3 hours after intra-cardiac injection of 1.5 × 10
6
  labelled cells. 
Colour scale from 6.93 × 10
3
 to 2.20 × 10
4
 p/sec/cm
2
/sr.   
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5.5.2.1 Ex vivo Persistent luminescence imaging of dual labelled cells 
The ex vivo biodistrubution of dual-labelled cells was assessed by imaging the 
persistent luminescence of main organs (i.e. liver, lungs brain, spleen, heart and 
kidneys). For this, the animal was sacrificed 4 hours after injection and organs were 
fixed with PFA and left in PBS for 24 hours, allowing any residual bioluminescence 
signal from luciferase to be extinguished. The half-life of luciferase in mammalian 
cells was reported to be approximately 2 hours.
40
 Imaging of organs was performed 
before and after excitation by white LED lamp. Persistence luminescence, associated 
with ZGO:Cr NPs was found in the liver, the kidneys and the brain (Figure 5.14), 
showing that cells accumulate in these organs after IC injection. This is in agreement 
with the in vivo imaging obtained by bioluminescence and MSOT. These data show 
that ZGO:Cr NPs are suitable probes for the study of ex-vivo monitoring of labelled 
cells, which for example would enable their use as tools for ex vivo microscopy 
studies.  
 
Figure 5.14: Ex vivo PL imaging of main organs after injection of ZGO&GNRs 
labelled cells. Main organs were extracted and imaged for 2 minutes before and after 
exposure to a white LED lamp for 5 minutes. Note that organs after LED exposure 
were closer between them to be uniformly irradiated with our LED source. Colour 
scale is from 1.19 × 10
4
 to 5.37 × 10
4
 p/sec/cm
2
/sr.    
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5.6.3 Bioluminescence Imaging (BLI) 
Bioluminescence was used to validate data obtained by MSOT and persistent 
luminescence.  1.5 × 10
6 
cells were injected via intracardiac injection and 
intraperitoneal injection of D-luciferine was administrated 3 hours later. Whole body 
imaging was performed 15 minutes after luciferine injection. The results confirmed 
that MSCs accumulate in the brain region, kidneys and liver (Figure 5.15), in good 
agreement with the MSOT in vivo imaging and persistent luminescence ex vivo 
imaging.   
 
Figure 5.15: In vivo cell tracking of cells labelled with GNRs + ZGO by BLI. 
Results are in agreement with cell accumulation in the brain region, kidneys, spinal 
cord and liver. Colour scale is from 9.85 × 10
5
 to 2.30 × 10
6
 p/sec/cm
2
/sr. 
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5.7 Conclusions 
MSCs labelled with PEG-COOH-GNRs, DMSA-ZGO and co-labelled cells were in 
vivo imaged after subcutaneous and systemic injection. First, the dilution effect was 
studied with GNRs-labelled cells after subcutaneous injection. The in vivo 
experiments showed that cells were detectable for up to 19 days. Conversely, 
luciferase-based bioluminescence imaging (BLI) intensity increased with the number 
of cells indicating that this approach is more appropriate if long-term tumour 
monitoring is required. In addition, down to 7.5× 10
5 
GNRs, ZGO and co-labelled 
cells were imaged by means of MSOT and IVIS spectrum system and all of them 
resulted in an obvious signal. ZGO NPs were “recharged” inside animals by 
exposure to a white LED lamp and NIR-light emitted by the lasted for up to 5 min. 
As expected, the persistent luminescence signal obtained in the presence of GNRs 
(i.e. co-labelled cells) was lower than when ZGO NPs were labelled independently. 
This decrease of signal intensity is probably due to absorption of the emitted light by 
GNRs.  
Imaging MSCs after systemic injection was more complicated since cells were 
distributed along the organism. Detection of persistent luminescence signal coming 
from ZGO NPs was not possible. This was partially due to the presence of noise 
from certain food components in the animal’s diet. Therefore, persistent 
luminescence could be only detected in ex vivo experiments. Optical imaging 
measurements of the main organs showed that cells were located in kidneys, liver 
and brain capillaries. In addition, in vivo BLI of systemically injected cells was 
successfully performed. In this case, bioluminescence offered great sensitivity for 
cell tracking, showing accumulation of cells in kidneys, brain capillaries and liver. 
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This was in good agreement with the ex vivo imaging. Since cell viability can be 
monitored by this method, validation of imaging results obtained using NPs was 
possible.  
MSOT imaging was also conducted to track cells after systemic injection. Optical 
properties of GNRs were improved when the gold cores are separated by co-labelling 
with ZGOs (see chapter 4, section 4.5.1). For this reason, MSOT signal was higher 
when cells were co-labelled with both types of NPs than when they were labelled 
only with GNRs, as subcutaneous experiments showed. Consequently, only co-
labelled cells could be tracked after intra-cardiac injection showing that cells 
accumulated mainly in kidneys, spinal cord and brain capillaries. 
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Conclusions and Future work 
6.1 Conclusion 
GNRs were synthesized by the seed-mediated growth method and the conditions 
were adjusted to obtain GNRs with an aspect ratio (A.R.) ≈3. The LSPR peak 
position obtained is around 750 nm, ideal for in vivo MSOT imaging since overlaps 
with the NIR window. As synthesized GNRs were cytotoxic due to the surfactant 
used in the synthesis (CTAB), which is toxic for the cells at the concentration 
required to stabilize the GNRs. CTAB was exchanged with poly ethylene glycol 
(PEG) in order to obtain biocompatible GNRs. In addition, PEGylation of GNRs also 
resulted in an improvement of colloidal stability. Indeed, PEG-GNRs were stable 
under the harsh conditions of cell culture medium, with high ionic strength and 
presence of a variety of molecules including proteins, sugars, etc.  A two-step 
method was developed to modify the surface of GNRs with SH-PEG-COOH. It 
involved a controlled agglomeration of GNRs in acidic pH to maximize loading, 
followed by a second step under basic conditions to recover stability. This method 
allowed the surface modification of the positive CTAB-GNRs with a negative ligand, 
while solving irreproducibility problems from batch to batch related to the small 
changes in the purification of CTAB excess and improving ligand loading. SH-PEG-
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COOH conferred electrostatic stability to the NPs due to the negative charge of 
carboxylic acids at physiologic pH. In addition, carboxylic acids can be used as 
scaffolds for covalent binding of biomolecules or other structures. The conjugation 
with BSA and TAT peptide was achieved via EDAC/NHS coupling chemistry to 
form an amide bond between the carboxylic acids on the surface of GNRs and 
amines in the biomolecules. Colloidal stability was guaranteed thorough the process 
by controlling the number of carboxylic acids to be activated. The main advantage of 
this method is the versatility since composites can be built with any structure 
containing amines, including other contrast agents to form a multi-modal probe.  
ZGO NPs were synthesized by a single step hydrothermal approach. These NPs 
could be “recharged” even inside animals by exposure to a white LED lamp. NIR-
light emitted by the contrast agents could be detected for up to 5 min. This enabled 
an imaging time window, i.e. excitation and emission measurement can be separated 
in time, reducing the tissue auto-fluorescence and ultimately improving signal-to-
noise ratio. Surface of Cr:ZGO was modified with DMSA, achieving a stable 
coordination bound. DMSA has been used to modify the surface of different NP 
(GNPs, silver nanoparticles, iron oxide, zinc oxide nanorod arrays and CdSe 
quantum dots). However, to the best of our knowledge, DMSA has not previously 
been used to functionalize LPNPs. 
Negative surface charge of PEG-COOH-GNRs enabled protein adsorption which 
increased the colloidal stability in physiological media and favoured uptake by cells, 
in contrast to its uncharged counterpart. TAT and BSA-GNRs bioconjugates were 
studied. While the different bioconjugates exhibited different surface charge in 
aqueous solution, after incubation with cell culture media, the average surface charge 
shifted to negative in both cases.  Adsorption of proteins on the surface of the NPs is 
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the responsible for this. Therefore, to fully understand the NP-cell membrane 
interactions, physicochemical properties of NPs need to be assessed before and after 
exposure to physiological environments. Cell uptake of ZGO was significantly 
increased while maintaining colloidal stability by the conjugation to DMSA. 
MSCs were imaged after subcutaneous and systemic injection. For this a multimodal 
approach was chosen, the high resolution and penetration depth of MSOT were 
combined with the sensitivity and whole-body imaging that pure optical methods 
offer. Cells were co-labelled with PEG-COOH-GNRs and DMSA-ZGO. 7.5× 10
5 
labelled cells were imaged by MSOT and IVIS spectrum system after subcutaneous 
injection. All conditions tried, i.e. GNRs, ZGO and co-labelled cells, resulted in an 
obvious signal recorded by both instruments. Persistent luminescence signal recorded 
with co-labelled cells was lower than when ZGO NPs were labelled independently. 
This is expected from the mixture of two optically active materials that can interfere 
with each other optical properties. We believe that this decrease in intensity is very 
likely to be due to absorption of emitted light by GNRs. GNRs with other optical 
signature would minimise this effect, however they might not be as optimal for 
MSOT imaging.  
Tracking systemically injected MSCs was far more challenging since cells were 
distributed along the organism. Persistent luminescence signal of labelled cells was 
undetectable since the intensity of the background was higher than the luminescent 
intensity of ZGOs. Certain food components have been reported to be responsible for 
this unexpected luminescence background. Persistent luminescence was restricted to 
ex vivo imaging. The ex vivo optical imaging of the main organs revealed that cells 
were accumulated in kidneys, liver and brain capillaries while lungs and spleen and 
heart did not show a significant signal. In addition, co-labelled cells were detected by 
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MSOT showing that MSCs accumulated mainly in kidneys, spinal cord and brain 
capillaries. Interestingly, co-labelling preformed much better than GNR-labelled 
cells in MSOT imaging. Confinement of GNRs in endosomes caused packing of 
GNRs, which was translated in plasmon coupling and reduction of absorbance 
intensity. Consequently MSOT intensity was reduced since the technique relies in the 
absorption of light by probes. Moreover, the flattening of the LSPR band made more 
difficult the spectral recognition in the presence of endogenous absorbers. When both 
NPs were incubated simultaneously, ZGOs physically separated GNRs improving 
like this the optical properties of GNRs in cells (GNRs were physically separated by 
the more abundant ZGO NPs). These results highlight the importance of checking 
optical properties of cells after labelling when the application relies on the SPR of 
GNRs.  
For our experiments, we used cells previously modified to express luciferase, which 
allowed bioluminescence imaging of injected cells. Bioluminescence offers great 
sensitivity for cell tracking. In addition, cell viability can be monitored. Therefore, it 
is a good method to validate the results obtained using NPs as contrast agents. 
Results obtained by BLI showed that cells accumulated in liver, kidneys and brain 
capillaries being consistent with the PL ex vivo imaging and the MSOT in vivo 
imaging. In addition, approaches based on genetic reporters such as luciferase do not 
suffer from signal dilution after cell division like direct method. While GNRs-
labelled cells could only be imaged for up to 19 days, BLI intensity increased with 
the number of cells. Therefore, this approach would be needed if long-term tumour 
monitoring was required.  
MSOT imaging provided a much higher resolution for in vivo imaging than other 
optical-based methods. However, some organs such as lungs and stomach cannot be 
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imaged by MSOT. Also, presence of endogenous absorbers with similar optical 
profile could potentially lead to misinterpretations of results. Taking a multimodal 
approach with a complementary imaging method such as optical imaging helps to 
overcome these drawbacks. BLI is a well-studied approach, providing less spatial 
resolution than MSOT, but very good sensitivity. However, this approach cannot be 
used always. For instance, primary cells have very low transfection efficiency. These 
cells are a niche for PLNPs. In addition, BLI is obviously restricted to preclinical 
models due to the need to genetically modify the cells. Thus, although it is still in the 
early stages, the emerging field of PLNPs has a huge potential to extend the use of 
luminescence for in vivo imaging.  
6.2 Future work 
 The strategy used for binding molecules to PEG-COOH-GNRs can be used with any 
structure that has amines available. Therefore, this can be used to fabricate bimodal 
probes with dyes or fluorescent particles. In addition, the binding of ZGO to GNRs 
could be improved if problems with colloidal stability of APTES-ZGO were solved. 
However, our calculations indicate that we need several orders of magnitude more 
ZGO NPs than GNRs. Therefore, it is likely that the bimodal probe would not work 
for cell labelling while if the bimodal probe was needed for direct injection of probes 
on the blood torrent, this would be the way forward.  
Our observation regarding the effect that DMSA ligand on ZGO surface might have 
on the enhancement of PL intensity respect to as synthesized ZGO needs to be 
confirmed. For this monitoring the intensity of luminescence with different number 
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of DMSA molecules would provide more information. Ligand with different 
polarities could also be used to determine if polarity was the reason of this effect. 
Luminescent background in mouse observed in our imaging with ZGO might be 
reduced if animals are fed with appropriate food for persistent luminescence 
measurements. This might allow imaging of ZGO-labelled cells after systemic 
injection too. For this, the project licence for animal experiments would need to be 
updated. To minimize the absorption of PL light by GNRs, GNRs absorbing at 
longer wavelengths in the NIR, around 850 nm, could be used to reduce the overlap 
of absorption. Use of cells modified to express luciferase allowed the validation of 
our results with bioluminescence imaging, which is an established method for 
preclinical imaging. Our system would make possible further validations and 
analysis. For example, histology exploration would be possible since gold 
nanoparticles offers good contrast in microscopy techniques such as photothermal 
microscopy. Moreover, luminescence signal of ZGO could be used also in confocal 
microscopy with the appropriate filters, getting rid of autofluorescence in tissues. 
Obviously, the metallic nature of both NPs would add contrast to electronic 
microscopy or would enable quantification by means of ICP-MS. In terms of 
multimodal imaging, other techniques such as X-ray micro-CT could be added for 
further exploration. Gold is a high atomic number element and therefore shows a 
good contrast for X-Ray based imaging. This technique offers a good resolution and 
no penetration depth limitations.  
Finally, the use of long persistence luminescence nanoparticles for biological 
applications is an emerging field with many potential applications beyond preclinical 
imaging such as bio-detection, image guided surgery, labels for electronic 
microscopy and confocal microscopy, and theranostics amongst others. Advances in 
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synthetic routes, functionalization strategies, better understanding on how 
luminescence can be tuned, or study cell-NPs interactions might therefore contribute 
to extend their uses.   
 
 
